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The facultative intracellular pathogen L. monocytogenes has acquired a versatile arsenal of 
adaptor proteins. It uses these proteins to invade and undermine the host immune surveillance 
system, as well as to survive and propagate within the host cell. Our understanding of how 
L. monocytogenes infects cells points towards an interplay between bacterial proteins and human 
host factors. It has become apparent that this interplay is critical for the establishment and spread 
of infection. Here we describe a high throughput screening approach to assay for potential 
human host factors involved in L. monocytogenes infection. In this methodology, we applied a 
high-density siRNA array comprising of the kinome, phosphatome, ubiquitome and protease 
encoding human genes that enabled rapid parallel screening for human host factors through 
reverse transfection into overlaid HeLa cells. The siRNA transfected HeLa cells were exposed to 
L. monocytogenes expressing the green fluorescent protein. The high content screen comprised a 
total of 15 replicate screens or 47, 250 individual siRNA experiments. Using a combination of 
image-based analysis and the data-mining tool of Principal Component Analysis, genes whose 
silencing visually impaired or enhanced bacteria invasion/proliferation were selected as 
candidate genes. The 65 strongest genes were subjected to a secondary screening for validation. 
Among the 15 confirmed hits, we recognized some cellular membrane proteins that might 
function as cell receptors for bacteria entry and others that may be related to calcium release 
triggered by bacteria during cell invasion. In addition, we identified a transcription factor bromo 
adjacent homology domain-containing 1 (BAHD1) protein, whose interplay with the bacterial 
virulence factor LntA has recently been shown to modulate IFN-!-mediated immune response to 
control bacterial colonization of the host cell. Also, we identified the inositol polyphosphate-5-
phosphatase (INPP5B) that may regulate bacterial internalization by modulating actin dynamics 
at bacterial internalization sites as shown with oculocerebrorenal syndrome of Lowe (OCRL), 
whose OCRL gene shares an identical sequence and overlapping enzyme activities with 
INPP5B. We also identified the large tumor suppressor kinase 2 (LATS2) that may play a 
potential role in bacterial colonization by modulating the expression of the host E-cad receptor 
gene. This study represents a significant step toward unveiling the key molecular requirements 
for host cell invasion and undoubtedly provides an avenue of new therapeutic drugs against 
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Infectious diseases continue to be a leading cause of childhood and adult 
morbidity and mortality, with greater than 14 million deaths per year (Haghighat and 
Seveau 2010). Over 90% of these deaths occur in developing countries, where 
disadvantaged communities are predominately affected. The current strategy for 
managing infectious diseases has mainly focused on targeting processes or enzymes 
unique to pathogens with specific drugs to eradicate the causative pathogen. The 
advantage of this approach is the minimal toxic side effects to the host due to 
evolutionary divergence between host and pathogen. However, despite success stories, a 
serious disadvantage of this pathogen-directed strategy has been the development of 
drug resistance, resulting in the re-emergence of infectious diseases notably tuberculosis. 
This has become an increasingly serious problem, necessitating the development of 
more effective vaccines and identification of new drug targets that can be used against 
resistant or mutated microbial pathogens. The goal of this thesis was to screen for and 
identify human host factors involved in L. monocytogenes infection. This was 
approached using a combination of visual cell based assays with genome wide RNAi 
screening.  
Understanding disease and the processes of disease has been advanced through 
genome scaled methods. Genome wide RNA-interference is one such technology that 
has emerged as a potent means to identify genes involved in disease through their 
function. As an example, this has been applied to defined human host factors required 
for HIV infection in human cells (Brass, Dykxhoorn et al. 2008; Goff 2008; König, 
Zhou et al. 2008; Zhou, Xu et al. 2008). Current RNAi technology for capturing such 
interactions between host and pathogens is limited to large-scale laboratories and 
expensive, cumbersome technology.  A consequence of this is that RNAi screening is 
costly and limited to researchers in the developed world. The central goal of this project 
was to apply a novel miniaturized technology to genome scale screening that will exceed 
these limitations. 
The miniaturization processes implemented in this research involved the 
development of a high-density siRNA arrays. A printer was used to produce a 
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high-density array of siRNAs contained in an encapsulation mixture on to the surface of 
a cover glass or optical wafer. These arrays comprised of optically addressable spots that 
contain a pool of siRNA targeting one gene. Cells were then seeded on to the surface. In 
the case of HeLa cells, the cells adhered over the entire surface of the slide. However, 
only cells in contact with the spotted siRNA were transfected. In these spots, a given 
gene is robustly silenced 48 hours post transfection. Since the arrays were printed using 
fractional amounts of siRNA, this enabled both mass production and very efficient 
screening. A single array covered the entire RNAi complement of the kinome, 
phosphatome, ubiquitome and protease encoding genome and was screened by imaging 
individual siRNA experiments. Because of the inherent miniaturization on the arrays, 
3000 experiments were imaged and screened faster than conventional technologies 
allow: in less than 1 hour using an automated confocal microscope. This screen occurs in 
just one plate compared to the 30 or more required with conventional methods, reducing 
the time for a single screen from two weeks to an hour. Since the position of each 
siRNA was known, as if they were wells, observed phenotypic changes could be 
attributed to specific siRNAs. 
The research work presented set out to exploit the miniaturized high throughput 
screening technology to find human host factors involved in Listeria infection. To 






Intracellular pathogens remain a serious threat to quality of life. They are 
responsible for a vast number of infectious diseases, morbidity and mortality worldwide 
(Vannberg, Chapman et al. 2011; Thi, Lambertz et al. 2012). These pathogens 
encompass bacterial, viral and eukaryotic parasite infections that enable reproduction by 
co-opting the host cell’s endogenous pathways. The impact of these pathogens is 
widespread, for despite their relatively small genome component compared to humans, 
they have evolved sophisticated mechanisms to counter and evade immune surveillance. 
Several bacterial pathogens share this capacity to evade immune responses, such as 
microorganisms from the genus Listeria. 
1.2 Genus Listeria 
1.2.1 Taxonomy of the genus Listeria 
For several years, the genus Listeria generic taxonomy remained unclear. The 
organism was originally classified based on the sixth and seven editions of Bergey's 
manual of Determinative Biotechnology in the family Corynebacteriaceae (Rocourt and 
Mollaret 1988). However, based on results obtained from many biochemical studies, 
DNA homology, numerical taxonomic and 16S rRNA sequencing homology, organisms 
under this genus are now classified into the domain: bacteria, kingdom: eubacteria, 
division: firmicutes, class: Bacilli, order: bacillales, family: Listeriaceae and genus: 
Listeria. 
The genus Listeria currently includes six species: L. monocytogenes, L. ivanovii, 
L. innocua, L. seeligeri, L. welshimeri, and L. grayi (Vazquez-Boland, Kuhn et al. 2001). 
However, recent studies have revealed a new species (L. marthii) as a member belonging 
to the genus Listeria (Graves, Helsel et al. 2010). Despite their relative taxonomical 
similarities, only two species of the genus Listeria have been significantly associated 
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with severe illnesses in both humans and animals: L. monocytogenes and L. ivanovii 
(Hain, Chatterjee et al. 2007; AbdEl-Malek, Ali et al. 2010). 
Reports suggest organisms under this genus descended from a common ancestor. 
Phylogenetic studies, based on the 16S and 23S rRNA genes and the prs, iap, vclA, vclB, 
and ldh genes reveals genes required for intracellular survival, transcription factors, and 
LPXTG- and LRR-containing proteins and 55 genes involved in carbohydrate transport 
and metabolism that were deleted from the nonpathogenic species over time (Hain, 
Steinweg et al. 2006). The latter statement has been supported through characterization 
of the genetic unit containing the virulence genes cluster of Listeria species. The 
virulence genes (prfA, plcA, hly, mpl, actA and plcB) required for its intracellular life 
cycle are physically linked in a 9-kb chromosomal island called the PrfA-dependent 
virulence island or the Listeria pathogenicity island 1 (LIPI-1). 
The LIPI-1 chromosomal fragment is found in two of the six Listeria species: 
L. monocytogenes and L. ivanovii and are flanked by two housekeeping genes prs and 
Idh, both encoding for the enzymes phosphoribosyl-pyrophosphate synthase and lactate 
dehydrogenase respectively (Schmid, Ng et al. 2005). In the plcB-Idh intergenic region, 
one virulence cluster locus (vcl) or open reading frame (orf), orfB is found in all six 
Listeria species, indicating that the insertion point of the virulence island is between the 
prs and orfB loci. Another orf, present in all species, with the exception of L. grayi, is 
the orfA. Other genes potentially controlled by the master virulence regulator PrfA 
(positive regulatory factor A) include: dplcB, orfD, orfE, orfK, orfL, orfX, and orfZ 
while others such as the orfC, orfF1, orfF2, orfG1, and orfG2 of the L. seeligeri and 
L. grayi are not controlled by the PrfA (Vazquez-Boland, Kuhn et al. 2001). The fact 
that the LIPI-1 fragment is located at the same position within members of the same 
phylogenetic groups (L. monocytogenes and L. ivanovii) but missing in other members 
of the same groups, clearly indicates that LIPI-1 has been acquired by or evolved in a 
common ancestor of the present Listeria species and has been deleted from the 




Figure 1.1: Transcriptional organization of the virulence gene cluster locus in the six Listeria 
species. 
The key genes (prfA, plcA, hly, mpl, actA, and plcB: colour coded grey) are responsible for intracellular 
parasitism and are physically linked in a 9-kb chromosomal island: the Listeria pathogenicity island 
1(LIPI-1). This figure was adapted from Schmid, M. W. et al., 2005; Vazquez-Boland, J. A. et al., 2001 
with modification. 
Generally, organisms in this genus express close morphological and biological 
similarities but varied pathogenicity (Vazquez-Boland, Dominguez-Bernal et al. 2001). 
Therefore, it is important that pathogenic and nonpathogenic Listeria species are 
adequately differentiated. Several molecular and phenotypic (such as biochemical and 
serological tests) procedures have been implemented for the identification and 
differentiation of Listeria species. Some of which include: multiplexed PCR (Bubert, 
Hein et al. 1999 ; Liu 2006), hemolysis, acid production from D-xylose, L-rhamnose, 
alpha methyl-D-mannoside, and mannitol tests, as depicted in Table 1 (Bille, Catimel et 







Table 1.1: Identification of Listeria species by biochemical tests and their virulence. 
1.2.2 History of the genus Listeria  
The origin of the discovery of these intracellular microorganisms dates back a 
century. In 1911 the Swedish microbiologist G. Hülphers isolated a bacterium causing 
liver necrosis in the rabbit and because of its characteristic affinity to the liver, the 
organism was named Bacillus hepatitis (Hulphers 1911). The first officially documented 
record of the pathogen was when Murray et al. isolated a 1–2 µm long, 0.5 µm wide, 
round-ended Gram-positive rod as the etiological agent of a septicemic disease affecting 
rabbits and guinea pigs in their laboratory in Cambridge, United Kingdom (Murray, 
Webb et al. 1926). This organism was given the name Bacterium monocytogenes based 
on the potent monocytosis-producing activity this microorganism had in rabbits and 
guinea pigs. In 1927, Pirie isolated the same organism from a gerbil suffering from 
“Tiger River” disease. The causative intracellular pathogen isolated was named 
Listerella hepatolytica, a generic name in honour of the English pioneer of sterile 
surgery, Joseph Lister. Because the name Listerella was generally given to a group of 
slime molds in the 1906, Pirie changed the name in 1940 to Listeria monocytogenes 






1.2.3 Characterization of the genus Listeria 
The genus Listeria are a group of closely related micro-organisms with a low GC 
DNA content (36-42%) and measuring about 0.5 µm in width and 1-1.15 µm in length 
(Liu 2006). They are Gram-positive, non-spore-forming, motile (at 20-250C), catalase 
positive, rod shaped and facultative-anaerobic bacteria. These intracellular pathogens are 
ubiquitous and are generally considered to be hardy bacteria. They are exquisitely 
adaptable environmental bacteria capable of surviving and multiplying in a wide range 
of environmental temperatures (0 to 450C), high salt concentrations (10% NaCl) and at a 
broad pH range (4.5 to 9) (Hain, Chatterjee et al. 2007). Because of their ability to 
invade and proliferate under adverse environmental conditions, these bacterial pathogens 
have been isolated from a wide variety of origins including healthy individuals and 
animals, soil, water, decaying plants, meat, faeces, dairy products and food processing 
plants (Ivanek, Grohn et al. 2006). Since these micropathogens are widely distributed in 
the environment, humans and animals are likely to come in contact with the pathogens. 
Upon infection, the intracellular pathogens manipulate their way through the host 
defense mechanisms and propagate their survival within host cells. If the presence of the 
bacteria within the host is not controlled, it may lead to the severe disease state of 
listeriosis, especially in hosts with impaired immune systems. 
1.2.4 Human Listeriosis 
Listeriosis is a severe food-borne disease generally caused after consumption of 
food contaminated with bacteria from the genus Listeria (Allerberger and Wagner 
2010). Upon ingestion, the microorganism crosses the intestinal barrier and later 
disseminates from the mesenteric lymph nodes to the spleen and the liver (Figure 1.2). If 
not properly controlled by the immune surveillance system or antibiotic administration, 
the bacteria will migrate to other organs such as the brain or the placenta, resulting in 






Figure 1.2: Stages in Human listeriosis. 
Successive stages of human listeriosis affecting the different organs in humans. Adapted from Lecuit 
2007. 
The disease is generally considered to be contracted from food contaminated by 
the pathogen, although there have been reports attributing infection to other modes of 
transmission. For instance, in 1989 an outbreak of nosocomial listeriosis was reported in 
Costa Rica involving the use of contaminated mineral oil for cleaning newborn babies 
after delivery (Schuchat, Lizano et al. 1991).  
Listeriosis is generally classified into two forms: non-invasive listeriosis and 
invasive listeriosis. In non-invasive listeriosis, which generally occurs after infection of 
a healthy person, the disease is mild and causes symptoms including gastrointestinal 
illness, fever, vomiting and diarrhea. Meanwhile, invasive listeriosis can be more severe 
leading to serious complications, such as septicemia, meningitis, meningoencephalitis or 
febrile gastroenteritis and can cause stillbirths and abortions (Ramaswamy, Cresence et 
al. 2007; Cossart and Archambaud 2009). Invasive listeriosis is fairly common among 
newborn children (100 cases per million), the aged (14 cases per million), and pregnant 
women (Lecuit 2007; Poulsen and Czuprynski 2013). Also, individuals with an 
immunocompromised system, such as bone marrow transplant patients, blood-borne 
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cancer patients and those with full-blown AIDS are 20 to 40 times more vulnerable to 
the infection than a healthy individual (Patil, Nadiger et al. 2007; Ramaswamy, Cresence 
et al. 2007). 
Despite efforts by research organizations and food industries to reduce the 
incidence of the disease, infection as result of this pathogen remains a threat to human 
health. This disease has been of serious concern in most European countries as well as in 
the United States (Goulet, Jacquet et al. 2006; Goulet, Hedberg et al. 2008). For 
example, in the United States, approximately 2,500 individuals are diagnosed with 
listeriosis with an estimate of 1,520 hospitalizations and 200 to 500 related deaths each 
year (Mead, Slutsker et al. 1999; Nadon, Woodward et al. 2001; Cartwright, Jackson et 
al. 2013). Isolation and characterization of the microorganism from infected humans and 
animals indicated Listeria monocytogenes (L. monocytogenes) is the principle Listeria 
strain responsible for listeriosis. 
1.3 L. monocytogenes  
1.3.1 General life cycle of L. monocytogenes 
L. monocytogenes is an opportunistic intracellular bacterial pathogen that has 
evolved specialized adaptor molecules that interact with specific host cell receptors to 
facilitate its internalization into host cells (Braun and Cossart 2000). After 
internalization, the bacterium is transiently trapped in a tight phagosomal compartment 
before accessing its replicative niche. In this compartment, the bacteria begins recruiting 
bnactin filaments for generating an actin-“rocket” tail that it uses to propagate itself 
within the host cytoplasm then to access neighboring cells (Cossart and Lecuit 1998; 
Schuppler and Loessner 2010). Extensive studies have been conducted on several of the 
bacteria proteins (virulence factors) facilitating the intracellular life style of the 
pathogen.  
Virulence factors playing important roles during invasion and proliferation of 
L. monocytogenes have been identified (Weiglein, Goebel et al. 1997; Cossart and 
Lecuit 1998; Schuppler and Loessner 2010). These factors include: Internalins (Inl), 
hemolysin (Hly), the actin assembly-inducing protein (ActA) and the Phospholipase 
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(Plc), which are regulated by the bacteria transcriptional regulatory factor PrfA. During 
invasion, the bacteria uses bacterial surface proteins, called Inl or invasins, which exist 
in two forms, InlA and InlB, to induce its uptake into the host cell. lnlA and lnlB 
facilitate the entry of the pathogen by activating signaling pathways via interaction with 
host cell membrane-bound receptors. InIA binds the cell adhesion protein E-cadherin (E-
cad), whereas InIB binds to and activates the MetA tyrosine kinase receptor (Marino, 
Banerjee et al. 2002). These interactions lead to the internalization of the pathogen into 
the host cell phagosomal compartment (Marino, Banerjee et al. 2002). After 
internalization, the pathogen produces the endotoxin hly, which generates Listeriolysin 
O (LLO). LLO hydrolyses the phagosomal membrane to allow the bacteria to into the 
cytosol. LLO not only mediates the escape of the pathogen from the phagosome into the 
cytosol but is also required for the pathogen escaping, with the help of plc and ActA, 
from a double-membraned vacuole established during cell-to-cell spread (Pentecost, 
Otto et al. 2006).  
Figure 1.3: Invasion and intracellular life cycle of L. monocytogenes. 
The invasion and intracellular life cycle of L. monocytogenes can be grouped into 9 stages: [1] Cell 
membrane invagination, [2] Bacterial entrapment by cell phagosomal membrane, [3] Phagosomal 
membrane disintegration, [4] Freed cytoplamic bacteria, [5] Actin recruitment and replication, 6. Bacteria 
intracellular movement mediated by the actin rocket tails, [7] Cell-to-cell spread by formation of 
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listeriapods, [8] Double membrane formation, and [9] Lysis of the double membrane vacuole by LLO and 
PlcB releasing a free bacteria in the adjacent cell where the cycle is repeated. Adapted from Tilney & 
Portnoy 1989 with modifications. 
It is therefore critical to understand how this pathogen manipulates the host cell 
to induce its uptake, survival, replication and cell-to-cell migration. Beginning with host 
cell receptor binding and phagocytosis, the pathogen processes through multiple cellular 
compartments and pathways. Once inside the cell, the bacteria are protected from 
immune surveillance and upon escaping the phagosome, they hijack the cellular actin 
machinery to drive themselves into the neighboring cell (Vazquez-Boland, Kuhn et al. 
2001) as shown in Figure 1.3. 
1.3.2 L. monocytogenes host cell invasion  
The invasive intracellular bacteria L. monocytogenes has evolved a versatile 
arsenal of virulence proteins for its adhesion and internalization in a variety of host cell 
types. These virulence factors form part of a large family of proteins, the InI family. 
Also known as adhesins, they are generally characterized by proteins sharing a similar 
structural organization that includes a variable leucine-rich repeats (LRR) region at their 
amino (N)-terminal, a highly conserved inter-repeat (IR) region and a carboxylic 
(C)-terminal domain (Bonazzi, Lecuit et al. 2009). Based on their C-terminal association 
with the bacteria surface, the InI are usually classified into three different groups; InI 
covalently linked to the bacteria surface peptidoglycan by the Leu–Pro–X–Thr–Gly 
(LPXTG) motif, those that are loosely anchored to the bacteria surface via a C-terminal 
that contains repeats of 80 amino-acids carrying the Glycine-Tryptophan-rich (GW) 
dipeptide motif at their starting sequence (Jonquières, Pizarro-Cerda et al. 2001) and 
finally, the InI molecules lacking the anchoring motifs. Though several of these bacterial 
association proteins have been identified (Seveau, Pizarro-Cerda et al. 2007), InIA and 
InIB are the only two InI proteins that have been extensively studied and associated with 
L. monocytogenes adhesion and internalization within the host cells (Bierne and Cossart 
2007). Despite the structural similarities existing between the two InI molecules, they 
bind different human host cell receptors to initiate their respective invasion processes 
(Bierne and Cossart 2007). 
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1.3.3 Characterization of L. monocytogenes internalin molecules 
The first characterized InI protein whose function was associated with mediating 
L. monocytogenes anchoring and invasion of host cells was InIA (Gaillard, Berche et al. 
1991; Mengaud, Ohayon et al. 1996). InIA consists of approximately 800 amino acids 
characterized by two functional units; the N-terminal comprising in addition to the 
signaling peptide, 15 LRR units (A repeats) and the C-terminal comprising of three 
longer repeat sequences (B repeats). Also incorporated within the InI structure is a cell 
wall anchor sorting motif, the LPXTG motif and a 20 amino acid hydrophobic 
membrane (Bonazzi, Lecuit et al. 2009), Figure 1.4A. The adhesin protein is covalently 
linked to the bacterial cell envelope by the LPXTG motif through a process catalyzed by 
the enzyme sortase (Bierne, Garandeau et al. 2004). Because most human cells lack the 
E-cad receptors, InIA/E-cad mediated entry has been associated with a limited number 
of human cells, such as epithelial Caco-2 cells (Pentecost, Kumaran et al. 2010). 
InIA mediates entry by binding to its host receptor E-cad, a protein first 
identified as a receptor for InIA by running an extract of Caco-2 cells through a 
covalently linked InIA affinity column (Mengaud, Ohayon et al. 1996). E-cad is a 
calcium-dependent transmembrane glycoprotein composed of a short cytoplasmic 
component of 152 amino acids that can be subdivided into a membrane proximal 
cytoplasmic domain (MPCD) and a catenin binding domain (CBD), Figure 1.4B. The 
MPCD is important for p120 catenin binding while the CBD binds the #$-catenin 
molecules (Bossche, Malissen et al. 2012). Also incorporated in the domain structure of 
the E-cad is a transmembrane region and an extracellular component of 555 amino acids 
that consist of five tandemly repeated cadherin-motif subdomains with calcium binding 
sites (Serra and Chetty 2008; Bonazzi, Lecuit et al. 2009). They are localized to 
adherens junctions at the basolateral surface in epithelial cells and are generally involved 
in cell-to-cell interaction and recognition (Serra and Chetty 2008). The InIA binding site 
exploits the E-cad signaling pathway to propagate bacterial entry by binding onto a 
specific epitope located on the E-cad receptor. As revealed by recent studies and X-ray 
crystal structure, the InIA molecule through its LRR domain interacts with the proline 
residue in amino acid position 16 (Pro 16) located at the extracellular compartment of 
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the E-cad (Pizarro-Cerdá, Sousa et al. 2004 ; Hamon, Bierne et al. 2006), as shown in 
Figure 1.4C. 
Figure 1.4: Domain representations and crystal structures of InIA/B and their respective cell 
receptors E-cad and Met. 
[A] Domain organization of InIA and InIB. Homologous regions are color coded: the cap domain; green, 
LRR domain; maroon, inter-repeat region (IR); lime, B-repeats (BR) and signal sequence (SS); dark gray, 
cell wall spanning region (Cws); light grey, membrane anchor (MA); yellow, Gly-Trp-repeats (GW); grey. 
[B] Domain organization of the cell E-cad Met receptors. The extracellular domain of the E-cad comprises 
of five extracellular cadherin repeats (EC) harboring the p16 amino acid that mediates its interaction with 
the LRR region of InIA while its cytoplasmic domain interacts with cytoplasmic adaptor catenin 
molecules p120 and #/$ catenin to mediate its association to the cell actin cytoskeleton. The extracellular 
region of the Met receptor comprises of two main domains; the sema and Ig domains. The latter is 
responsible for mediating binding with the LRR of the InIB. The cytoplasmic domain of the Met harbors 
the tyrosine kinase that recruits downstream adaptor proteins to initiate signal transduction. Abbreviation 
TM: transmembrane, JM: juxta membrane, MPCD: membrane proximal cytoplasmic/conserved domain, 
CBD: catenin binding domain, sema: semaphorin, PSI: plexin-semaphorin-integrin, Ig: immunoglobulin. 
[C] Crystal structure illustrating the interplay between the InIA/B and their cell surface receptors E-cad 





The second well-characterized L. monocytogenes adhesin molecule is the InIB 
bacteria surface protein (Braun, Ohayon et al. 1998; Shen, Naujokas et al. 2000). These 
adhesin molecules have been reported to mediate bacterial invasion in a wide variety of 
mammalian cells including, hepatocytes, fibroblasts and epitheloid cells such as HeLa, 
CHO, L2, Vero, HEp-2, and S180 cells (Pentecost, Kumaran et al. 2010). InIB is a 
67 kDa molecule whose primary structure is mainly characterized by two regions of 
repeats: the C-terminal, comprising of a GW dipeptide motif also known as the cell 
surface anchor (Csa) domain and the N-terminal which carries the bacterial signaling 
proteins LRR, IR and the B repeats (Figure 1.4A). The Csa domain is responsible for 
mediating a loose association of the InI molecule with the bacteria cell surface, mainly 
through non-covalent interactions with the lipoteichoic acid polymer present on the 
bacterial cell surface (Jonquieres, Bierne et al. 1999). 
InIB mediates host cell invasion by interacting with the hepatocyte growth factor 
receptor; generally known as the Met receptor (Niemann, Jäger et al. 2007; Seveau, 
Pizarro-Cerda et al. 2007; Bonazzi, Lecuit et al. 2009). Met is a disulfide-linked 
heterodimer transmembrane protein composed of an extracellular domain of a 42 kDa 
#-subunit harboring the InIB binding receptor and a 145 KDa $-subunit spanning the 
cell membrane harboring a tyrosine kinase catalytic domain on the cytoplasmic region 
(Furge, Zhang et al. 2000 ; Schubert, Göbel et al. 2001), Figure 1.4B. Phosphorylation of 
the tyrosine receptor initiates the downstream processes, which eventually lead to the 
internalization of the bacteria. Unlike InIA where bacteria internalization is solely 
mediated by the interaction of InIA with the E-cad receptor, InIB mediated 
internalization is not only achieved through its N-terminal interaction with the Met 
receptor, but also through its C-terminal (GW domains) interaction with extracellular 
glycosaminoglycans (GAGs) and with the gC1q-R protein (Marino, Banerjee et al. 2002; 






1.3.4 Mechanisms of internalization of L. monocytogenes 
L. monocytogenes invades non-phagocytic host cells through the zipper 
mechanism (Lecuit, Ohayon et al. 1997; Bierne and Cossart 2002). The mechanism 
involves the binding of the bacteria surface proteins to the cell-membrane receptors. 
This interaction triggers a signaling cascade that reorganizes the cell actin cytoskeleton 
to facilitate internalization of the pathogen. As previously discussed, L. monocytogenes 
can use two different cell surface proteins, InIA and InIB for its invasion (Figure 1.5 and 
1.6). 
1.3.5 Model for InI A-mediated internalization of L. monocytogenes  
InlA-mediated internalization occurs when the protein binds to its cell surface 
receptor, the E-cad. As revealed by genetic and biochemical studies, the major 
interaction between the bacterial surface protein and the cell surface receptor is site and 
domain specific. The interaction occurs between the pro 16 region located on the 
outermost extracellular domain of the E-cad and the LRR/IR domain of the InIA (Figure 
1.4). The LRR is believed to interact directly with E-cad, while the IR region is required 
for a proper folding of the LRR region (Lecuit, Ohayon et al. 1997). Interaction between 
InIA and its main signaling receptor E-cad leads to the phosphorylation of the E-cad: a 
process involving both the lipid raft associated caveolin-1 protein and Src cytoplasmic 
protein (Pizarro-Cerdá and Cossart 2009). Phosphorylation of the E-cad triggers its 
ubiquitination by the ubiquitin ligase Hakai which enables the receptor to recruit several 
molecules particularly members of the catenin family (p120, #- and $-catenin), septin 
and clathrin leading to the formation of adheren junctions (Mostowy, Nam Tham et al. 
2009; Pizarro-Cerdá, Bonazzi et al. 2010; Bonazzi, Vasudevan et al. 2011; Mostowy and 
Cossart 2011). Recruitment of the #-catenin has been shown to be dependent on 
ARHGAP10, a Rho-GAp domain protein that associates with the small GTP-binding 
protein Arf6 (Seveau, Pizarro-Cerda et al. 2007). The formation of the signaling cascade 
subsequently triggers the rearrangement of the cell actin cytoskeleton and membrane 
extension, which leads to the invagination of the cell membrane entrapping the bacteria 
in a tight phagosomal compartment within the cell cytosol (Figure 1.5). It is believed 
other cytoplasmic proteins including Rac-1, Arf6, Myosin VIIA and vezatin may be 
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involved in the formation of adheren junction/bacteria internalization, albeit their 
participation in this process needs to be fully established (Pizarro-Cerdá, Sousa et al. 
2004 ). 
Figure 1.5: InIA-Mediated internalization pathway of L. monocytogenes.  
Interaction of InIA with the E-cad located within the lipid rafts initiates the activation of some cytoplasmic 
adaptor proteins, which in turn triggers the rearrangement of the cell actin cytoskeleton and the 
internalization of the bacteria. Dashed arrows indicate hypothetical steps. 
1.3.6 Model for InI B-mediated internalization of L. monocytogenes 
InIB binds to the extracellular domain of its Met receptor tyrosine kinase and 
induces multifunctional cellular responses leading to the internalization of the bacteria. 
Studies have shown InIB can mediate entry into the host cells in two ways; by 
dissociating from the bacterial surface and its soluble form interacting with its host 
proteins GAGs, gC1q-R and Met or by interacting with the host cell receptors while 
conjugated to bacteria. Upon interaction, the bound InIB induces membrane aberration 
and Met activation. This process triggers a series of downstream biological reactions 
particularly the phosphorylation of several adaptor proteins, including Gabl, Cbl, Shc 
and CrkII (Dokainish, Gavicherla et al. 2007). These adaptors then recruit the 
phosphatidylinositol 3-kinase (PI3K) which in turn activates Rac-1 (Schmeck, 
Beermann et al. 2006). The activation of Rac-1 orchestrates a signaling cascade via the 
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Arp2/3 and wave/N-wasp proteins that leads to cell actin rearrangements and the 
subsequent internalization of the bacteria. Once in the cell cytoplasm, the internalized 
bacteria are entrapped in the phagosomal membrane (Figure 1.6). Reports suggest the 
involvement of other cellular effectors such as the Sept2 and PI4K in the internalization 
process, although their functions need to be characterized (Pizarro-Cerdá and Cossart 
2009). 
Figure 1.6: InIB-Mediated internalization pathway of L. monocytogenes. 
Interaction of InIB with the Met located within the lipid rafts initiates the activation of some cytoplasmic 
adaptor proteins, which in turn triggers the rearrangement of the cell actin cytoskeleton and the 
internalization of the bacteria. InB can either bind to its host receptor as a soluble molecule or be 
conjugated to the bacteria cell wall. Dashed arrow indicates poorly understood steps. 
1.3.7 Listeriolysin O (LLO) and phospholipases C (PLCs): L. monocytogenes 
escape route from the cell phagosomal compartment 
Following internalization, the bacteria are localized in an acidic phagosomal 
compartment. How the intracellular organism progresses from this point will depend on 
its ability to subvert or avoid the host autophagy surveillance innate immune system (Py, 
Lipinski et al. 2007).  
Autophagy is a catabolic process put in place by the host cell to target cellular or 
foreign materials and process them for degradation through the action of the cytolytic 
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lysozyme (Hamon, Ribet et al. 2012). Once in the phagosome, some intracellular 
bacteria have found a way around the host defense machinery, by activating their 
virulence protein(s), which firstly delays maturation of the membrane vacuole and later 
lyses the phagosomal membrane to release bacteria from the phagocytic vacuole into the 
cell cytosol. L. monocytogenes has adopted the latter process to evade autophagic 
surveillance and promote its intracellular growth within the host cell (Tweten 2005). 
L. monocytogenes achieves this process by secreting its pore-forming cytolysin 
listeriolysin O (LLO) and two phospholipases C (PLCs) (Gründling, Gonzalez et al. 
2003), that are both largely responsible for mediating perforation of the phagosomal 
membrane, thereby allowing the bacteria to access its replicative niche in the cytoplasm 
(Kayal and Charbit 2006; Schnupf and Portnoy 2007). 
1.3.8 Characterization of listeriolysin O 
L. monocytogenes LLO belongs to a superfamily of thiol-activated 
cholesterol-dependent pore-forming cytolysin (CDCs) which includes perfringolysin O 
(PFO) and streptolysin O (SLO). The three dimensional (3D) monomeric structure of 
LLO has not yet been determined. However, based on the existing sequence similarities 
between members of the CDC family (40-70 %) and the known 3D structures of PFO 
and SLO (Rossjohn, Fell et al. 1997), it is assumed with a reasonable degree of certainty 
that the LLO monomer (50 KDa-80 KDa) shares the same structural organization as 
PFO and SLO. Figure 1.7 depicts a proposed 3D model of the LLO. 
Despite their sequence similarities, LLO is unique among members of the CDCs 
in that it has a low pH activity range (5.5 to 6) which permits LLO to induce pores in 
phagosomal membranes, causing a passive flux of ions and macromolecules without 
destroying the host cell (Dramsi and Cossart 2002). Four domain regions, based on the 
PFO structure, were used to characterize the monomeric structure of LLO. The first 
domain is located on the N-terminal, the C-terminal is comprises of the conserved fourth 
domain while domains two and three are located between them. Found on the fourth 
domain are two conserved loops: the tryptophan rich undecapeptide motif made of 11 
amino acids (ECTGLAWEWWR) and the cholesterol binding motifs that are believed to 
be crucial in recognizing the cholesterol raft within the vacuolar membrane. Located on 
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domain three are two sets of #-helices transmembrane $-hairpins (TMH 1 and 2) that 
make up the $-barrel of the pore complex as well as the pH sensor acidic triad D208, 
E247 and D320. 
 
Figure 1.7: Ribbon structure of the water-soluble LLO monomer. 
Four domains (D1-D4) characterize the monomer as depicted. D3 comprises of two transmembrane $-
hairpins (TMH 1and 2), which are responsible for forming the $-barrel of the pore complex while D4 
comprises of two conserved loops, the cholesterol binding and undecapeptide motifs that are responsible 
for binding the cholesterol on the cell membrane. Relevant amino acids (D208, E247 and D320) within D3 
are highlighted by space filled models of their side chains. The structure is based on the PFO crystal 
structure (Rossjohn, Fell et al. 1997). 
1.3.9 LLO in host cell signaling 
In addition to its ability to induce pore formation, LLO has been reported to 
mediate several other cellular processes that enable prolonged survival of the pathogen 
in the host cell. These include: activation of the NF-"B, MAPK, calcium, protein 
kinase-C and phosphatidyl-inositol signaling pathways (Hamon, Bierne et al. 2006; 
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Kayal and Charbit 2006). In this regard, LLO alters bacterial uptake, induces mucus 
exocytosis in intestinal cells, induces apoptosis in dendritic cells, causes degranulation 
and leukotriene formation in neutrophils, induces pro-inflammatory cytokines and 
chemokines in macrophages, phosphoinositide metabolism and lipid mediator generation 
(Vazquez-Boland, Kuhn et al. 2001; Kayal and Charbit 2006; Schnupf, Zhou et al. 
2007). Recent experimental evidence has also shown that the bacterial toxin regulates 
host gene expression through histone modification. This adaptive process is orchestrated 
by the intracellular pathogen’s ability to silence its host immune defenses thus 
propagating pathogen survival and intracellular growth (Hamon, Batsche et al. 2007; 
Gekara, Zietara et al. 2010). 
1.3.10 L. monocytogenes: suggested mechanism of vacuolar escape 
Although there is evidence that supports the role of LLO in mediating pore 
formation within the phagosomal membrane, it is important to note that the actual 
mechanisms by which LLO-pore formation results in bacterial escape into the cytosol 
still remain unclear (Tweten 2005). Recent studies have demonstrated that successful 
bacterial intracellular growth depends on restricting LLO activity to the phagosomal 
compartment (Schuerch, Wilson-Kubalek et al. 2005). As documented, unregulated 
expression of the LLO within the bacteria intracellular niche could lead to the 
perforation of the host organelles and plasma membrane causing cell death and 
destruction of the intracellular bacterial compartment (Glomski, Decatur et al. 2003). 
This results in exposing the bacteria to the host surveillance immune system and the 
subsequent degradation of the bacteria. Though several mechanisms have been 
suggested to regulate the LLO activity within the phagosome, the best understood rely 
on its sensitivity to pH and temperature (Schuerch, Wilson-Kubalek et al. 2005). As 
shown in previous studies (Beauregard, Lee et al. 1997), vacuolar membrane integrity is 
lost once the phagosome reaches a pH between 4.9 and 6.7. The pH sensitivity of the 
LLO is regulated by a triad of acidic residues located within domain 3 of the LLO 
monomer. At neutral pH at temperatures above 300C, a rapid denaturation of the LLO 
occurs, resulting from premature unfolding of the domain 3 TMHs, the structures 
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responsible for the formation of the transmembrane $-barrel pore (Shatursky, Heuck et 
al. 1999). 
Figure 1.8: Schematic representation of the LLO mechanism of pore formation. 
[A] Shows a structural model of the L. monocytogenes LLO monomer with each domain color-coded 
similarly to the structural model depicted in Figure 1.7. [B] Illustrates the mechanism of pore formation. 
Following secretion, the bacterial LLO monomers bind to the cholesterol (purple ring clusters) within the 
host membrane’s lipid layer and diffuse laterally to oligomerize in a pre-pore complex. A conformational 
change followed by a vertical collapse in the monomer height allows the TMHs in D3 to insert into the 
membrane and to form a large transmembrane $-barrel pore which the bacteria then uses to exit into the 
cell cytosol. Adapted from Hamon, M. A. et al 2012 with modifications. 
Shortly after accessing the phagosomal acidic milieu, L. monocytogenes LLO 
induces small membrane perforations, which allow the efflux of vacuolar Ca2+ leading to 
an increase in vacuolar pH and a subsequent delay in vacuolar membrane maturation 
(Henry, Shaughnessy et al. 2006).  During this period, it is assumed that LLO binds to 
the cholesterol rich regions of the host biological membranes using their cholesterol-
binding motif located on domain 4 of the LLO. This interaction triggers the toxin 
monomers to diffuse laterally and homo-oligomerize into a ring-like pre-pore complex. 
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A structural rearrangement of domain 2 causes two set of #-helices present on domain 3 
to unfurl forming extended amphipathic $-hairpins (TMH1 and TMH2), thus allowing 
the switch from a pre-pore complex into an effective pore. Subsequently, a 40-Å vertical 
collapse of domain 2 during the conformational transition facilitates the insertion of the 
$-hairpins into the membrane bilayer to form a large transmembrane $-barrel pore of 
approximately 35 nm (Figure 1.8). 
However, studies conducted using an LLOL461T mutant demonstrated the 
involvement of other human host factors acting with LLO to facilitate phagosomal 
escape of L. monocytogenes (Hamon, Ribet et al. 2012). These host factors include the 
enzyme GILT (!-interferon-inducible lysosomal thiol reductase and the CFTR (cystic 
fibrosis transmembrane conductance regulator) which are both highly expressed in 
macrophages. GILT knockout studies performed in macrophages demonstrated a delay 
in bacteria phagosomal escape and in vivo GILT knockout mice were more resistant to 
bacterial infection than wild-type mice (Singh, Jamieson et al. 2008). CFTR on the other 
hand is a chloride channel located on pathogen-containing phagosomes that acts in 
concert with LLO to potentiate pore formation by increasing phagosomal chloride 
concentration (Cossart 2011; Radtke, Anderson et al. 2011). 
Notably, the requirement of LLO in vacuolar lysis has been demonstrated to be 
cell specific (Gründling, Gonzalez et al. 2003). Several human-derived cell lines 
including: WS1, Henle 407, HeLa, HEp-2 and human dendritic cells have recently been 
identified as cells in which LLO is not required by the L. monocytogenes to facilitate 
their escape into the cell cytosol (Portnoy, S. et al. 1988; Paschen, Dittmar et al. 2000; 
Hense, Domann et al. 2001; O’Riordan, Yi et al. 2002). However, in the above listed cell 
lines, bacterial escape into the cytosol is mediated by the bacterial PLCs (Gründling, 
Gonzalez et al. 2003). 
1.3.11 Vacuolar escape is enhanced by two bacterial phospholipases C 
Apart from the LLO mediated phagosomal escape, two bacteria phospholipases 
C; phosphatidylinositol-specific and broad-range phospholipases C, PI-PLC and 
PC-PLC, have been reported to facilitate rupturing of the phagosomal membrane 
(Schnupf and Portnoy 2007). PI-PLC is secreted by the bacteria in an active state and 
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catalyses the production of inositol phosphate (IP) and diacylglycerol (DAG) through 
cleavage of the membrane phospholipids. PC-PLC is generally secreted as an inactive 
33-KDa proenzyme and cleaved to an enzymatically active 28-KDa form by the 
bacterial metalloprotease (mpl) enzyme (Smith, Marquis et al. 1995; Gründling, 
Gonzalez et al. 2003). Studies conducted in bone marrow derived macrophages 
(BMDMØs) following the deletion of PI-PLC resulted in a 15 % decrease in the escape 
efficiency of the bacteria. A similar study carried out using PC-PLC mutant in 
BMDMØs, had no effect on bacteria phagosomal escape but the virulent activity of the 
bacteria was decreased by 20 fold (Camilli, Tilney et al. 1993). Notably, when both 
PI-PLC and PC-PLC were deleted, the bacterial ability to escape from the phagosomal 
compartment was more impaired than with either mutation alone, suggesting the 
overlapping involvement of both PI-PLC and PC-PLC in phagosomal disruption (Smith, 
Marquis et al. 1995). Though studies have demonstrated the involvement of the PLCs in 
bacteria phagosomal escape, the actual bacteria/host protein interactions leading to this 
process remain rudimentary. 
1.3.12 Actin-based intracellular motility of L. monocytogenes 
Dissemination of L. monocytogenes within the host cell cytosol is a key step in 
its intracellular life cycle (Vazquez-Boland, Kuhn et al. 2001; Ireton 2013). As 
previously discussed, following internalization and entrapment of the bacteria pathogen 
within the phagosomal compartment, by means of its pore forming virulence factors 
(LLO and PLCs), the bacterium accesses the cell cytoplasm where it initiates 
recruitment of F-actin. Recruitment of the F-actin cloud is triggered by the bacterial 
surface protein ActA, which stimulates polymerization of actin monomers (G-actin) 
following its interaction with several host cellular proteins (Ireton 2013). Actin filament 
polymerization generates an actin “rocket” tail that allows for the directional force, 
actin-based motility that propels the bacteria through the cells’ cytoplasm. Intracellular 
movement eventually propels the bacteria to the peripheral membrane of the host cell 
where it pushes the membrane outward, forming distinct filopods. Adjacent cells often 
digest the filopods, and the cycle is repeated. It is important to note that the actual 
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molecular events leading to bacterial dissemination as well as filopod formation are still 
under investigation. 
1.3.13 Characterization of the bacterial ActA protein, the mammalian Arp2/3 
complex and VASP proteins 
Intracellular movement of L. monocytogenes within the host cytoplasm is 
achieved following polymerization of the host actin on the surface of the bacteria. The 
bacteria surface protein ActA orchestrates the hijacking of the host actin network. ActA 
is a 610-amino acid protein and comprised of three main domains; the N-terminal 
domain that binds and activates the host Arp2/3 complex, the proline rich repeats that 
recruit proteins from the vasodilator-stimulated phosphoprotein (VASP) family and a 
C-terminal domain that anchor the protein to the bacterial surface (Travier, Guadagnini 
et al. 2013), (Figure 1.9). 
The human receptor for bacterial ActA is the Arp2/3 protein complex (Welch, 
Rosenblatt et al. 1998). The Arp2/3 complex is generally located in cellular regions 
characterized by dynamic actin filament activity, it plays a major role in host actin 
regulation (Humphries, Balcer et al. 2002). The Arp2/3 complex is composed of seven 
conservative subunits (ARPC1-5, Arp2 and Arp3) with Arp2 and Arp3 harboring the 
surface features required for dimerization and to initiate an actin filament growing in the 
barbed end direction (Beltzner and Pollard 2004). The complex is intrinsically inactive 
in actin nucleation and branching and becomes activated by members of the Wiskott-
Aldrich-syndrome family protein (WASP, N-WASP, WAVE, and WASH) (Beltzner and 
Pollard 2004). The C-terminal region of the WASP share the same sequence similarity 
to the 144 to 162 amino acid residues within the N-terminal of the L. monocytogenes 
ActA (Pistor, Gröbe et al. 2000). Following stimulation, the Arp2/3 complex through 
side branching facilitates nucleation of monomeric actin from existing filaments 
(Schoumacher, Goldman et al. 2010; Firat-Karalar and Welch 2011). 
In addition to the Arp2/3 complex, other cellular proteins especially proteins 
belonging to the Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) family 
have been identified to be involved in L. monocytogenes actin polymerization. This was 
confirmed by studies where deletion of VASP resulted in a slower rate of bacterial 
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movement (Smith, Theriot et al. 1996; Haas, Kusinski et al. 2007). Members of the 
Ena/VASP family (Mena, n-Mena, EVL and VASP) contain a number of conserved 
proline-rich domains spread throughout their central regions. They are responsible for 
binding cytoplasmic profilin, which forms a 1:1 complex with the monomeric actin as 
well as concentrating the profilin-actin complex near the sites of actin polymerization 
(Machesky 1997). 
1.3.14 Model for L. monocytogenes actin assembly 
L. monocytogenes initiates the process of actin polymerization by releasing its 
ActA protein. The ActA directly interact with, and activate, the Arp2/3 complex. The 
Arp2/3 complex is responsible for recruiting monomeric actin to the barb end of the 
bacteria. The cycle of assembly of actin filaments is predicted to include seven steps: [1] 
free profilin in the cytoplasm binds to actin monomer; [2] profilin–actin complex binds 
to VASP protein; [3] VASP-profilin-actin complex binds to the proline rich domain of 
the bacterial ActA, [4 and 5] VASP hands over the profilin-actin complex to the Arp2/3 
complex where nucleation and elongation of the actin tail on the bacteria surface takes 
place, alternatively [6], profilin–actin may add directly to the barbed end of the actin 
filament, possibly by being handed over to the Arp2/3 complex, which binds both 
profilin and actin; or [7] profilin dissociates from the barbed end complex and may be 
released to restart the cycle  as illustrated (Figure 1.9). 
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Figure 1.9: Model for actin assembly by ActA of L. monocytogenes. 
In the cytoplasm of an infected cell, L. monocytogenes ActA protein serves as a scaffold, recruiting host 
proteins leading to the formation of an actin-rich “comet tail” on the bacterial surface. Briefly, free 
circulating profilin binds to actin monomer and the VASP protein then recruits the complex. The VASP-
profilin-actin complex is then bound to the proline rich domain on the ActA. Binding of VASP to the 
bacterial ActA protein moves the profilin-actin complex closer to the Arp2/3 complex where actin 
polymerization and nucleation take place. 
1.3.15 Conclusion 
For the past twenty years, L. monocytogenes has been the stereotypical bacterium 
used to understand how intracellular pathogens invade and cause pathological conditions 
in humans (Cossart 2011). Although there is significant knowledge on the virulence 
proteins used by the intracellular pathogen to invade and subvert the host defense 
machinery (Vazquez-Boland, Kuhn et al. 2001; Poulsen and Czuprynski 2013), it is 
unclear how the bacterial proteins interact with their host receptors to trigger the 
expected responses. Several models have been established to explain bacteria/host 
proteins interactions leading to the bacteria entry, phagosomal escape and actin 
polymerization (Lee and Liu 2008; Cossart 2011). However, based on the literature 
discussed above it is without doubt that to fully understand how this intracellular 
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pathogen invades and circumvents the host immune system, more of the human adaptor 
proteins involved in the process need to be established. 
A major challenge faced by researchers in the past was the unavailability of 
appropriate tools to carry out their research work. With the introduction of new 
biological techniques such as reverse transfection and the RNAi technology (Ziauddin 
and Sabatini 2001), researchers are now better equipped to study and understand the 
bacteria/host protein interaction at cellular and sub-cellular levels. A major challenge 
using the latter method is the time it takes to screen a pool of siRNAs that usually 
comprises of hundreds of thousands of individual siRNA molecules. There is therefore a 
rising need for new and robust experimental approaches that will facilitate the easy but 






















2.1 Specific objectives 
Specific objective [1] is to validate the screening technology using known 
model/control siRNAs, to determine if it is suitable for screening using gene silencing.  
Specific objective [2] will extend this: to show if a cohort of arrays retains 
similar characteristics, therefore demonstrating that the production process itself is 
robust and suitable for screening. 
Specific objective [3] will then test the arrays in screening. This will be by 
applying arrays to screen a well-known cell based model: TNF-# induced nuclear 
translocation of RELA/p65. This is a well-understood pathway and accessible to image 
analysis. If successful, this will validate the arrays as a screening platform.  
 Specific objective [4] is to develop a cell-based assay of Listeria infection then 
screen this assay to identify host factor genes required for infection. 
2.2 Brief description of each objective 
2.2.1 Objective 1: Validation of gene silencing and reverse transfection 
This objective was geared at assessing the potency of gene silencing achieved 
using reverse transfection of cells from printed spots. A major challenge generally 
encountered in this technology is developing a suitable transfection encapsulation 
mixture for the siRNA for adequate spotting and delivery of the siRNA by reverse 
transfection into the cells. 
2.2.2 Objective 2: siRNA array production validation 
The second objective demonstrated whether a cohort of glass chips retain similar 
gene silencing characteristics. Therefore demonstrating that the production process itself 
is robust. For this validation, > 2000 siRNA spots comprising of known controls were 
printed onto a glass chip and that was repeated for more than 1500 contiguous copies of 
the arrayed siRNA in a single print cycle. Gene silencing, spot size and spot intensity 
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were sampled across the entire array production. The latter quantification parameters 
were introduced to check for printing accuracy. 
2.2.3 Objective 3: siRNA array validation in screening: Identification of genes 
implicated in the regulation of the TNF-! induced p65 (NF-"B) signaling pathway 
using high throughput cell based RNA interference 
The third objective was to demonstrate that the arrayed siRNA on glass chips 
were effective at defining genes involved in a cellular pathway through screening. TNF 
alpha induced nuclear translocation of RELA/p65 was selected as the model, since it is 
well-understood and accessible to image analysis. Furthermore, the pathway is 
significantly well understood compared to Listeria and therefore a suitable validation 
model. 
Arrays of siRNA comprising of all kinases, phosphatases, ubiquitinylases, and 
proteases in the human genome were printed on glass chips. These were used to identify 
proteins implicated in the TNF# induced p65 (NF-"B) signaling pathway. The screen 
comprised a total of 32 replicates, and > 100,000 individual extracted and analyzed 
phenotypic experiments. Each experiment consisted of image analysis of cells exposed 
to a single siRNA spot for 48 h, then stimulated, and analyzed individually for the 
phenotypic effect of the reverse transfected siRNA on RELA/p65 nuclear translocation.  
The screen yielded 51 hits affecting the pathway, of these, 26 (51%) were 
identified as direct interactors with the TNF to NF-"B pathway, including two of its 
known regulators CHUK and IKK. This validated the glass chip siRNA technology, as 
well as the entire image-handling pipeline from cell handling, staining through to 
acquisition and analysis as a powerful platform for functional genomics and high content 
screening. 
2.2.4 Objective 4: Screening for genes involved in L. monocytogenes infection of 
cells 
The final objective is to apply arrayed siRNA screening to identify genes 
implicated in Listeria infection. 
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The first sub-objective was to develop a cell-based assay of Listeria infection. 
For assay development, two well-characterized human cell lines were used: HeLa and 
U2OS. A human cell model is required because the screening library silences the human 
genetic repertoire but not other species. The assay used a L. monocytogenes strain that 
expresses green fluorescent protein (GFP) to monitor cell infection by confocal imaging. 
Algorithms were developed to measure intracellular bacteria and changes in cell surface 
morphology from images of living cells exposed to a serial titration of Listeria and 
varying infection times. Based on the statistical measurements obtained, the optimal 
Listeria multiplicity of infection was determined [MOI: 25] and time of infection was set 
at 3 h.  
The assay was then combined with the glass chip arrays to screen for human host 
factors required in Listeria infection. The screen was performed on 15 replicate glass 
chip arrays, comprising a total of > 40, 000 individual experiments. Data were extracted 
and analyzed from which 67 human host factors out of 3150 genes were identified to 
















EXPERIMENTAL PROCEDURES/MATERIALS AND METHODS 
3.1 Introduction 
There have been major advances in molecular biology techniques in the past few 
years that have led to the discovery of new analytical tools to study and manipulate 
human host factors at the subcellular level. Two such techniques include 
siRNA-mediated RNA interference (RNAi) screens in which the effects of gene 
silencing on biological phenotypes can be systematically explored and reverse 
transfection in which nucleic acid (siRNA, miRNA, shRNA, DNA) coupled to a 
biological substrate is taken up by the cells. When coupled, these techniques generate a 
powerful experimental approach that seeks to identify possible regulators implicated in 
general biological processes: cell size, shape and cell proliferation, mitosis or the 
efficiency of viral/bacterial infection. In this chapter, all the chemicals and general 
molecular biology techniques that were used throughout the thesis are described. 
3.2 Chemicals 
All fine chemicals were purchased from Sigma-Aldrich (SA). DRAQ5 was from 
BioStatus (Shepshed, UK). All siRNA duplexes were purchased from Dharmacon 
(USA). The SMARTPool human whole-genome siRNA library was purchased from 
Thermo Scientific Dharmacon (West Lafayette, CO. USA). Primary antibodies were 
purchased from Santa Cruz Biotechnology (CA) and fluorescent secondary antibody was 
purchased from Molecular Probes, Invitrogen (Carlsbad, CA). Transfection reagents 
were purchased from Qiagen (Valencia, CA). All culture media and their supplements 
were purchased from Gibco (Invitrogen, Carlsbad, CA). 
3.3 siRNAs array printing 
The siRNA library comprises a collection of pools of 4 individual siRNAs. Each 
pool is designed to target a single gene as a mixture of four siRNAs per target gene. The 
library comprises a total of 18,174 pools of siRNAs. The siRNA library is supplied as 
lyophilized siRNA in 96-well plates with each well containing 0.5 nMol of the dried 
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nucleotide. Lyophilized siRNAs were resuspended in a 1X siRNA buffer to a final 
concentration of 12.5 %M, sealed and stored at -200C until required for printing. The 
siRNA microarray printing solutions were prepared following protocols adopted from 
methods previously described (Erfle and Pepperkok 2005; Erfle, Neumann et al. 2007; 
Erfle and Pepperkok 2007; Simpson, Cetin et al. 2007). Prior to printing, frozen siRNAs 
were thawed at room temperature for 60 minutes and samples concentrated at the bottom 
of the wells by centrifugation at 1000 rpm for 1 minute (220C). The siRNA samples used 
for array printing were prepared by dispensing 5 µl of 12.5 %M (final 2.72 %M) of the 
individual siRNAs into 96-well matrix microplates (Thermo Scientific, Denmark). The 
siRNA were encapsulated for reverse transfection by dispensing 18 µl of the 
encapsulation mixture (1.5 M sucrose: Sigma-Aldrich, USA, 0.4% w/v gelatin: Sigma-
Aldrich, USA, EC buffer:  QIAGEN GmbH, Hilden, Germany and lipofectamine: 
Invitrogen, USA) by means of a WellMate liquid dispensing robot (Matrix, USA). The 
encapsulation mixture was supplemented with the addition of red fluorescent non-
targeting siRNA (3 %l of 20 %M, final 2.6 %M) as an optically addressable marker (red 
si-GLO, Thermo-Fisher, USA) (Genovesio, Giardini et al. 2011; Genovesio, Kwon et al. 
2011). 
Microarray printing was performed with a custom-built microarray printer from 
Dr Emans’ laboratory. Prior to printing, siRNA encapsulation mixtures were loaded by 
capillary action using micro-fluidic filling plates into 330 %m diameter printing elements 
pre-mounted onto printing plates. Each print element was individually filled with a 
different encapsulated siRNA. The print plates were mounted onto a custom built Z axis 
movable printing head. Using a 2.5 seconds contact time, an array of the individual 
siRNA spots was printed onto a poly-L-Lysine (PLL) modified glass Substrate. Arrays 
were kept under a stream of humidified air and 55-65% RH during the print run. Post 
printing, trays of arrays were stored in light- and air-tight custom-made desiccators 
(Pieter Fourie Design and Engineering cc, Pretoria). All array manipulations were 
carried out in an ISO4 custom-built 2.5 m3 clean bench with two down facing HEPA 
filters (VividAir PTA, Pretoria). 
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3.4 Array coverslip Poly-L-Lysine coating 
For optimal adhesion of the siRNA, array coverslips 24X60 mm (Marienfeld, 
Germany) were chemically treated with 0.01% Poly-L-Lysine (Sigma-Aldrich, USA), 
prepared by dissolving PLL powder (100 mg) to 10 ml in autoclaved MilliQ water. PLL 
Solution was filtered with a 0.45 µm acrodisc syringe filter (Nalgene, USA) and a 0.01% 
PLL coating buffer was made by making up the solution to 1L using MilliQ water. Prior 
to coating, coverslips were carefully loaded into custom-built racks with each rack 
containing a maximum of 50 coverslips. Racks were placed into chambers and 
autoclaved for 30 minutes at 1210C. 500 ml of the PLL solution was dispensed into each 
chamber containing the array coverslips and incubated at room temperature for 1 hour. 
To prevent uneven coating, coverslips were rinsed in MilliQ water and excess water on 
the coverslips was removed by centrifugation. Array coverslips were air dried overnight 
and later stored in sterile airtight boxes for subsequent use. 
3.5 Routine experimental cell culture  
Three commonly exploited cell lines were examined in this thesis. HeLa (H-3) is 
a human negroid cervix epitheloid carcinoma cell line. U2OS is a human Osteosarcoma 
cell line and TZM-BL a human epithelial cell line derived from a HeLa cell clone that 
constitutively expresses CD4, Co-receptor CCR5, and CXCR4 (Platt et al., 1998) and 
contains two reporter genes, firefly luciferase and E. coli Beta galactosidase under the 
control of the HIV-1 LTR promoter. The characteristics of the HeLa cells have allowed 
the cell line to be widely used in many in vitro models of infection. HeLa, U2OS cells 
were utilized between passages 5 to 30 and maintained in Dulbecco’s modified Eagle 
Medium 1X (DMEM, GIBCO, Grand Island, NY) supplemented with penicillin (100 
U/ml)/streptomycin (100 µg/ml) (Pen-strep, GIBCO, Invitrogen) and 10% fetal bovine 
serum (FBS, GIBCO, Invitrogen). The TZM-BL cells were maintained in DMEM 
supplemented with 50 µg/ml gentamicin (gentamicin, GIBCO, Invitrogen), 26 µM 
HEPES solution (HEPES, GIBCO, Invitrogen) and 10% FBS. Cells were routinely 
grown in T75 tissue culture flasks at 370C in an atmosphere of 5% CO2 in air. 
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3.6 Reverse transfection of printed siRNA into cultured cells 
Array coverslips were transferred from the airtight custom made desiccators into 
Ø100 X 20 mm tissue culture dishes (TPP, Switzerland) prior to cell culturing. Culture 
cells were trypsinized and resuspended in Opti-MEM tissue culture medium (Opti-
MEM, GIBCO, Grand Island, NY) supplemented with 5% FBS and penicillin (100 
U/ml)/streptomycin (100 µg/ml). For reverse transfection, typically 1X106 cells in 20 ml 
Opti-MEM (final 5X104 cells/ml) were plated per siRNA array coverslip. Prior to cell 
seeding, the siRNA array coverslips were washed for 10 minutes by incubating the 
coverslips with 10 ml of the culturing medium at 370C. Medium was aspirated and the 
medium containing the cells was dispensed into tissue culture dishes containing the 
siRNA array coverslips and grown for 48 hours at 370C in a humidified atmosphere 
containing 5% CO2. 
3.7 Immuno-labeling 
Coverslips with adherent cultured cells were mounted in a custom watertight 
chamber (Chamlide, Korea). Cells were gently washed in Dulbecco’s phosphate 
buffered saline (PBS++, GIBCO, Invitrogen), fixed for 10 minutes in 4% (w/v) 
paraformaldehyde (Powder 95%, Sigma-Aldrich, USA): PBS and permeabilized for 
10 minutes with 0.1% TX-100 (v/v) in PBS at room temperature. For immunostaining, 
NF"B p65 (A) rabbit polyclonal IgG (Santa Cruz Biotechnology) (0.2 µg/ml) or XPO1 
(H-300) rabbit polyclonal IgG antibody (Santa Cruz Biotechnology) (1 µg/ml) was used 
with (1 µg/ml) Alexa 488 goat anti-rabbit IgG (H+L) (molecular probes, Invitrogen, 
USA) as secondary antibody. 10% goat serum (Sigma-Aldrich) was used as a blocking 
buffer to eliminated all non-specific binding. Cells were stained in primary antibody 
diluted in blocking buffer (1 hour, room temperature) and secondary antibody diluted in 
blocking buffer (30 minutes, room temperature). Array coverslips were washed four 
times in PBS between each staining step for 10 minutes. Nuclei were counterstained 
with 1 %M DRAQ5 in PBS (Biostatus, UK). All incubation steps were carried out on an 
ultraRocker (Bio-rad Laboratories, Hercules, CA). 
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3.8 4% (w/v) paraformaldehyde buffer 
For fixation of culture cells, a 4% (w/v) paraformaldehyde (PFA) in PBS ++ 
solution was used. Briefly, for a 500 ml solution 20 g of PFA powder was added into a 
beaker containing a magnetic stirrer and 350 ml of boiled milliQ water. The beaker was 
placed on a magnetic stirring plate with temperature set at 600C. Adding 10N Sodium 
hydroxide solution in 100 µl steps cleared milky PFA solution. Using a pH strip, the pH 
was checked and adjusted to pH 8 using fuming hydrochloric acid. 50 ml of 10X PBS++ 
was added to the solution and using MilliQ water, the final volume of the solution was 
adjusted to 500 ml using a volumetric flask. The solution was aliquoted into 50 ml 
falcon tubes and stored at -200C for subsequent use. 
3.9 Microarray acquisition and spot analysis  
Immuno-labelled arrays in chambers were mounted in a microtiter plate dummy 
for imaging. Arrays were acquired with a point scanning confocal reader (Image express 
Ultra, Molecular Devices, USA). DAPI (excitation 405 nm, emission 400-450 nm), 
FITC (488 nm, emission 500-550 nm), TEXAS RED (excitation 561 nm, emission 600-
650 nm) and CY5 (excitation 635 nm, emission 650-670 nm) fluorescence were 
captured using sequential acquisition to generate separate image files for each. A 10X 
extra long working distance magnification objective, pixel binning of 2 and five 
averages was used during all acquisitions. Images were acquired as 16 bit TIFF files 
written directly to an external database on an external 8TB server. Image processing was 
performed using ImageJ v1.44 and Array-pro analyzer v6.3 (Media Cybernetics, USA) 
softwares. Adaptive grid fitting was applied to identify, annotate and export siRNA 
spots within an entire array. The siRNA spots were fitted and annotated before exporting 
as cropped, annotated 48 bit RGB TIFF spot images. Image analysis of spots and cell 
morphology used both commercial and in-house algorithms. 
3.10 Curve fitting and pathway analysis 
Measurements were expressed as the mean and standard deviation for all 
cells in four images per well, per treatment and exported to a spreadsheet. 
Assay development data was analyzed using Graphpad Prism (Graphpad, 
USA). Curve fitting to determine was performed using sigmoidal dose response 
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fitting of six titrations. Hits from the screen were analyzed using Pathway 
Studio (Elsevier, USA). 
3.11 TNF-! induced p65 (NF-"B) nuclear translocation cell based assay 
validation 
HeLa (H-3) cells were trypsinized from cell culture flasks and plated into 
96-well tissue culture Greiner plates at plating density of 7.5 X 103 cells per well and 
cultured overnight at 37°C in a humidified, 5% CO2 incubator. Twenty-four hours after 
plating, cells were washed twice in DMEM supplemented with 1% FBS. Cells were later 
starved for an hour with DMEM (1% FBS). For TNF-# induced p65 nuclear 
translocation, cells culture plates were stimulated for 1 hour with different TNF-# 
concentrations (0 to 200 ng/ml) (GIBCO, Invitrogen) in 1% FBS DMEM medium. Cells 
were subsequently treated for immunofluorescence as described in section 3.7. 
3.12 Forward transfection of siRNAs and TNF-! stimulation of HeLa cells 
For validation of the individual pooled siRNA, 3.75 X103 HeLa cells per well 
were cultured in 96-well tissue culture Greiner plates. Cells were cultured in 100 µl 
antibiotic free Opti-MEM medium supplemented with 5% FBS for 5 to 7 hours. Cells 
were later supplemented with 20 µl (antibiotic and serum free medium) of the 
transfection mix containing the individual siRNAs (20 nM) and lipofectamine. Cells 
were further incubated for 48 hours. Prior to TNF-# stimulation, cells were washed 
twice in DMEM supplemented with 1% FBS. Cells were later starved for an hour with 
DMEM (1% FBS) before stimulated with TNF-# (100 ng/ml) for 1 hour. Transfected 
cells were subsequently treated for immunofluorescence as described in section 3.7. 
3.13 Bacteria strains, culture conditions, media and maintenance 
The bacteria strain used in this study was GFP-L. monocytogenes obtained from 
the Institut of Pasteur France (Paris). Bacteria were cultured in enriched tryptic soy broth 
(Becto, Dickinson and company, USA) supplemented with 7 µg/mg of chloramphenicol. 
Briefly, culture flasks containing bacteria were grown at 370C by agitation (110 rpm) for 
12 hours. At OD600 ~1 the bacterial medium was diluted 1 to 3 and further grown until 
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OD600 was between 0.3 to 0.6. Culture medium was supplemented with glycerol (20% 
final concentration), aliquoted and stored at -800C until required. 
3.14 GFP-L. monocytogenes invasion assay 
H-3 HeLa cells were routinely cultured in T75 TC flasks as described in section 
3.5. Cultured cells were washed twice with 10 ml PBS++, which was then aspirated. 
3 ml of Trypsin-EDTA was added to the flasks and incubated for 1 minute at room 
temperature. Trypsin-EDTA solution was removed and TC flask further incubated for 3 
to 5 minutes at 37°C with 5% CO2. Trypsinized cells were then resuspended in full 
serum medium. Prior to infection, cells were seeded in a humidified atmosphere of 5% 
CO2 at 37°C in 96 well imaging (glass based) culture plates (Greiner Bio-one 
CELLSTAR®, Neuburg Germany) at a number of 7.5 X 103 cells per well.  Cells were 
grown for Twenty four hours, washed three times with PBS and infected with 
GFP-L. monocytogenes at different multiplicity of infection concentrations (MOI 0 to 
100) in an antibiotic free medium. Infection was carried out at different time points and 
at the end of each time point, cells were washed and incubated further (1 hour) in 
medium containing 50 µg/ml gentamicin to eliminate extracellular bacteria and to 
prevent reinfection. 
3.15 Immuno-labeling of GFP-L. monocytogenes infected cells 
Arrays with adherent cultured cells were mounted in a custom watertight 
chamber and gently washed once in PBS. GFP-L. monocytogenes infected cells were 
fixed in 4% w/v Paraformaldehyde: PBS for 10 minutes followed by treatment of cells 
for 10 minutes with 0.1% v/v Triton X-100 in PBS. Cells were washed four times with 
PBS++. Infected cells were labelled for 1 hour with 0.1 µM ATTO 647 Phalloidin 
(ATTO-TEC, Germany) in PBS to stain for the actin cytoskeleton, and the nuclei were 
counterstained with 12 µg/ml Hoechst 33324 (Invitrogen, Eugene, Oregon, USA) in 
PBS. Array coverslips were imaged as described in section 3.9 using the ImageXpress 
confocal imaging system. All fixing, staining and washing steps were carried out at 




3.16 Forward transfection of pooled siRNAs and GFP-L. monocytogenes infection 
of HeLa cells 
For validation of the individual pooled siRNA, 3.75 X103 HeLa cells per well 
were cultured in 96-well tissue culture Greiner plates. Cells were cultured in 100 µl 
antibiotic free Opti-MEM medium supplemented with 5% FBS for 5 to 7 hours. Cells 
were later supplemented with 20 µl (antibiotic and serum free medium) of the 
transfection mix containing the individual siRNAs (20 nM) and lipofectamine. Cells 
were further incubated for 48 hours. Prior to GFP-L. monocytogenes infection, cells 
were washed twice in DMEM supplemented with 10% FBS. Cells were subsequently 
infected with 100 µl of DMEM (10 % FBS) containing the GFP-L. monocytogenes at 
MOI of 25. Bacteria internalization and growth was allowed to proceed for 3 hours. 
Extracellur bacteria were eliminated from the infected cells by treating the infected cells 
with 50 µg/ml of gentamicin. Infected cells were later treated for immunofluorescence as 
described in section 3.7 with a slight modification in the nuclei staining and the addition 
of cell actin cytoskeleton stain. The nuclei were counter-stained with 12 µg/ml Hoechst 















ARRAY PRODUCTION AND CHARACTERIZATION 
ABSTRACT 
Systematic screening and characterization of gene function is a key challenge, 
especially after the sequencing of the human genome and those of many other 
organisms.  
High throughput screening technology using RNA-interference (RNAi) has been 
widely used by researchers to study gene function. RNA interference results in the 
silencing of expression of a desired target gene and a loss-of-function phenotype. This 
enables identification of genes involved in a cellular process. 
Here we demonstrate and validate a new high-throughput screening technology 
in which a cohort of siRNAs are mechanically spotted onto a chemically modified glass 
cover slip. This approach differs from others in that thousands rather than a few dozen 
well defined nuclei acid spots are simultaneously deposited on a support.  
To validate the process, we applied criteria to determine if the printed spots were 
uniform and also to verify if the nuclei acid activity within the printed spot was optimal. 
Using a computational-based approach, we were able to characterize: the spot size, 
relative distance between the spots, mean intensity of the printed spots, functionality of 
the nucleic acids through reverse transfection of two human cell lines (HeLa and U2OS) 
as well as spot to spot crossover. 
4.1 Introduction 
 Given the size of the human genome, strategies for screening the genome have 
relied on automation of experiments. These include systematic well-plate based 
screening using robotic or manual handling of samples, as well as arrayed screening of 
printed siRNA, and pooled screening of shRNA libraries (Pust, Morrison et al. 2005; 
Mullenders, Fabius et al. 2009; Sims, Mendes-Pereira et al. 2011; Dow, Premsrirut et al. 
2012; Strezoska, Licon et al. 2012) Pooled screening is achieved by introducing a library 
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of different shRNA simultaneously into a population of cells and the cells are then 
subsequently selected for a phenotype of interest. 
Classical siRNA screening exploits fluid phase delivery of an siRNA complexed 
with a transfection reagent into cells grown in well plates (Cheng, Magdaleno et al. 
2011). Introduced siRNAs then enter cells and trigger silencing of their cognate gene 
product. This is a labor-intensive process and for scale up to the level of the human 
genome, the strategy has been to automate the process, rather than miniaturizing it. 
Reverse transfection technology inverts the classical siRNA process (Ziauddin 
and Sabatini 2001) in which the siRNA transfectant complexes are deposited on the base 
of a well and then overlaid cells grow over the complexes and are transfected. Reverse 
transfection has been efficiently miniaturized to where up to 3888 siRNA: transfectant 
complexes can be mechanically deposited onto a glass slide (Genovesio, Giardini et al. 
2011; Genovesio, Kwon et al. 2011). These arrays have been used to screen for cellular 
proteins involved in HIV infection as well as in the identification of human host factors 
required for Trypanosoma cruzi infection. 
Reverse transfection arrays emerged through the application of arraying 
technology to cDNA or siRNA deposition, using robotic arrayers depositing small 
volumes through contact printing. Typically, spots are deposited using a print element 
that iteratively prints a sample, and a library one sample at a time (Genovesio, Giardini 
et al. 2011).  
Here, the objective was to demonstrate that gene silencing using reverse 
transfection was effective before moving onto large-scale screening. Three 
measurements based on the known outputs expected from RNAi array experiments were 
applied: siRNA spots should be uniformly printed, gene silencing is effective and 
measurable and spot-to-spot cross contamination should be minimal.  
4.2 Results and discussion 
4.2.1 siRNA spot characterization 
 When printing microarrays, consistency in spot morphology is a very important 
aspect to take into consideration. Printed spots should have similar shape, size and 
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uniformity as discrepancies in the latter parameters could lead to inconsistent results. To 
demonstrate the production of siRNA spots for reverse transfection, the deposition of 
siRNA onto the glass substrate was tested. For this method to work the following 
conditions need to be met, the siRNA must be retained in the printed spot by 
encapsulating the siRNA using the appropriate encapsulation chemistry, printed spots 
should be fluorescently labelled for rapid identification and the encapsulated siRNA 
must be printed on a chemically modified glass substrate to minimize dissipation of the 
siRNA during use. 
To achieve this, a print element was filled with an encapsulation solution 
containing a red fluorescent siRNA, mimicking transfection conditions. The print 
element was coupled to a Z-axis drive and brought into contact with a glass substrate, 
then imaged using a fluorescent confocal microscope. The size of printed spots varied as 
a function of print element size, contact time and relative humidity (Figure 4.1).  
Figure 4.1: siRNA array spot quantification. 
Printed encapsulated siRNA spots demontrate reproducibility in spot intensity and shape after measuring a 
few hundreds of the siRNA printed spots (n=750 spots, >10 individual capillaries). Contact printed 




After optimization, printed spots were imaged as relatively regular and circular 
with an average diameter of 351 %m±0.5 %m (SEM; n=2377 imaged spots) and a tight 
diameter distribution (Figure 4.1 A and B). These results indicated reproducibility of the 
siRNA printed spots was possible. 
4.2.2 Printed siRNA(s) do not cross-contaminate neighbouring spots 
In the course of printing siRNA microarrays there is a possibility of adjacent 
spots cross contaminating each other. However, for data reliability, cross contamination 
between the individual printed siRNAs spots should be minimal. This could result from 
loading the individual printing element or from the spreading of the encapsulation 
solution during the print cycle. 
To assess for cross contamination from delivering encapsulated siRNAs into the 
printing element or during the print cycle, printing elements were alternately loaded with 
solution containing either green fluorescent labelled or red fluorescent-labelled 
encapsulated siRNA. A line of spots with intercalated red and green spots was then 
printed to a substrate. Printed spots were air dried and subsequently imaged. Image 
analysis of the printed siRNA spots show no detectable overlap indicating that there 
were no crossovers between neighbouring siRNAs during filling or in the course of 
printing the individual nuclei acids spots. It should however be noted that the image 
presented in Figure 4.2 is a section of a much larger array. 
Figure 4.2: Array spot-to-spot crossover fluorescent image verification. 
 Spot to spot crossover detection using 488 nm and 568 nm excitable fluorescently conjugated siRNA 
loaded into capillaries and printed onto a glass wafer. Scale bar 200µm. 
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4.2.3 Quantification of gene silencing by reverse transfection 
In order to achieve this objective, it was necessary to focus on optimizing the 
chemistry of the siRNA spots for optimal cell transfection. Conventional forward 
transfection siRNA yields 60-70% gene knock down within 24 to 48 hours (Devling, 
Lindsay et al. 2005). Therefore if reverse transfection is used then the silencing 
efficiency obtained should be comparable (Huang, Hancock et al. 2009).  
To accurately evaluate the efficiency of gene silencing via reverse transfection, 
p65 (NF-"B subunit), XPO1 (nuclear export of cellular proteins bearing a leucine-rich 
nuclear export signals), INCENP (gene required for the normal segregation of the 
chromosome during cell division) and control (non-targeting) siRNA were encapsulated 
with gelatin, printed, dried and overlaid with HeLa cells for 48 hours. These samples 
were then fixed and stained by indirect immunofluorescence for RELA/p65 & XPO1 
expression, or imaged for the formation of polynucleate cells after INCENP silencing 
and nuclear staining. Silencing was quantified after image analysis of  > 20 experiments. 
Images of the cells overlaying siRNA spots were acquired in three channels red, 
blue and green depicting the printed siRNA spots, the nuclei and immuno-labeled cells 
respectively (Figure 4.3 to 4.5). Here we demonstrate efficient gene knockdown when 
HeLa cells are reverse transfected with the siRNA. Reverse transfection with the p65 
siRNA gave > 75%, (p<0.0001, n = 2918) silencing efficiency while XPO1 gave > 70%, 
(P<0.0001, n= 297 spots) when both siRNAs were compared to cells transfected with 
the control non-targeting siRNA (Figure 4.3 and 4.4). 
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Figure 4.3: Silencing of p65 directed siRNA printed spot.  
[A] On the upper row, the red spot shows the non-targeting control siRNA. Next to it is an image of the 
nuclei stained with 1 µM DRAQ5. The third image shows HeLa cells stained for the NF-"B p65 subunit 
by immunofluorescence while the last image is a 3-color overlay. On the bottom row, the red spot shows 
the p65 siRNA, followed by the nuclei, p65 staining and the overlay in the right most panels. Scale bar 
100 %m. [B] Quantification of p65 silencing after automatic cell detection and image analysis. (n=2918 
spot pairs and P value <0.0001). 
Figure 4.4: Silencing of XPO1 directed siRNA printed spot. 
[A] HeLa cells were overlaid onto printed XPO1 and non-targeting siRNA spots. Cells were reverse 
transfected for 48 hours. For immunofluorescence, HeLa cells were stained with CRM1 (exportin) rabbit 
polyclonal antibody and the nuclei were counter-stained with 1 µM DRAQ5. [A] Images were acquired in 
three channels: column 1 highlighting the printed siRNA spots (red), column 2 showing the nuclei (blue), 
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column 3 the immunofluorescence detection of XPO1 and the last column showing the 3 color overlay. 
[B] Quantification of XPO1 silencing after automatic cell detection and image analysis. (n=297 spot and P 
value <0.0001) Scale bar 100 %m. 
To further demonstrate the effectiveness of gene silencing from siRNA spots, the 
cytokinetic regulator gene, INCENP siRNA was printed onto a glass substrate along 
with non-targeting siRNAs. The siRNA spots were reverse transfected into HeLa cells 
for 48 hours. Prior to imaging, cells were stained for immunofluorescence with p65 
antibodies and the nucleus counter stained with DRAQ5 fluorescent dye. Images were 
acquired in three channels as mentioned above. As demonstrated in figure 4.5 below, 
polynucleated cells were observed on the INCENP siRNA spot. Polynucleated cell is a 
characteristic behaviour resulting from an aberrant mitotic cell division, a phenomenon 
triggered by knocking down the INCENP gene. The INCENP gene forms part of the 
mitotic regulatory complex (chromosomal passenger complex) that orchestrates 
chromosome alignment, histone modification, and cytokinesis (Blank and Shiloh 2007). 
Figure 4.5: Silencing of INCENP directed siRNA printed spot. 
[A] HeLa cells overlaid for 48 hours on a glass substrate containing INCENP and non-targeting control 
siRNA spots. Cells were immuno-stained with p65 antibody and nuclei counter-stained with 1 µM 
DRAQ5. The upper panel represents the non-targeting siRNA printed spot overlaid with HeLa cells while 
the lower panel shows the INCENP siRNA printed spot overlaid with HeLa cells. Aberrant mitotic cell 
divison is observed with the HeLa cells exposed to the INCENP siRNA spot. [B] Frequency histogram of 
nuclei/cell distribution for the non-targeting and the INCENP siRNA printed spots. (n=350 spots, twelve 
independent print runs) Scale bar 100 µm. 
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4.2.4 Gene silencing is localized to the spot 
For siRNA printing to be an effective tool in screening, the deposited siRNA 
must remain on or close to the printed spot to avoid cross activity resulting from the 
different nucleic acids printed. To verify that the printed siRNA are localized to the 
printed spot, siRNA directed against p65 were printed as single spots on a glass chip. 
The siRNA spot was overlaid with U20S cells for 48 hours to permit reverse transfection 
and gene silencing. After immuno-fluorescent staining of p65 expression, the chip was 
imaged (Figure 4.6). 
Figure 4.6: Gene silencing is restricted to the siRNA printed spot. 
Gene silencing was measured using a p65 siRNA spot and three equivalent areas out from the center at 
500 %m interval. U20S cells were reversed transfected with p65 siRNA spot for 48 hours. Cells were 
fixed, permeabilized and stained with p65 primary antibody. The cells’ nuclei were counter-stained with 
1µM of DRAQ5 nuclear stain. Images were acquired in three channels (red, green and blue) using a 
confocal imaging system. [A] Shows the overlaid image of all three channels, [B] image of the immuno-
labeled cells (green) without the p65 siRNA spot and the nuclei, [C] an overlay image of the p65 siRNA 
spot (red) and the immuno-labeled cells green), [D] an overlaid of the nuclei (blue) and the immuno-
labeled cells (green) and [E] showing a confocal images of U2OS cells overlaying the p65 spot and the 
equivalent areas simulating neighboring spots (dotted lines). 
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Human p65 expression was automatically quantified by detecting the stained cell 
nuclei (Figure 4.6 E blue) within the regions of interest. A cell recognition algorithm 
was used to detect the cell cytoplasm surrounding the nuclei and then quantify for p65 
expression (staining intensity). 
Figure 4.7: Frequency distribution histogram of p65 cytoplasmic intensity/cell for the p65 spot and 
three simulated spots at 500, 1000 and 1500 #m from the p65 spot center.  
The p65 and control populations are well separated. At these levels, the number of cells having a silencing 
phenotype in the areas simulating spots was the same as cells from arrays never exposed to p65 siRNA 
and represents inaccuracies in imaging, cell permeabilization, labeling and detection (n>20 spots>200 
cells). 
As observed from images (Figure 4.6 A-D), the p65 siRNA spots demonstrated 
that silencing was exclusively localized on and within 100 %m of the spot boundary. 
Gene silencing is observed as low intensity/dark cells on and around the siRNA spot 
since in the absence of p65 there is little p65 specific antibody binding and little 




Gene silencing was quantified from cells on the spot, and at areas equivalent to a 
spot, 500, 1000, 1500 %m from the siRNA. This was achieved by creating regions of 
interest around the siRNA spot then over the same area at increasing intervals from the 
siRNA spot center (Figure 4.6 E dotted lines). These three additional simulated siRNA 
spots were then used to determine the extent of siRNA spread into cells, by detecting 
any silenced cells. 
Figure 4.8: Statistical quantification of mean intensity of p65 and three simulated spots at 500, 1000 
and 1500 #m from the p65 spot center. 
The p65 silencing/cell/spot was quantified with >70% reduction in p65 expression compared to control 
within the p65 spot with a p<0.0001 between p65 and the +500 %m spot. In contrast, cells from the +500 
to +1500 %m simulated spots were statistically indistinguishable from control cells (p=0.5564 (+500 %m), 
p=0.5926 (+1000 %m), p=0.2268 (+1500 %m). 
Experimental chip data (Figure 4.7 A) and a spot area from a control chip that 
had no printed siRNA are shown. Cells exposed to p65 siRNA show a distribution of 
p65 expression that is lower than the control and simulated spots (Figure 4.7 B). Most 
cells on the p65 spot are silenced and the number of cells scored with a silencing 
phenotype in the simulated spots was the same as cells from arrays never exposed to p65 
siRNA and represents inaccuracies in imaging, cell permeabilization, labeling and 
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detection. P65 silencing was also demonstrated after a statistical analysis of the mean 
intensity of p65 and three simulated spots at 500, 1000, 1500 %m (Figure 4.8). 
4.2.5 siRNAs array validation 
The technology used for printing enables the production of many copies of the 
same siRNAs as arrays. To determine glass chip quality throughout a production cycle, 
we quantified gene silencing from a set of production cycles. Each cycle comprised 
more than one thousand contiguously printed chips from one load of the printer. 
For assessing production, alternating columns of siRNA spots were printed to 
chips, depositing either p65 or non-targeting control siRNA. The printed array 
comprised of alternating columns of either p65 or non-targeting control siRNA across 
the entire array surface. This gave a chip of 75 columns of 35 spots containing 2625 
individual experiments, identical but for the siRNA sequence. In three independent print 
cycles, >1400 arrays were printed in less than 2 hours in one continuous cycle (Figure 
4.9). 
Sets of measurements were applied to determine print quality, which were 
chosen based on the known outputs expected from RNAi array experiments. Criteria 
included the number of printed spots, dried spot intensity, shape and efficiency of p65 






 Figure 4.9: High density microarray comprising of 2625 siRNA spots (alternate p65 and non-
targeting siRNA spots) overlaid with HeLa cells. 
HeLa cells were reversed transfected for 48 hours on the high-density array. Cells were fixed, 
permeabilized and immuno-stained for p65. Column 1 shows the siRNAs printed spots, column 2, the 
imaged nuclei after cells’ nuclei were counter stained with 1µM DRAQ5 and column 3, HeLa cells stained 
with p65 antibody. 
To determine the fraction of printed spots and spot quality before use in cell 
based experiments, dry arrays were acquired on an automated confocal microscope then 
automatically fitted to identify spots, then spot images extracted using custom scripts for 
quantifying the spot characteristics and dimensions (Figure 4.10 A-C). Each spot 
contained a red fluorescent siRNA enabling identification of the spots during imaging. 
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Figure 4.10: Quantification of large-scale siRNA/RNAi array printing process, print quality and 
gene silencing from a contiguous production of 1207 arrays. 
Spot intensity measured using the red fluorescent siRNA. (n=>300 spots/point for A-C). [B] Spot diameter 
quantified using a MetaXpress inbuilt algorithm. [C] Fraction of printed spots compared to array 1. Spot 







Spot areas were sampled from an entire array and the same spots across the print 
cycle were extracted for quantification. Figure 4.10 A and B demonstrate computational 
quantification of the spot mean intensity (n> 300 spots) and spot average diameter across 
the entire cycle of the array production. Spot intensity and spot average diameter was 
constant, as observed during the print cycle. We then went on to quantify a more critical 
parameter, the fraction of printed spots on the chip over the cycle. In figure 4.10 C, a 
series of spots (n= 24) were selected and similar spots followed across the print cycle. 
The number of printed spots started decreased after a certain point (>1000) of the 
print cycle. Decrease in spot number however could be attributed to the printing element 
running out of print solution or unable to deposit the siRNA spot due to mechanical 
stress encountered from the repeated up and down motion of the printer Z-axis.  
Another important aspect taken into account in this quantification was to 
determine how effectively the nucleic acids within the printed spots could function in 
gene silencing. This was achieved by measuring p65 silencing after arrays comprising of 
alternate p65 and non-targeting siRNAs were overlaid with HeLa cells. To measure for 
gene silencing across the print production, arrays for analysis were taken at different 
time point in a single print cycle. Here, p65 expression was detected with indirect 
immuno-labeling, array imaging, image extraction and analysis from fitted arrays 
(Figure 4.11 A and B). The p65 siRNA spots (n> 1000) were sampled from the 
individual arrays in the production cycle. As depicted in figure 4.11 B, p65 silencing 
was maintained during production but began to decline after the 750th round of the print. 
The decrease in p65 silencing could be attributed to the print element running out of 
siRNA. For robust and reproducible results, it was therefore reasonable to establish 
arrays 1-750 as the ideal chip set for screening. 
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Figure 4.11: Quantification of p65 silencing across array production. 
[A] Shows an immunofluorescence of HeLa cells overlaid on printed p65 and non-targeting siRNA spots. 
HeLa cells were reverse transfected for 48 hours, fixed and stained with p65 polyclonal antibody. Images 
were acquired using an automated confocal microscope. The upper panel shows p65 silencing on cells 
overlaid on p65 siRNA spots while the lower panel with non-targeting siRNA spots depicts no p65 
silencing. [B] Quantification of p65 silencing in arrays overlaid with HeLa cells for 48 hours after grid-




In the past, the use of genome-wide analysis to study loss-of-function phenotypes 
on a genome-wide scale was very difficult. However, with the introduction of the siRNA 
technology by Andrew Fire and Craig Mello (Fire, Xu et al. 1998), researchers are now 
using this method as a powerful approach to silence the expression of genes and to 
analyze loss-of-function phenotype in intact living cells.  
Here, the feasibility of a technology stemming from the initial reverse 
transfection microarray technology is demonstrated. This was introduced by Ziauddin 
and Sabatini (Ziauddin and Sabatini 2001), in which they demonstrated that cells grown 
on a glass wafer could take up DNA-lipid complexes that had been mechanically 
deposited on the glass substrate. Using this basic principle, we demonstrate a flexible 
approach for the production of high-density microarrays, which could be used with great 
ease for highly parallel phenotype analysis in living cells.  
Here we show that thousands (>2700) of siRNAs in an encapsulation mixture 
could be mechanically spotted in parallel onto a microarray glass substrate and 
subsequently be used to analyze for gene silencing studies in HeLa cells. To assess print 
quality of the siRNA microarray, three measurements based on the known outputs 
expected from RNAi array experiments were applied: siRNA spots should be printed, 
spot size and mean intensity should be fairly constant during production, gene silencing 
be measurable and spot-to-spot cross contamination should be minimal. It was 
demonstrated that printed siRNA spots were relatively regular and circular with diameter 
of 351 %m ± 0.5 %m across the array print cycle. Spot intensity was maintained for a 
given range of printed arrays. Gene silencing was shown to be measurable with silencing 
efficiencies >70%. Printed p65 siRNAs were effective in knocking down the expression 
of the target genes. Cell morphology was unaltered on spotted control siRNA compared 
to unspotted regions of the array with 50-120 cells/spot. It was therefore concluded that 
for consistent image acquisition and data interpretation, it was vital arrays used for all 
future experimental screens be selected from a specific group of arrays from the entire 




This validation subsequently led to the printing of 3150 siRNA spots comprising 
of a subset of the human siRNA library covering kinases, phosphatases, ubiquitinylases 
and proteases. For array quality control, a series of control siRNAs that span the entire 




























IDENTIFICATION OF HUMAN HOST FACTORS INVOLVED IN TNF-! 
INDUCED P65 (NF-"B) NUCLEAR TRANSLOCATION 
ABSTRACT 
Implementing a cell-based assay for screening requires some in-depth 
understanding of the endpoint measured, the correlation with cell viability, and the 
limitations of the assay chemistries. Here in order to use the high-density chip to screen 
for genes implicated in the Listeria infection pathway, it was reasonable to validate the 
array using a simpler cell based assay model before moving into a more complex system 
such as that of Listeria. It was expected that if using this simpler model on the 
microarrays yielded suitable outcomes in identifying key players in a pathway, it will 
therefore be reasonable to use the array in a more complex model.  
Three different biological nuclear translocation assays were evaluated: EGF 
(epidermal growth factor) induced ERK (extracellular signal regulation kinase) nuclear 
translocation, anisomycin induced Phospho-c-jun nuclear translocation and TNF-# 
(tumor necrosis factor-alpha) p65 (NF-"B) nuclear translocation. After statistical 
quantification of half-maximal activity concentration (AC50’s) and Z’ (30) for each of 
the above assays, the TNF assay was chosen for the validation since it gave a Z’ of 
> 0.7, suitable for biological assays and an AC50 of 25 ng/ml corresponding to those 
mentioned in the literature. The NF-"B signaling pathway has over the years been 
reported to play a key role in the regulation of numerous cellular processes by inducing 
targeted gene transcription. The current large number of genes regulated by this pathway 
has made it a subject of intense research. Another reason why the aforementioned 
signaling pathway was used for the validation was because the pathway has been 







Complex cellular processes maintain growth, differentiation and development. 
These cellular processes are orchestrated by the expression of a wide variety of genes 
tightly regulated by their respective transcription factors. These transcription factors   
form families such as the nuclear factor-kappaB (NF-"B) family. It is known to play a 
pivotal role in many cellular functions, including cell proliferation and survival, 
apoptosis, organ development, innate and adaptive immunity, stress and inflammatory 
responses (Weih and Caamaño 2003; Bonizzi and Karin 2004). The NF-"B is a dimeric 
transcription factor comprising of five different family members including: NF-"B1 
(p50), NF-"B2 (p52), RelA (p65), RelB, and c-Rel (Rel), which can either coexist as 
homo-dimers (RelA/RelA, p50/p50, p52/p52) or hetero-dimers (p50/RelA, p50/c-Rel, 
p52/c-Rel, p65/c-Rel, RelB/p50 and RelB/p52) (Krappmann and Scheidereit 2005; 
Moynagh 2005; Hoffmann, Natoli et al. 2006; Oeckinghaus and Ghosh 2009). 
These proteins possess an N-terminal region harboring the structurally conserved 
300 amino acids Rel homology domain (RHD), comprising of the dimerization, nuclear 
localization signal (NLS) and DNA-binding domains (Karin, Cao et al. 2002; Lätzer, 
Papoian et al. 2007), (Figure 5.1 A). The NF-"B dimers are sequestered in the cytoplasm 
of unstimulated cells in a latent inactive form, non-covalently bound to the inhibitory 
protein I"B protein complex. The I"B inhibitory complex comprises of seven different 
subunits; I"B#, I"B$, I"B&, I"B', BCL3, p100 and p105, all characterized by the 
presence of ankyrin repeats known to be the docking site for the NF-"B dimer 
(Moynagh 2005; Cervantes, Markwick et al. 2009; Miyamoto 2011), (Figure 5.1 A). Its 
dissociation from the NF-"B dimer is mediated by two homologous subunits, CHUK 
(IKK#/IKK1), IKBKB (IKK$/IKK2) and NEMO/IKK( (IKBKG) (Hayden and Ghosh 
2008), (Figure 5.1 B). 
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Figure 5.1: The NF-"B, I"B Family and NEMO/IKK$ ribbon structure. 
[A] Domain organization of NF-"B/Rel and I"B proteins. The RHD consists of two folded domains, the 
amino-terminal domain (NTD) or DNA binding domain and the dimerization domain (DimD) that are 
joined by a short flexible linker and a carboxy-terminal flexible region that contains the nuclear 
localization signal (NLS). Three members of the NF-"B, p65, c-Rel, and RelB, contain a transcription 
activation domain (TAD) at their C-terminal ends while the other two, p100/p52 and p105/p50 together 
with all I"B subunits contain the ankyrin repeats at their C-terminal. RelB contains a predicted leucine 
zipper motif (LZ) amino-terminal to its RHD. [B] Illustrates the ribbon structure of the 
IKK2/IKK$:NEMO/IKK( complex. Individual polypeptides are labeled, as well as some of the conserved 
hydrophobic amino acid side chains from IKK2/IKK$. Adapted from Karin, Cao et al. 2002 and Hayden 
and Ghosh 2008 with modifications. 
Hundreds of stimuli including cytokines (such as the Tumour Necrosis Factor 
Alpha; TNF-#, interleukin-1; IL-1), growth factors, lymphokines, oxidant-free radicals, 
viral and bacteria products have been reported to mediate the activation of the I"B 
complex (Oeckinghaus and Ghosh 2009). Upon stimulation with the TNF-# ligand, the 
tumor necrotic factor receptor (TNFR) engages proximal adaptor proteins TRADD 
(TNF receptor-associated death domain protein), RIP (receptor-interacting protein) and 
TRAF2 (TNF receptor-associated factor 2) that mediate the ubiquitination/activation of 
of the IKK complex (Miyamoto 2011). This leads to the activation of the NF-"B/I"B 
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complex by signal-induced phosphorylation of the I"B at specific serine residues (ser-32 
and ser-36). This process triggers the ubiquitination of the I"B and its subsequent 
degradation from the NF-"B complex exposing the DNA and NLS domains of NF-"B 
which enables the p65 (NF-"B) to be translocated to the nucleus where it binds to a 
specific DNA to regulate targeted gene transcription (Figure 5.2). 
 
Figure 5.2: TNF alpha induced p65 (NF-"B) signaling pathway (Canonical pathway). 
Tumor necrotic factor receptor (TNFR) is stimulated by TNF-#, to signal receptor bound proteins 
TRADD, RIP and TRAF2 to activate the IKK complex. IKK activation induces the phosphorylation and 
ubiquitination of the NF-"B complex leading to the dissociation of I"B from the complex. This 
dissociation enables freed NF-"B to be translocated into the nucleus for targeted gene transcription. Dash 
arrows represent unknown steps. 
Researchers are currently exploiting the RNAi technology to better understand 
the involvement of the respective upstream proteins in the regulation p65 (NF-"B) 
nuclear translocation (Takaesu, Surabhi et al. 2003; Chiang, Berghman et al. 2009).  
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Implementing a novel high throughput RNAi array screening technology, the 
goal here was to use the well characterized NF-"B signaling pathway to validate the 
technology and also to identify key genes that may potentially be involved in the 
regulation of the NF-"B signaling pathway. 
5.2 Results and discussion 
5.2.1 TNF-! induced p65 (NF-"B) nuclear translocation assay development 
A cell based assay for TNF-# induced p65 nuclear translocation was automated 
and validated in 96-well plates using HeLa cells. This cell line has been well 
characterized and has been used as a model cell line in the validation of many biological 
assays (Chong, Swiss et al. 2009; Balestrino, Hamon et al. 2010; Stavru, Bouillaud et al. 
2011). The cell line was used to validate the assay in which p65 was translocated into 
the nucleus upon stimulation of the cell with TNF-# ligand. 
Briefly, the p65 protein co-exists as a dimeric protein coupled to c-Rel 
(p65/c-Rel). The dimeric protein is sequestered in the cytoplasm of unstimulated cells in 
a latent inactive form non-covalently bound to the I"B protein complex (Nishikori 2005; 
Oeckinghaus and Ghosh 2009). Stimulating the cells with TNF-# activates the complex 
by signal-induced phosphorylation of I"B, releasing p65 from the I"B complex. The 
freed p65 is then translocated to the nucleus where it binds to a specific DNA site to 
regulate targeted gene transcription (Nishikori 2005). 
To validate this assay, cells were cultured in 96-well plates for 24 hours. Prior to 
TNF-# stimulation, cells were serum starved for 1 hour and then exposed to a TNF 
titration (0 to 200 ng/ml) for 1hour. Cells were then fixed, permeabilized and p65 
stained by immuno-fluorescence. Imaging used an automated confocal imaging system 
(Figure 5.4). Nuclear localization of p65 was quantified by analyzing images using 
existing off the shelf industrial standard algorithms to quantify for nucleus-to-cytoplasm 
average intensity difference of p65 within the cells. Assay conditions were optimized to 
give maximal p65 transport into the nucleus. Figure 5.3 is a schematic representation of 
the approach used in developing the TNF assay. 
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Figure 5.3: TNF pilot assay. 
[A] Illustration of TNF-# induced p65 nuclear translocation experimental approach. [B] Expected 
outcome when cells are stimulated with TNF-#. 
Visual inspection of the immunofluorescent images illustrated an increase in 
nucleus-to-cytoplasmic staining intensities when HeLa cells were exposed to an 
increasing titration (0 to 200 ng/ml) of TNF-# (Figure 5.4). To statistically validate this 
methodology, the nuclear and cytoplasmic staining intensities were compared to give the 
nuclear-to-cytoplasmic, cytoplasmic-to-nuclear ratio and the correlation coefficient as a 
relative measure of p65 nuclear localization (Figure 5.5 A-C). Here, the nuclear and 
cytoplasmic data were first normalized for the total number of data points included in 
the analysis and then comparison was made of the nucleus-to-cytoplasm average 
intensity of p65 within the unstimulated and stimulated cells. With an R2 value of > 0.9 
for each dose response curve, existing data were subsequently used to compute for the 




Figure 5.4: TNF-! induced p65 (NF-"B) nuclear translocation. 
Immunofluorescence of HeLa cells stimulated with an increasing concentration of TNF-# for 60 minutes. 
HeLa cells were cultivated for 24 hours and later exposed to different concentrations (0 to 200 ng/mL) of 
TNF-# for 1 hour. Cells were fixed then stained with p65 polyclonal antibody (green) and 1µM DRAQ5 
(red). Images were acquired using a confocal imaging system. The upper panels show p65 
immuno-labelling of the cells and the lower panel shows cells labeled with both the p65 antibody and 
DRAQ5 nuclei stain. Images depict (from left to right) increase in p65 accumulation in the nucleus as the 
TNF-# concentration was steadily increased. 
Results obtained from the assay yielded a statistical effect size of (Z’) > 0.7 and 
an AC50 of 25 ng/ml. corresponding to those mentioned in the literature (Warhurst, 
Hopkins et al. 1998). The Z’ value indicates a robust assay for high throughput 
screening (Zhang, Chung et al. 1999) (Figure 5.5). It was then predicted that this assay 
would be suitable for identifying human host factors taking part in the NF-"B signaling 
pathway after stimulation of the NF-"B cell surface receptors with the TNF-# ligand. 
An ideal assay condition was then set as: 60 minutes stimulation with an excess 
of 10 times the AC50 (100 ng/mL) of TNF-#. This was to ensure maximum stimulation 
of the cells and nuclear import of p65 (NF-"B). This assay was then transposed to the 
microarrays comprising of printed siRNA covering the kinases, phosphatases, 





Figure 5.5: Quantification of the AC50 and Z’ for TNF-! induced p65 (NF-"B) nuclear 
translocation. 
HeLa cells were exposed to different concentrations of the TNF-#. A-C. Determination of the AC50 of 
TNF-# induced nuclear import of p65 using the [A] cytoplasmic/nuclear ratio, [B] nuclear/cytoplamic 
ratio and [C] the correlation coefficient. [D] Z’ calculations for image analysis. Column 1: parameters 
used in the quantification p65 nuclear/cytoplasmic quantification. Column 2: AC50s measured for the 
different parameters. Column 3 shows R2 values for the respective graphs and column 4 gives the Z’ for 





5.3 High content RNAi screen for regulators of the TNF induced p65 nuclear 
transport pathway 
A major challenge faced by most high throughput screening platforms is random 
errors resulting from poor biological assays, poor instrumentation and cell variability 
related influence (Gunter, Brideau et al. 2003). These factors lead to selection of false 
positive candidate genes (hits). However increasing the numbers of replicates used in 
screening have recently been shown to greatly reduced the number of false negative 
without increasing the number of false positive hits (Malo, Hanley et al. 2006). 
Incorporation of the above assay (TNF-# induced p65 nuclear translocation) and 
utilizing the high-density siRNA reverse transfection arrays, we demonstrate the use of 
high replicate screens to identify effectors of TNF-# induced p65 (NF-"B) nuclear 
translocation. 
A set of 32 screens was performed corresponding to 32 X 3150 = 100,800 
individual experiments. Array images from each individual screen were exported, grid 
fitted, annotated as individual images. Each individual siRNA spot was then extracted 
and the cells within the spot analyzed using off-the-shelf industrial standard algorithm 
software. The screening data was processed through principal component analysis and 
yielded 51 hits, of these 26 (51%) were identified as direct interactors with the TNF to 
NF-"B pathway including the known NF-"B kinases and regulators CHUK and IKBKB. 
Multi-dimensional analysis showed that the median number of screens required to 
robustly select from the cohort of siRNAs was 12 replicates.  
These results demonstrated the arrays were optimal and could be used in 
screening more complex biological assays such as the Listeria infection assay. 
5.3.1 TNF-! induced p65 nuclear translocation screen 
The cell-based assay described in 5.2.1 was adapted for this screen. HeLa cells 
were seeded onto the arrays and reverse transfected for 48 hours. Cells were then serum 
starved for 1 hour and subsequently exposed to 100 ng/ml (10X its AC50) of TNF-# for 
1 hour. The transfected array was fixed, permeabilized and stained with p65 antibody. 
Each siRNA experiment was extracted, analyzed using image recognition algorithms 
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and the raw data exported to spreadsheets. Each image yielded data on >10 parameters 
including cell-by-cell data on p65 expression level, cell number, p65 distribution 
between the cytoplasm and nucleus per cell and nuclear morphology (elliptical form 
factor), taking into account the variation in phenotypes that may result from the different 
genes present in the siRNAs cohort. The data for each screen and each measurement was 
center reduced to permit cross array comparison and normalize for variance in image 
acquisition. All 32 screens were automatically compiled and the data expressed as the 
median value/siRNA for n=32 replicates. 
Figure 5.6: NF-"B screening approach. 
Schematic representation in approach used in screening for human host factors taking part in the NF"-B 
signaling pathway after TNF-# stimulation. 
5.3.2 Primary hit selection 
High throughput screens generate large quantities of data in a short period of 
time, making data mining a difficult task to perform (Hampel, Ronchetti et al. 1986). 
Data resulting from high throughput screens if not properly analyzed using the 
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appropriate analytical approach, will lead to false negative and false positive results. 
Several analytical tools are currently being used to analyze data generated by high 
throughput screens (Ben-Hur and Guyon 2003). One of such analytical tools used to 
analyze and to exploit the information contained in gene expression is the principal 
component analysis (PCA). PCA is a popular and powerful operation in statistical 
analysis (Jolliffe 1986) and has been used in high-content screens to interpret huge data 
sets (Sexton, He et al. 2010; Ashcroft, Newberg et al. 2011; Kota, Eaton et al. 2013). 
PCA operates by constructing a correlation matrix of all variables. This is achieved by 
reducing the dimensionality of a data set consisting of a large number of interrelated 
variables, while retaining as much of the variation present in the data sets as possible 
(Jolliffe 1986) making data mining easier to understand and interpret. 
In this study, our initial goal was to demonstrate that the inbuilt controls could be 
identified as different to the screen using the PCA. The two control genes XPO1 and p65 
used are known players in the NF-"B pathway. It should be noted that XPO1 is the 
nuclear export factor for p65 and when silenced it leads to nuclear accumulation of p65 
(i.e an increase in nucleus-to-cytoplasm ratio of p65). While p65 on the other hand is a 
nuclear factor NF-kappaB p65 subunit and when silenced leads to a 75% reduction in 
p65 expression within the cell (Lu, Zhang et al. 2010; Tian, Fan et al. 2012). 
The control genes were targeted with XPO1 and p65 siRNAs dispersed across 
the array. It was of interest to determine whether the phenotypes resulting from silencing 
these control genes could be identified and separated into distinct phenotypic classes 
using PCA. Since PCA is an objective analytical method, isolating XPO1 and p65 from 
the screen data would indicate that the process was effective for detecting new 
phenotypes. As shown by the PCA results (Figure 5.7), there was an excellent separation 
of the control data in 3D projections.  
Furthermore, some siRNAs affect cell viability and it was of interest to detect 
whether those gave a sufficiently differentiated phenotype to detect with PCA. Since cell 
number was used in the analysis, we anticipated that spots with a cell number less than 2 
standard deviation (STDV) from the median of the entire population could be defined as 




Figure 5.7: 3D projections of control siRNAs from the p65 (NF-"B) screen. 
3D projection from different 3D angles showing excellent separation of the p65 (blue), XPO1 (red), non-
targeting (green) and toxic siRNAs. 
As shown in figure 5.7, PCA gave a robust separation of the control XPO1 (red), 
p65 (blue) and toxic (brown) classes of phenotypes from the body of the screen.  
The human kinome consist of the RELA gene, which encodes for p65 (Nolan, 
Ghosh et al. 1991). So to further examine the effectiveness of the PCA in data 
separation, we looked for the relative position of the RELA the gene within the screen. 
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Silencing the RELA gene will result in a decrease in p65 expression within the cell 
allowing the PCA to project the gene in the same cloud as the p65 control used in the 
screen. As predicted by the PCA plot, the RELA gene from the kinome library was 
located together with the control p65 used in the screen (Figure 5.8).  
Figure 5.8: PCA plot depicting the relative position of RELA (p65) siRNA within the TNF-#  
induced p65 nuclear translocation screen. 
HeLa cells were transfected with a cohort of siRNAs comprising of kinases, phosphatases, ubiquitinylases, 
and proteases. Cells were subsequently stimulated with TNF-#, stained, imaged and analyzed using the 
PCA. PCA separates screen data into different clusters based on the cellular phenotypic expression after 
gene knockout. RELA (orange star) from the library, which encode for p65 was located within the p65 
control cloud. 
These results therefore indicated the siRNA screen, the analysis algorithms and 
the PCA itself were a viable platform to use for candidate genes selection. The PCA 
resolved three axes heavily influenced by the cell biology of the assay. PC-1 showed the 
greatest dependence on the import measurement as shown by finding the XPO-1 
controls at one end of the axis. The other two axes were strongly influenced by RELA 
(p65) expression and cell number/spot. We therefore selected “hits” as genes that gave 
the strongest import block phenotype on PC-1 and little/no effect on the other axes. The 
prediction was to find genes that block import but do not decrease RELA expression nor 




Figure 5.9: 3D projection used for hit selection. 
3D projection showing the strongest influences on the PCA axes. The colour coded siRNAs are p65 
(blue), XPO1 (red), non-targeting (green), toxic siRNA (brown), CHUCK (sky blue), and IKBKB (pink). 
Orange dots highlight region where targeted genes were selected. 
Interestingly, two known genes that influence p65 nuclear transport were found 
in this group. Suppressing the activity of these two genes will result in p65 accumulation 
in the cell cytoplasm (Gewurz, Towfic et al. 2012). These were CHUK [Conserved 
Helix-Loop-Helix Ubiquitous Kinase] and IKBKB [Inhibitor Of Kappa Light 
Polypeptide Gene Enhancer In B-Cells, Kinase Beta], which are regulatory subunits of 
the NF-"B complex. We exploited this to seek genes blocking nuclear import. These 
genes are located opposite to the XPO1 cloud, as expected since XPO1 is a nuclear 
export factor and leads to increased accumulation when silenced (i.e. opposite to desired 
phenotype), (Figures 5.7-5.9). A total of 51 genes were empirically identified (Appendix 
table 1) in the hit group containing CHUK and IKBKB. The “hit" genes were visually 
examined to confirm phenotype in 9/10 experiments (Figure 5.10 B). Using the Pathway 
Studio (http://www.elsevier.com/online-tools/pathway-studio/pathway-studio-web) 
analytical tool, genes were subsequently interrogated for protein-protein interaction by 
blasting the candidate genes against the NF-"B signaling pathway using. Data obtained 
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showed that 26 of the genes are known direct interactors with TNFR to NF-"B signaling 
pathway (Figure 5.10 A).  
Figure 5.10: Essential interactions of hits with the NF-"B pathway: Silencing of non-targeting, p65, 
XPO1, CHUK and IKBKB directed siRNA printed spots. 
[A] Yellow circles represent genes that have been reported by literature to directly interact with the TNFR 
to NF-"B signaling pathway while green circles are genes not currently reported to interact directly with 
TNFR to NF-"B signaling pathway. [B] Extrapolated immunofluorescent images from the screen showing 
HeLa cells overlaid on non-targeting, p65, XPO1, CHUK and IKBKB siRNA printed spots. Transfected 
cells were subsequently treated with 100 ng/ml of TNF-# and cell p65 and nuclei were counter-stained 
with p65 rabbit polyclonal antibody and DRAQ5 stains respectively. Images were acquired at 10X using a 
confocal imaging system. As shown in (a) the non-targeting siRNA had no effect on p65 nuclear 
translocation, (b) the p65 siRNA resulted in a decrease in p65 expression within the cell, (c) the XPO1 
siRNA resulted in p65 accumulation in the nucleus while CHUK and IKBKB siRNAs (d and e) prevented 
the p65 from entering the cell nucleus.  
5.3.2 Conclusion 
Our intention in this study was to show that the high-density siRNA array 
described in chapter four could be used effectively in screening for human host factors 
taking part in biological pathways. Also, we wanted to demonstrate that by using the 
PCA, datasets generated from screening could be adequately separated into different 
phenotypic classes.  
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In this objective, we developed and validated a phenotypic assay of TNF-# 
induced translocation of p65 (RELA/NF-"B) into the HeLa cell nucleus. Genes that 
impact the nuclear import pathway were screened for using siRNA arrays covering the 
human kinome as well as all phosphatases, ubiquitinylases, and proteases.  
Immunofluorescent images from the screen showed that the siRNA printed spots 
were localized during screening. The nucleic acid activity within the printed spots was 
observable as depicted by the internal p65 (RELA) and XPO1 controls siRNAs. Also the 
array and cell viability on overlaid printed spots (excluding toxic siRNA spots) was 
optimal (Figure 5.10 B). 
Using a multi-dimensional analysis (PCA) we were able to separate the datasets 
generated from the screen into different classes based on the similarities in cellular 
phenotype expressed by the individual genes (Figure 5.7-5.9). To further demonstrate 
the effectiveness of PCA in data separation, we selected a known gene (RELA) within 
the library that codes for p65 and looked for its relative position within the gene cloud.  
As expected, the RELA gene was located within the p65 control cloud (Figure 5.8) thus 
confirming the effectiveness of the PCA in placing genes expressing a similar phenotype 
into the same phenotypic group.  
Using the PCA we identified 51 genes as implicated in or controlling the TNFR 
to NF-"B (p65) signaling and translocation cascade. All 51-candidate genes (hits) came 
from a single cluster located directly opposite the XPO1 cloud. Based on the influence 
generated by PC-1, genes within this cluster were responsible for preventing p65 from 
entering the nucleus (Figure 5.10 B). Using Pathway Studio, a data mining and 
visualization software that rapidly connects relevant biological events based on existing 
literatures, we were able to demonstrate that 26 of the obtained hits were known direct 
interactors to the NF-"B pathway (Figure 5.10 A). Among the identified hits, two of the 
genes CHUK and IKBKB are known key regulators of TNFR to NF-"B (p65) signaling 
pathway (Connelly and Marcu 1995; Regnier, Song et al. 1997; Rothwarf, Zandi et al. 
1998; Mercurio, Murray et al. 1999; Yamamoto and Gaynor 2004). Therefore, the other 
25 genes could be potential new players in the NF-"B (p65) pathway. 
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Based on the above findings, it was reasonable to assume that the high-density 
array platform and data mining approach used in this screen was effective and could be 
used in screening for human host factors involved in more complicated biological assays 

























IDENTIFICATION OF HUMAN HOST FACTORS MEDIATING 
L. MONOCYTOGENES INFECTION USING RNAi SCREENING  
ABSTRACT 
Intracellular bacteria pathogens, such as L. monocytogenes orchestrate their 
internalization by subverting cellular functions through the interaction with specific host 
adaptor proteins. The bacteria initiate this process by means of its virulence proteins. 
Several of the bacterial proteins leading to their invasion and proliferation have been 
established. Identifying the corresponding human receptor proteins hijacked during the 
bacteria invasion is currently the focus of most research studies. To address this, we use 
high-density siRNA microarrays and computer-assisted image analysis procedures to 
quantify for intracellular bacteria in HeLa cells and subsequently look for potential 
human hosts factors involved in L. monocytogenes infection. 
Here we developed a GFP-L. monocytogenes invasion assay using a 96-well 
plate format. Using a computational based-approach, we quantified for the average 
number of bacteria within the cell as well as the morphological changes on the cell 
surface resulting from the bacterial infection. The assay was subsequently transposed 
onto a high-density siRNA microarray plate comprising of the kinases, phosphatases, 
ubiquitinases and proteases to screen for human host factors involved during 
L. monocytogenes infection. The screen had a total of 15 replicates and using a 
customized algorithm, we identified 65 candidate genes whose silencing visually 
impaired or enhanced bacterial invasion/proliferation. The 65 hits were further validated 
in a secondary screen by forward transfecting HeLa cells with the individual pooled 
siRNAs. Using a four standard deviation cut-off mark, we selected the 15 strongest 
genes whose silencing greatly enhanced bacterial invasion. 
Among the hits selected were transcription factors, genes involved in protein 
phosphorylation, proteolysis, intracellular signal transduction and in the regulation of 




The bacterial pathogen L. monocytogenes has evolved mechanisms (virulence 
factors) enabling it to invade the host cells, subvert and undermine the host immune 
system to propagate its survival. Most of the research work carried out over the past two 
decades to understand how this intracellular pathogen invades and proliferates within the 
host cells has been centered on the bacteria produced virulence factors (Agaisse, Burrack 
et al. 2005).  
Some of the bacterial virulence factors whose functions have been largely linked 
to host cell invasion include; Internalins, surface protein p104, Listeriolysin O (LLO), 
Phospholipases (PLC), Protein p60, ActA protein, Clp proteases and ATPases. The 
bacteria uses its virulence factors to exploit host proteins and propagate its invasion, 
phagosomal escape, proliferation, host actin polymerization, and cell to cell spread 
(Vazquez-Boland, Kuhn et al. 2001; Lee and Liu 2008; Cossart 2011; Ireton 2013). The 
human host factors implicated in this process have not been systematically described.  
The approach in this objective was to use the siRNA interference technology 
along with a reverse transfection strategy to silence all human genes in the kinases, 










6.2 Results and discussion 
6.2.1 L. monocytogenes infection assay 
The assay developed for this screen was geared at measuring the intracellular 
bacteria per cell after infection with L. monocytogenes To achieve this, two human cell 
lines were used in validating the assay: human epithelial carcinoma cells (HeLa) and 
human osteosarcoma cells (U2OS). Both cell lines have been used as model cell lines in 
the validation of many infectious assays (Niforou, Anagnostopoulos et al. 2008; Chong, 
Swiss et al. 2009; Balestrino, Hamon et al. 2010; Stavru, Bouillaud et al. 2011). 
We first defined the optimal multiplicity of infection (MOI) concentration of the 
bacteria required for infection and an optimal time course for invasion and proliferation 
of the pathogen within the host cell. To enable easy identification of bacteria without the 
use of secondary staining, a L. monocytogenes strain expressing the green fluorescent 
protein was used (GFP-L. monocytogenes). Quantification of the intracellular GFP 
expressing bacteria after cells were exposed to a titration of the GFP-L. monocytogenes 
was performed in fixed cells counter-stained with Hoechst 33342. Hoechst 33342 stain 
is a blue fluorescent dye with excitation and emission wavelength of around 350 nm and 
461 nm, which enabled bacteria to be detected without the need for GFP expression. 
Once the bacteria pathogen is internalized, its uses its virulence factor ActA to 
polymerize the host actin, generating an actin rocket tail which it then uses for its 
propagation within the cell cytoplasm. Therefore to ensure complete internalization of 
the bacteria, it was important to image the cell actin cytoskeleton. We demonstrated that 
staining the cell actin cytoskeleton with phalloidin 647 (excitation/emission: 650/668 
nm) we could identify internalized bacteria that have acquired the actin rocket tail. 
Figure 6.1 shows a schematic diagram illustrating the various steps used in developing 
the infection assay. 
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Figure 6.1: Stages involved in L. monocytogenes invasion assay.  
Schematic demonstrating the approach used in performing the L. monocytogenes infection assay. 
6.2.2 Image interpretation by visual inspection 
It order to develop an algorithm that will robustly measure for the intracellular 
bacteria per cell for subsequent infected images, it was necessary to select an image 
where cells infected with the bacteria depicted an observable infection characteristic. To 
demonstrate this, HeLa cells were cultivated for 24 hours in a 96-well plate and later 
exposed to a titration of GFP-L. monocytogenes (MOI: 0, 25 and 100) for 2 hours. Cells 
were fixed, permeabilized and cell nuclei and cell actin cytoskeleton counter-stained 
with 12 ng/ml Hoechst 33342 and 0.1 µM phalloidin 647 stains respectively. Images 
were acquired at 10X using a confocal imaging system (Figure 6.2). 
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Figure 6.2: HeLa cells infected with a titration of GFP-L. monocytogenes. 
HeLa cells were infected for 2 hours with different MOI concentrations (0, 25 and100) of the bacteria. 
Post-infection, cells were fixed, permeabilized and cell nuclei counter-stained with 12 µg/ml Hoechst 
33324. Images were acquired at 10X using a confocal imaging system. Column 1 represents the cell nuclei 
(blue); column 2 the GFP-L. monocytogenes (green) and column 3 represents overlay images of both the 
nuclei and GFP-L. monocytogenes. Scale 25 µm. 
In this experiment we further illustrated that the bacteria were not lying on the 
cell surface (that may affect intracellular bacteria quantification), but had invaded the 
cells and used the cell actin network to generate actin rocket tails, which they use to 
propel themselves within the cell cytosol (Figure 6.3). 
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Figure 6.3: Actin stained images of HeLa cells infected with different concentrations of GFP-
L.monocytogenes. 
HeLa cells infected with an increasing MOI (0, 25 and 100) of GFP-L. monocytogenes for 3 hours. Post-
infection, cells were fixed and permeabilized. The actin cytoskeleton and cell nuclei were counter-stained 
with 0.1 %M phalloidin 647 and 12 µg/ml Hoechst 33324 respectively. Images were acquired at 40X using 
a confocal imaging system. Top panel shows overlay images of the Hoechst (blue) and GFP-expressing 
bacteria colour coded as red while the lower panel represents the phalloidin stained images. Bacterial actin 
rocket tails are represented as tiny green fiber within the cell cytosol of the phalloidin stained images. 
Scale bar 40 µm. 
6.2.3 Quantification of intracellular bacteria post infection 
This assay was designed to measure the intracellular bacteria per cell after 
exposure of cells to the bacteria. Inconsistency in intracellular bacteria quantification 
will lead to erroneous data, thus affecting the end results of the screen. It was therefore 
necessary to design an algorithm that will robustly quantify for the actual number 
bacteria per cell. To achieve this, the intracellular bacterial concentration was measured 
by image analysis. This analysis was geared at obtaining an optimal MOI for infection 
and infection time for subsequent assays.  
The aim here was to generate a bacteria quantification software capable of [i] 
automatically finding cells and [ii] quantifying how many bacteria were present per cell.  
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To demonstrate the approach used in quantifying for the intracellular bacteria, 
7.5 X 103 HeLa cells/well were cultivated in 96-well plates for 24 hours.  Cells were 
later infected with the GFP-L. monocytogenes for 2 hours post infection; extracellular 
bacteria were removed by gentamicin treatment. Infected cells were subsequently fixed, 
permeabilized, and cell nuclei counter-stained with Hoechst nuclear stain before imaging 
(Figure 6.4).  
Figure 6.4: Image for intracellular bacteria quantification 
HeLa cells infected with GFP Listeria. [A] Shows the GFP-labeling and [B] the overlay with Hoechst 
staining. Intracellular bacteria are labeled with yellow, extracellular with white arrows. Scale bar 16 µm. 
A critical challenge was to be able to find the infected cells and exclude any 
extracellular bacteria from entering analysis. Extracellular bacteria, if not excluded from 
the analysis, will result in misleading data. This was addressed by using an adaptive 
algorithm to first identify cell and nuclear boundaries in images (Figure 6.5 a). We then 
expanded the area recognized using a cell recognition algorithm to create a mask 
corresponding to the footprint of the cells in the image (Figure 6.5 b). Automated 
thresholding (Figure 6.5 c) of the cell footprint segmentation image then automatically 
generated a binary mask (Figure 6.5 d) and an inverted mask (Figure 6.5 e) of the cell 
footprint. This detection is independent of the level of infection and not affected by it. 
The inverted mask was then used to isolate the cell footprint image (region of interest) 
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from both the Hoechst and GFP labeling images (Figure 6.5 g & h) while the excluded 
image portion from processing is shown in figure 6.5 f, as an example. Extracellular 
bacteria are essentially completely excluded from image analysis and only the excised 
cell (6.5 g) and intracellular bacteria images (6.5 h) are analyzed from this point onward. 
Figure 6.5: Steps used in intracellular bacteria quantification 
After developing the algorithm to extract infected cells without any contribution 
from extracellular bacteria, the next step was to use the processed images for automated 
analysis and recognition of intracellular bacteria. The algorithm used was selected to 
detect bacteria within cells based on a predetermined size and shape. It is not particularly 
sensitive to bacterial particle intensity instead it exploits the ‘shape’ of the bacteria 
within the cell image. Given the use of a thin confocal section for acquisition, bacteria 
lying on top of the cells were effectively removed following a Z-series acquisition 




 Figure 6.6: GFP-L. monocytogenes image analysis 
GFP-L. monocytogenes infected cells [A] and the image recognition result [B] with the detected bacteria 
shown in the right panel. Scale bar 16 µm. 
Identified bacteria are shown in white surrounding the automatically detected 
cell nuclei colour coded green (Figure 6.6 A and B). This approach robustly identifies 
cells, irrespective of cell number/image, and excludes extracellular bacteria because cell 
free regions of the image are identified and excluded (Figure 6.6). The image shown in 
panel B was then automatically segmented into individual cells and the number of 
bacteria per cell quantified and exported for analysis. 
To validate the effectiveness of the software in intracellular bacteria 
quantification, the algorithm was used to quantify intracellular bacteria after cells were 
exposed to a range of MOI for the bacteria pathogen. It was predicted that the algorithm 
should be capable of rigorously detecting differences in infection across images from 
HeLa and U2OS cells infected with a titration of MOI. 
Cells were infected with GFP-L. monocytogenes at increasing MOI (0 to 100 
units). Images of cells were then analyzed using the bacterial counting algorithm 1 and 
2 hours post-infection (Figure 6.7). 
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Figure 6.7: Graphical quantification of intracellular bacteria 
Average intracellular bacteria per cell measurement after exposing HeLa [A] and U2OS [B] cells to a 
titration of GFP-L. monocytogenes (MOI 0 to 100). (a) Quantification of intracellular bacteria per cell 
after 1 hour of infection and (b), the intracellular bacteria per cell after 2 hours of infection. For clarity and 
better graphical representation, the y-axis for each graph was scaled to depict the average intracellular 
bacteria per cell. 
These data demonstrated a semi-linear relationship between the MOI and the 
average bacteria per cell and also shows a graphical representation that depicts a 
standard bacteria growth curve. We could then conclude that the approach set for 
intracellular bacteria quantification was suitable. To measure the robustness of the 
analysis, T-tests were used to compare the detected numbers of bacteria in both the 
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HeLa and the U2OS cells. The T-test was performed on experiments with three MOI 
titrations (i.e. 0, 25 and 100). The T-test shows significant difference (p<0.0001) 
between the various MOI titration used (Figure 6.8). 
Figure 6.8: Student T-test for intracellular quantification. 
Image analysis. Quantification of average the bacteria per cell after 1 hour (a) and (b) 2 hours post 
infection in HeLa [A] and U2OS [B] cells. Student T-test gives a significant difference between 
uninfected (MOI=0) and infected cells (MOI=100) (P < 0.0001, n= 6). For clarity and better graphical 
representation, the y-axis for each graph was scaled to depict the average intracellular bacteria per cell. 
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Therefore the bacterial counting algorithm used was effective in measuring the 
intracellular bacteria per cell in both cell lines. The bacteria counting algorithm was then 
implemented in all subsequent experiments to measure the number of intracellular 
bacteria after cells were exposed to the bacteria. 
6.2.4 Infection time course 
Cellular processes such as apoptosis, anti-apoptosis and inflammatory related 
signaling pathways are reprogrammed after bacterial infection to help the cell to survive 
the stress induced by the infection (Cossart and Sansonetti 2004). However, prolonged 
exposure of cells to pathogenic bacteria decreases cell viability, which in turn leads to 
cell death. Since the assay developed for this study was directed at measuring the 
bacteria present in cells, it was therefore reasonable that an optimal MOI and time 
course for infection be determined that minimized cell death. To investigate the optimal 
MOI and time course for infection, HeLa cells were infected with the 
GFP-L. monocytogenes at different MOI concentrations (0 to 100). Cells were exposed 
to this pathogen over a period of 20 hours. At different time points post infection (1, 2, 
3, 4, 10 and 20 hours), cells were fixed, permeabilized, and DNA stained with 12 µg/ml 
Hoechst 33324. Treated cells were imaged and using the automated analysis package as 
described above, the intracellular bacteria and intracellular bacteria per cell were 
quantified. Data points were extracted and plotted as in figure 6.9. 
These results demonstrated the proliferation of the GFP-L. monocytogenes within 
the cells. For clarity, arrows and dotted lines were introduced to monitor bacterial 
proliferation. Using an MOI of 25, the growth of bacteria was monitored at the different 
infection time points. It was observed that at this MOI concentration, bacteria 
proliferation was at an exponential growth phase (light grey arrows). However, at 
4 hours post-infection at MOI 25, bacteria attained a maximum growth phase (brown 
arrow). After 4 hours of infection, further exposure of the cells to the bacteria resulted in 
depletion of the intracellular bacteria quantified (dark grey arrows). The decline in 
intracellular bacteria after 4 hours of cells being exposed to the bacteria could be 
attributed to: [i] cells losing their viability due to continuous exposure to the pathogen 
and [ii] bacteria lacking the necessary ingredients to continue proliferation. It was 
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therefore reasonable to set the optimal infection conditions at a time point and MOI 
concentration where cells exposed to the pathogen will neither be under or over-exposed 
to the pathogen (that is at the bacteria exponential growth phase). The optimal infection 
conditions were therefore set at MOI 25 and 3 hours for infection. These infection 
conditions were subsequently used for all future experiments. 
Figure 6.9: GFP-L. monocytogenes infection time course analyses 
HeLa cells were cultured for 24 hours and later infected with a titration (MOI 0 to 100) of 
GFP-L. monocytogenes. Bacteria cell invasion proceeded at different time points (1-4, 10, 20 hours). After 
each time point, cells were treated with gentamicin. Post infection, cells were fixed and permeabilized. 
Images were acquired using a confocal imaging system. Intracellular bacteria were quantified using the 
image counting algorithm developed as described in 6.2.3. Each data point is a representation of six 
individual experiments (n = 6). Arrows and dotted lines were used to monitor bacteria proliferation within 
the cells. Using MOI of 25 as an arbitrary reference point, the light grey arrows depict the exponential 
phase of the bacteria, the brown arrow show the stationary phase while the dark grey arrows show the 
declined phase of the bacteria during the invasion. MOI of 25 was used for all subsequent infection assays 
since based on the time course experiment, at MOI 25, bacteria were generally in their actively growing 
phase. For good representation, the y-axis scales were adjusted for each graph. 
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6.2.5 Bacterial actin quantification 
L. monocytogenes are known to propagate within the host cytoplasm or dissipate 
to adjacent cells by exploiting the actin cytoskeleton (Vazquez-Boland, Kuhn et al. 
2001). Image analysis of the actin cytoskeleton has been used for quantifying 
L. monocytogenes infection (Henmi, Tanabe et al. 2011). To exploit this as a measure of 
infection, the actin cytoskeleton was stained with red fluorescent phalloidin. Phalloidin 
is a seven amino acid peptide toxin isolated from Amanita phalloides mushroom that 
specifically bind the polymerized form of actin (F-actin) with high-affinity (KD 20 nM) 
(http://www.cytoskeleton.com/phdg1). F-actin is a linear polymeric microfilament 
formed after an assembly of the G-actin monomers (Carlier and Pantaloni 2007). In this 
work we made use of phalloidin conjugated to Alexa 647 dye (excitation/emission 
wavelength 650/668 nm) to avoid crossover into imaging channels used for cell or spot 
staining. 
Actin cytoskeleton is found in all cell types and they provide the cell with 
structure and shape. Because of its size, the cell actin cytoskeleton can change cell 
morphology simply by assembling or disassembling itself (Lodish, Berk et al. 2000). 
L. monocytogenes once in the cytoplasm of the cell, capitalizes on the actin network to 
polymerize actin rocket tails, which they use for mobility within the cell cytoplasm. It is 
therefore reasonable to believe continuous assembly of the actin rocket tail by the 
pathogen may alter the general stoichiometry of the actin cytoskeleton thus leading to 
changes in cell morphology. To access changes in cell surface morphology resulting 
from the latter process, parameters such as Cell Texture Index, Cell, Cellular Texture 
Index, Cell Gradient Index, Cell Cellular Gradient Index, Cell Laplacian Index and Cell 
Cellular Laplacian Index were used. The above measuring parameters mathematically 
calculate the local curvature of grayscale intensities in an image and serves as a method 
for picking up edges that is independent of edge orientation. Edges in images are areas 
with strong intensity contrasts. 
To demonstrate the changes in cell morphology resulting from L. monocytogenes 
infection, HeLa cells were infected for 3 and 4 hours at MOI 25. At 3 and 4 hours post 
infection, most of the bacteria should have invaded the cells and capitalized on the host 
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actin network to polymerize actin rocket tails which they use to move within the cell 
cytosol (Figure 6.3). Post infection, cells were fixed, permeabilized and the nucleus and 
actin cytoskeleton of the cells stained with 12 µg/ml Hoechst 33324 and 0.1 %M 
Phalloidin 647, respectively. Cell images were acquired using a confocal microscope. To 
measure for changes in cell surface morphology resulting from the infection, the cell 
surface measuring parameters listed above were used (Figure 6.10). We demonstrated 
that there was a direct relationship between the cell surface morphology and the number 
of bacteria (Figure 6.10: 3 hours infection). This linear relationship was however 
affected after 4 hours of infection at MOI 25. As shown in the figure, at 4 hours of 
infection there was a decline in measured parameters used in quantifying for cell surface 
morphology. To assess the decline in cell surface morphology, a student T-test was 
performed on the total cell number after cells were exposed to a prolonged culture of 
GFP-expressing bacteria. 
Figure 6.10: Correlation of cell actin morphology after HeLa cells were infected with 
GFP-L. monocytogenes. 
HeLa cells were exposed to different MOI concentration for 3 and 4 hours. Post infection, the actin 
cytoskeleton was stained with 0.1%M Phalloidin 647 while the nuclei were counter-stained with 12 µg/ml 
Hoechst 33324. Images were acquired using a confocal microscope and changes in cell surface 
morphology were detected using measuring parameters such as cell texture index, cell cellular texture 




Student T-tests were used to compare the total HeLa cell count after cells were 
exposed to the bacterial pathogen. 
Figure 6.11: Quantification of HeLa cells post GFP-L. monocytogenes infection. 
[A] Student T-test gives a significant difference in cell number between uninfected (MOI=0) and infected 
cells (MOI=100) (P < 0.05, n= 6) after 4 hours of infection while there was no significant difference 
observed at 3 hours post infection with the bacteria. [B] Immuno-labeling of HeLa cells infected with 
MOIs (0, 25 and 100) of GFP-L. monocytogenes for 3 and 4 hours. Cell nuclei and actin cytoskeleton were 
stained with Hoechst and Phalloidin 647 stains respectively. The upper panel shows cells infected for 3 
hours while the lower panel illustrates cells after 4 hours exposure to the bacteria. Column 1, 2 and 3 show 
the different MOIs used during infection. Scale bar 16 µm. 
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 The T-test was performed using three MOI titrations (i.e. 0, 25 and 100). The 
T-test shows significant differences (p<0.05) between the MOI 0 and 100 after cells 
were infected with the bacteria pathogen for 4 hours. However, no significant difference 
was observed in the total number of cells after cells were exposed to the pathogen for 
3 hours (Figure 6.11 A and B). This result demonstrated that cells exposed to prolonged 
bacterial infection can only maintain their viability up to a certain point, after which they 
begin to disintegrate. This explains why there was a decline in cellular morphology 
quantification following prolonged exposure of the cells to the bacteria. 
6.2.6 Conclusion 
The goal of this objective was to develop optimal conditions for screening cells 
infected with GFP-L. monocytogenes. Results obtained identified an optimal MOI 
concentration and time course for infection (MOI: 25; time: 3 hours). The optimal MOI 
for infection was chosen within the exponential growth phase of the bacteria after cells 
were exposed to the bacteria for a prolonged period of time. Also demonstrated was the 
effect of L. monocytogenes invasion on cell surface morphology. It was observed that 
continuous exposure of the cells to the bacterial pathogen affected the cell actin 
assembly. Having shown that these conditions were optimal for intracellular bacteria 
quantification, we then transposed the set conditions onto siRNA microarrays to identify 
human proteins implicated in L. monocytogenes infection. 
6.3 L. monocytogenes screen 
6.3.1 Approach used in screening for human host factors involved in 
L. monocytogenes infection 
The intracellular pathogen L. monocytogenes orchestrates its internalization, 
proliferation and cell-to-cell spread within the host cell by subverting the host defense 
machinery. Using the high-density microarrays validated for the TNF-# induced p65 
nuclear translocation screen, we screened for genes implicated in L. monocytogenes 
infection. A total of 15 replicate screens were performed using arrays of 3150 siRNAs. 
This corresponded to 15 X 3150 = 47 250 individual experiments. To demonstrate the 
screening protocol used, HeLa cells were seeded onto the arrays and reverse transfected 
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for 48 hours. Cells were then infected with the GFP-L. monocytogenes (MOI 25) for 
3 hours. To remove external bacteria, infected cells were subsequently treated for 1 hour 
with gentamicin and cells were fixed, permeabilized and the cell actin cytoskeleton and 
nuclei counter stained with 0.1 µM Phalloidin 647 and 12 µg/ml Hoechst 33324 
respectively. Images were acquired using an automated confocal imaging system. 
Images were exported, grid fitted and each siRNA spot was extracted as a single image. 
Using the same image counting algorithm and cell surface morphology quantification 
approach from the assay, analysis of the individual images were performed. 
Figure 6.12: High content screen workflow for human host factors involved in L. monocytogenes 
infection 
A high-density siRNA array was placed into a tissue culture dish and actively growing HeLa cells were 
added. After 48 hours incubation, cells were infected with GFP-L. monocytogenes for 3 hours. 
Extracellular bacteria were removed by gentamicin treatment and infected cells were fixed, permeabilized 
and stained with 12 µg/ml Hoechst 33324 and 0.1 %M Phalloidin 647. Images were acquired at 10X using 





The following measuring parameters were incorporated in the analysis: spot area, 
total nuclear count, cell shape, cell elliptical form factor, cellular bacteria, bacteria per 
cell, total bacterial area, mean bacterial area, average bacterial intensity, cell texture 
index, cell gradient index, cell cellular gradient index and cell cellular laplacian index. 
These measuring parameters were incorporated to account for any variation in 
phenotype resulting from the different siRNAs present within the screen array. Data 
obtained from the analysis were exported then processed by center reduction of each 
data set, that is, dividing each data set by its mean value. This transformation was to 
enable array-to-array comparison. The median value for each data point per spot 
obtained from the transformed data was used in the PCA. 
6.3.2 Data processing 
Data resulting from high throughput screens can be noisy, and using clustering 
algorithms may not effectively extract all the classes contained in the data (Ben-Hur and 
Guyon 2003). One approach shown to increase reliability in data is by increasing the 
number of screening arrays used when conducting screening assays (Yeung and Ruzzo 
2000). Another rate limiting step in screening is the sheer amount of data sets generated 
during the process. Analyzing such data sets requires an analytical tool capable of 
reducing the dimensionality of the large variables present in the data set while retaining 
as much of the variation present in the data as possible (Jolliffe 1986).  
In this study, we used a total of 15 replicate screens in conjunction the PCA to 
identify human host factors implicated in L. monocytogenes infection.  
Each screen array comprised of all the kinases, phosphatases, ubiquitinylases, 
and proteases and for quality control p65, XPO1, and non-targeting siRNAs were 
included in the array. To generate a statistically correct background, data obtained from 
each screen were transformed by mean center reduction. The median values of each 
corresponding data set were projected into the PCA for analysis.  
To examine the effectiveness of the PCA and the reliability of the arrays, we 
compared the PCA projections of the control siRNAs obtained from L. monocytogenes 
screen to that of the TNF-# induced p65 nuclear translocation screen previously 
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described. Figure 6.13 below shows 3D PCA projections of the control siRNA generated 
from both the L. monocytogenes and TNF-# induced p65 nuclear translocation screens.  
Figure 6.13: 3D projections comparing the distribution of the control siRNAs between the Listeria 
and NF-"B screens 
3D projections of the L. monocytogenes screen [A, B and C] and the TNF-# screen D, showing the 
distribution of the control siRNAs from the rest of the screen. As represented in A-C, the control siRNAs 
are more evenly distributed within the ungrouped siRNAs population while D depict a more reasonable 
separation of the control siRNAs. 
As expected from the 3D projections resulting from the L.monocytogenes screen 
(Figure 6.13 A-C), the control siRNAs distribution was more evenly distributed within 
the screen while the 3D projection from the TNF-# screen (Figure 6.13 D) showed an 
excellent separation of the control siRNAs from the body of the screen. The observable 
differences in siRNA distribution from both screens resulted from the different assay 
designs used in both screens. For the TNF-# induced p65 nuclear translocation screen, 
the assay was designed to look for proteins involved in p65 nuclear translocation. Since 
p65 and the XPO1 are both components of the p65 pathway, it was therefore expected 
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for the PCA to group these control siRNAs into separate classes based on the set of 
measurements used. However, p65 and XPO1 are not components of the Listeria 
pathway thus there was no statistical influence generated on the p65 and XPO1 axes by 
the PCA. This then led to an even distribution of the p65 and XPO1 control siRNAs 
within the body of the screen. This result demonstrated that using the PCA, data with 
similar patterns to each other could be grouped together into classes and there is no 
systemic bias toward the internal controls eliminating system error, as was the case with 
the TNF-# screen described in chapter 5. 
6.3.3 “Candidate gene (Hit)” classification 
Using the non-linear iterative partial least squares (NIPALS) algorithm and a 
maximum of seven principal components from the PCA, candidate genes from the 
screen were identified by ranking the hits according to the absolute values of the 
Z-scores and selecting those resolved from the body of the screen. Using the Z-score of 
±2 Standard deviation (STDV) from the mean of the median values, we classified genes 
resulting from the screen into four major classes: [i] cells with low bacteria infection, [ii] 
cells with high bacteria infection, [iii] low cell count and [iv] genes affecting cell actin 
cytoskeleton (Figure 6.14).  
However, since this project was geared at identifying candidate genes involved 
in propagating or prohibiting the invasion of the pathogen, we therefore used the first 
two classes for hit identification. Two approaches were implemented for hit selection [i] 
statistical interpretation of screen data and [ii] image-based triage (using visual 
observation) of hits resulting from the statistical interpretation hit lists. Image triage 
compensated for errors in acquisition and analysis where extraordinary phenotypes 
existed (damaged spots, contamination of the spot and aberrant cell growth). Based on 
this system of classification, we identified 65 candidate genes, which may potentially 
interact with the L. monocytogenes invasion pathway (Appendix table 2). Since we 
performed a total of fifteen independent screens, it is important to keep in mind that for a 
gene to be considered a hit; it should have a 2/3 pass score after visual observation of the 
different screens. All genes that attained or exceeded the above set pass score threshold 




Figure 6.14: 3D projections depicting groups of selected hits 
3D projections from the PCA depicting the different classes used in hit selection. [A] siRNAs resulting in 
low bacteria infection per cell. [B] siRNAs resulting in high bacteria infection per cell. [C] siRNA toxic to 
the cells (low cell count). [D] and [E] siRNAs affecting cells surface morphology (cell actin cytoskeleton). 
While [F], is a combination of all the different phenotypic groups. 
6.3.4 Gene cluster classification 
The phenotypic groups created by the PCA as mentioned ealier were classified in 
four major classes. Class one was defined as high bacteria infection per cell.  Genes 
within this cluster were those that scored >2 STDV more bacteria/cell compared to the 
negative control (non-targeting siRNA spot). Class two were those siRNAs spots 
harboring cells with low bacteria infection. Genes in this class were those that scored a 
> 2 STDV fewer bacteria/cell compared to the control. Class three was defined as 
cytotoxic siRNAs. These were spots with > 2 STDV fewer cells/spot compared to the 
negative control (non-targeting spot). Class four were genes affecting cell actin 
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cytoskeleton. Genes within this class all scored > 2 STDV low cell laplacian compared 
to the negative control.  
The subsequent immunofluorescent images illustrate the different classes used in 
the hit selection. For the control class, we use images of the distribution of the 
GFP-L. monocytogenes and the cell actin cytoskeleton after HeLa cells were reverse 
transfected with a non-targeting siRNA spot. As observed from the image 
(GFP-labeling), the GFP-L. monocytogenes (green) were evenly distributed within and 
outside of the siRNA spots. This result demonstrated that the non-targeting siRNA had 
no influence on how the cells reacted to the L. monocytogenes infection. Also shown in 
this figure is the cell actin cytoskeleton after infected cells were counter stained for actin 
with fluorescent Phalloidin 647. These images were used as a baseline control to select 
positive hits (2/3 pass score) by visual observation after screen data were statistically 
quantified using PCA. 
6.3.4.1 Class one: High infection 
The first phenotype we defined was high Listeria infection and is defined as cells 
with > 2 STDV more bacteria/cell compared to the negative control (non-targeting 
control) (Figure 6.15 A and B). The figure illustrates two genes TLK1 (tousled-like 
kinase 1) and LATS2 (large tumor suppressor, homolog 2). TLK1 is known to regulate 
processes involved in chromatin assembly while LATS2 is involved in protein 
phosphorylation. As depicted in the figure, the first panel comprises of the non-targeting 
siRNA spot showing a > 2 STDV fewer bacteria/per cell compared to panels 2 and 3 
where we see examples of two siRNA spots whose silencing visually enhanced bacterial 
invasion. Column 1 shows the GFP-bacteria distribution, column 2 the nuclei, column 3 
the siRNA spots and column 4 overlay images of all three channels. 
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Figure 6.15 A: GFP-Labeling: Silencing of TLK1 and LATS2 directed siRNA printed spots 
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Figure 6.15 B: Actin-Labeling: Immunofluorescent images of the cell actin cytoskeleton following 
treatment of HeLa cells with TLK1 and LATS2 siRNAs 
Immunofluorescent images of HeLa cells exposed to GFP-L. monocytogenes. HeLa cells were reverse 
transfected with human siRNAs for 48 hours. Transfected cells were exposed to the bacteria (MOI: 25) for 
3 hours and later treated with gentamicin for 1 hour. Post infection, cells were fixed, permeabilized and 
the cell nuclei and actin cytoskeleton were counter-stained with 12 ng/ml Hoechst 33473 and 0.1 µM 
Phalloidin 647 respectively. Images were acquired at 10X using a standard confocal imaging system. [A] 
GFP-labeled images demonstrating high bacteria/cell (TLK1 and LATS2) compared to the non-targeting 
control (panel 1). Column 1 of each image shows the GFP-bacteria, column 2 the nuclear images, column 
3 the siRNA spots while the last column overlays images of the respective channels. [B] The 
corresponding actin-labeled images of the non-targeting control, TLK1 and LATS2 siRNAs. Column 1 of 
each image shows actin-stained images; column 2 the nuclear images; column 3 the siRNA spots while the 







6.3.4.2 Class two: Low infection 
The second phenotype we defined was low Listeria infection and is characterized 
as cells with > 2 STDV fewer bacteria/cell compared to the negative control (non-
targeting control) (Figure 6.16 A and B). Here we demonstrate two siRNA spots PPP6C 
(protein phosphatase 6, catalytic subunit) and PON1 (paraoxonase 1) whose silencing 
visually hindered bacteria entering. 
 
Figure 6.16 A: GFP-Labeling: Silencing of PPP6C and PON1 directed siRNAs printed spots 
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Figure 6.16 B: Actin-Labeling: Immunofluorescent images showing the cell actin cytoskeleton 
following treatment of HeLa cells with PPP6C and PON1 siRNAs 
Immunofluorescent images of HeLa cells exposed to GFP- L. monocytogenes. HeLa cells were reverse 
transfected with human siRNAs for 48 hours. Transfected cells were exposed to the bacteria (MOI: 25) for 
3 hours and later treated with gentamicin for 1 hour. Post infection, cells were fixed, permeabilized and 
the cells’ nuclei counter-stained with 12 ng/ml Hoechst 33473 and 0.1 µM Phalloidin 647 respectively. 
Images were acquired at 10X using a standard confocal imaging system. [A] GFP-labeled images 
demonstrating fewer bacteria/cell (PPP6C and PON1) compared to the non-targeting control (panel 1). 
Column 1 of each image shows the GFP-bacteria, column 2 the nuclear images, column 3 the siRNA spots 
while the last column overlays images of the respective channels. [B] Corresponding actin-labeled images 
of the non-targeting control, PPP6C and PON1 siRNAs. Column 1 of each image shows actin-stained 
images; column 2 the nuclear images; column 3 the siRNA spots while the last column represents the 







6.3.4.3 Class three: siRNA induced cell death  
The third class of phenotype was siRNAs that induced host cell death. We scored 
this class as > 2 STDV fewer HeLa cells/siRNA printed spots compared to the non-
targeting control. The gene selected from this class as an example is the potassium 
voltage-gated channel (KCNB1), which is a shab-related subfamily, member 1. 
Members of this family have been shown to play critical roles in cellular signaling 
processes regulating neurotransmitter release, heart rate, insulin secretion, neuronal 
excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume 
regulation (Shieh, Coghlan et al. 2000). As illustrated by some research work, changes 
in K+ channel function have been linked with apoptosis, oncogenesis and cardiac 
hypertrophy (Shieh, Coghlan et al. 2000). Here we demonstrated that there was a 
significant (> 30%, p< 0.0002) reduction in cell number compared to the negative non-
targeting control after cells were treated with the KCNB1 siRNA (Figure 6.17 B).  
 Figure 6.17 A and B: GFP-Labeling: Silencing of KCNB1 directed siRNA printed spot 
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Figure 6.17 C: Actin-labeling: Phenotype induced by KCNB1 directed siRNA printed spot. 
HeLa cells were reverse transfected with human siRNAs for 48 hours. Transfected cells were exposed to 
the bacteria (MOI: 25) for 3 hours and later treated with gentamicin for 1 hour. Post infection, cells were 
fixed, permeabilized and cells’ nuclei and actin cytoskeleton counter-stained with 12 ng/ml Hoechst 33473 
and 0.1 µM Phalloidin 647 respectively. Images were acquired at 10X using a standard confocal 
microscope. [A] GFP-labeled images depicting the distribution of the bacteria on the KCNB1 siRNA spot. 
The upper panel represents the non-targeting images while the lower panel shows the KCNB1 images. 
Column 1 of the image shows the GFP-bacteria. Column 2, shows the cell nuclei images. Column 3, the 
siRNA printed spots and the last column shows the overlay images of the three channels. [B] Unpaired 
student T-test showing the relative significant in cell number between the non-targeting control and the 
KCNB1 siRNAs (p< 0.0002). n= 180 for non-targeting and n=10 for KCNB1. [C] Actin labeled images 
demonstrating the effect of KCNB1 on the cell actin network. Upper panel represents the non-targeting 









 6.3.4.4 Class four: Genes affecting the cell actin cytoskeleton  
One probable phenotype are genes whose silencing disrupts the cell actin 
cytoskeleton and as a result affects infection (Figure 6.18). Interestingly, one of the 
genes (ras homolog family member A; RHOA) within this cloud belongs to the GTPase 
family. Members within this family are generally known to regulate the actin 
cytoskeleton (Sit and Manser 2011; Blajecka, Marinov et al. 2012). The phenotypic 
expression resulting from the RHOA siRNA spot may have resulted in membrane actin 
disintegration, which in turn compromised cell viability. This may have played a key 
role in slowing down the bacteria proliferation within the cell cytoplasm as observed 
with the ditribution of bacteria within the RHOA siRNA printed spot (Figure 6.18 A). 




Figure 6.18 B: Actin-Labeling: Silencing of RHOA directed siRNA printed spot. 
HeLa cells were reverse transfected with human siRNAs for 48 hours. Transfected cells were exposed to 
the bacteria (MOI: 25) for 3 hours and later treated with gentamicin for 1 hour. Post infection, cells were 
fixed, permeabilized and cells’ nuclei and actin cytoskeleton were counter-stained with 12 ng/ml Hoechst 
33473 and 0.1 µM Phalloidin 647 respectively. Images were acquired at 10X using a standard confocal 
imaging system. [A] The upper panel shows the distribution of bacteria on and round a non-targeting 
siRNA spot while the lower panel shows the distribution of bacteria on and around the RHOA siRNA 
spot. Column 1 of each siRNA image shows the GFP expressing bacteria. Column 2 shows the nuclear 
images. Column 3 the siRNA spots while the last column overlay images of the respective three channels. 
[B] Shows the corresponding actin stained images for the RHOA siRNA printed spot. HeLa cells within 
the RHOA siRNA spot look aberrant that is when compared to the HeLa cells localized within the non-
targeting siRNA control spot. Scale bar 100 µm. 
6.3.5 Identification of essential protein interactions using Pathway Studio 
software 
To obtain an initial understanding on the possible protein interactions taking 
place, the human host factors (proteins) identified from the screen were employed to 
construct a protein interaction network using the Pathway Studio. Pathway Studio is a 
pathway analysis tool which harvests information from deposited literature in PubMed 
and other public sources and provides us with an understanding of the possible 
interactions taking place between proteins and other small molecules both at the 
molecular and cellular level (Nikitin, Egorov et al. 2003; Hosseinpour, HajiHoseini et al. 
2012). This analytical tool was then used as a scaffold to establish comprehensive 
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information on the possible interactions existing between the potential genes identified. 
Of the 65 proteins projected into the software for protein-protein interaction, 23.07 % of 
the genes had direct interaction with one or more members from the cohort 
(Figure 6.19). Table 6.1 provides the protein-protein interactions between the genes as 
well as the PMID as reference where these genes have been shown to interact with each 
other. 
Figure 6.19: Identification of essential proteins interactions using Pathway Studio. 
A cohort comprising of 65 genes was projected into the Pathway Studio for possible protein-protein 
interaction. As shown, 23.07% of these genes interacted directly with one or more members of the group. 
Genes were localized in the nucleus and cytoplasm as well as in the cell membrane. 
 
Table 6.1: Primary hits protein-protein interaction and their respective PMID 
Genes Interactions Reference, PMID 
NEK4---NEK6 Binding 21605211 
STK4---LATS2 ProtModification 18640976, 17442573, 19878866, 22898666, 22898666, 22898666 
STK4---MAPK9 Regulation 10699464 
MAPK6---MAPKAPK5 Regulation 17947239, 16971392,  
MAPK6---MAPK9 Regulation 20409730 
DUSP1---MAPK6 Expression 19789277 
EPHA4---MAPK9 ProtModification 10617634, 9334169,  9545354, 9553058, 10575005 
ZAP70---MAPK9 Regulation 10521707 
PRKCZ---MAPK9 Regulation (positive) 15313379, 15313379 
DUSP1----MAPK9 ProtModification (negative) 8626452, 20708668, 20708668, 15855046, 21350193, 11139479, 
21255694, 15059639, 20708668 
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PRKCZ---PPP1R12A Regulation (positive) 19011165 
PRKCZ---PON1 Expression (positive) 15380450, 20092859 
EPHA4---DUSP1 Expression (positive) 9280068 
EPHA4---EPHB1 Binding 12084815 
EPHA4---MPHB2 ProtModification 11754835 
EPHB2---EPHB1 Regulation 11136979, 10600686 
PRKCZ---EPHA4 Binding 10962008, 15164763 
EPHB2---EPHA4 Binding 19875447, 20633976 
EPHB1---EPHB2 Regulation 9499402, 19303107, 12971890, 10600686 
6.3.6 Conclusion 
The objective of this study was to identify human host factors (proteins) 
implicated in L. monocytogenes infection. Using arrays of 3150 siRNA spots comprising 
of all human kinases, phosphatases, ubiquitinylases, and proteases we screened for genes 
whose silencing may either hinder or enhance bacterial invasion of cells. A total of 15 
replicate screens were performed. Data were centrally reduced using the mean value of 
the negative control (non-targeting siRNA). Using a multi-dimensional analysis (PCA) 
we separated the genes into four different classes based on their similarities in expressed 
cellular phenotype:  
• genes whose silencing led to an increase in intracellular bacteria,  
• genes whose silencing led to a decrease in intracellular bacteria,  
• siRNAs that may result in cellular toxicity or whose gene silencing led to cell 
death,  
• genes whose silencing may affect the cell actin cytoskeleton.  
 Implementing an image based triage approach we were able to identify 65 
candidate genes, which may potentially be involved in L. monocytogenes infection. 
Using the Pathway Studio, we also demonstrated that 23.07 % of the genes had a direct 
interaction with one or more other genes from the cohort of gene. 
6.4 Secondary screen validation 
To eliminate internal errors that may have resulted from the high-density array 
screening, a new set of siRNA pool targeting the 65 genes identified in the primary 
screen were validated against the existing values of the array. The secondary screen 
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assay was validated in 96-well plates, a robust and well-established approach regularly 
used for screening. As was previously established for the high-density microarray 
screen, this 96-well format also had to be validated before proceeding with the 
screening. We performed a total of six replicate screens for this assay and the screen 
gave rise to fifteen strongest hits some of which have already been implicated in 
L. monocytogenes infection. 
6.4.1 Quantification of silencing efficiency by forward transfection 
To confirm the 65 candidate genes identified during primary screening, we 
performed a secondary screen validation assay in 96-well plates by forward transfecting 
HeLa cells with the individual siRNA pool. The process of forward transfection involves 
exposing the cells to nucleic acids after seeding the cells. This validation was performed 
to ensure that phenotypic gene silencing resulting from forward transfection was the 
same as that obtained from the microarray technology in which reverse transfection was 
used. It is important to note that if inappropriate siRNA concentrations as well as 
inadequate time of transfection are used, there will be an increased risk of misidentifying 
off-target genes as candidate genes during data analysis after the secondary screening. 
The goal here was to establish an siRNA concentration and time of transfection that will 
give similar silencing efficiency as in the microarray screen where spotted nucleic 
acidsw were reversibly taken up by the cells. 
To validate this format, HeLa cells were seeded in 96-well plates 6 hours prior to 
siRNA treatment. Non-adherent cells were aspirated and 100 µl of Opti-mem media 
pipetted into each well.  20 µl of lipofectamine transfection mixture containing a titration 
of the p65 siRNA (0 to 50 nM) was added in to the respective wells. Transfection was 
allowed to proceed for 48 hours at 370C in a humidified atmosphere. Post transfection, 
cells were fixed, permeabilized, and p65 expression and cell nuclei were 
immunofluorescently labeled using rabbit polyclonal antibody (1:1000) and 1µM 
DRAQ5. Imaging was performed using a confocal imaging system and cytoplasmic p65 
expression was measured by quantifying the intensity of the p65 staining. 
As demonstrated by the immunofluorescent image (Figure 6.20 A and B), there 
was a significant increase in cytoplasmic to nucleus p65 expression after HeLa cells 
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were exposed to the non-targeting siRNA control. On the other hand, there was an even 
distribution of p65 expression between the cytoplasm and the nucleus after Hela cells 
were treated with the XPO1 siRNA. The latter observation was as a result of p65 being 
unable to relocate back into the nucleus since the nuclear export factor responsible for 
the process was silenced. Another important observation was the decrease in cell number 
as the concentration of the p65 siRNA was increased (Figure 6.20 C). This result depicts 
that at high concentrations, the siRNAs are toxic to the cells. 
Based on this findings, the ideal assay concentration for the siRNA and time of 
transfection was set at 20 nM and 48 hours respectively to ensure the same level of 
silencing as on the microarray screening (Figure 6.20 B and C).  
Figure 6.20: Validation of the secondary sceening 
Forward transfection of HeLa cells with a titration of p65 siRNA. [A] Non-targeting and RELA siRNA 
duplexes [10-50 nM] were forward transfected into HeLa cells for 48 hours and RELA (p65) expression 
imaged and [B] Quantified as % RELA expression relative to control non-targeting siRNA [RELA 
intensity/pixel/cell]. [C] Student T-test performed on the number of viable cells following siRNAs 
treatment expressed as % cell scoring: (10 nM: p=0.3, 20 nM: p=0.8, 30 nM: p=0.03, 40 nM; p<0.005, 50 
nM: p<0.0004). Scale bar 15 %m. 
To ensure the effectiveness of the chosen concentration, two different control 
siRNAs (INCENP and XPO1) were tested (Figure 6.21). Results obtained depicted both 
a poly-nucleate phenotype following silencing of the cytokinesis regulator INCENP 
(middle panel) and a reduced nuclear to cytoplasmic p65 translocation (lower panel) 
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after the silencing of the nuclear export gene XPO1. These assay conditions were later 
used to further validate the candidate genes obtained from the primary screen. 
 
Figure 6.21: Silencing of INCENP and XPO1 directed siRNAs. 
HeLa cells were cultured in a 96-well plate for 6 hours prior siRNA treatment. Cells were forward 
transfected with non-targeting, INCENP and XPO1 siRNAs for 48 hours at 370C. Transfected cells were 
treated for immunofluorescence and imaged at 10X using a standard confocal microscope. The upper 
panel shows the immunofluorescent image of cells treated with the non-targeting siRNA, the middle panel 
shows a poly-nucleate phenotype following treatment of the cells with INCENP siRNA while the lower 







6.4.2 Secondary screen validation for genes involved in L. monocytogenes 
infection 
Adopting the experimental approach described in section 6.4.1, a new batch of 
the 65 candidate genes identified from the primary screen was validated against 
L. monocytogenes infection. Here, HeLa cells were seeded in 96-well plates 6 hours 
prior to siRNA treatment. Non-adherent cells were aspirated from each well, washed and 
100 µl Opti-mem media added to each well. Twenty micro-liters of the lipofectamine 
tranfection mixture containing the different siRNAs at concentration of 20 nM (final) 
were added in to the respective wells. Cells were cultured for 48 hours at 370C in a 
humidified atmosphere. Transfected cells were exposed to GFP-bacteria for 3 hours and 
subsequently treated with gentamicin to exclude extracellular bacteria.  Post infection, 
cells were fixed, permeabilized, and the cell actin cytoskeleton and cell nuclei were 
counter-stained with 0.1 %M Phalloidin 647 and 12 µg/ml Hoechst 33324 stains 
respectively. A total of four images were captured per well using an automated confocal 
imaging system. It should be noted that for adequate silencing quantification, p65, 
XPO1, INCENP and non-targeting siRNAs were introduced as internal controls. 
Figure 6.22 shows a layout of the screen plate and the positions of the different 
siRNAs used during screening. Briefly, the white circles represent the potential siRNAs 
from the primary screen whose involvement in human cells either enhanced or impaired 
bacteria entry. The colour coded circles represent the control siRNAs; the blue circles 
represent wells containing cells that were neither siRNA treated or infected with the 
GFP-bacteria, the green circles comprise of GFP-bacteria infected cells but no siRNA 
treatment, while the pink, yellow, red and brown colour coded circles represent the 
internal p65, non-targeting, XPO1 and INCENP control siRNAs respectively. 
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Figure 6.22: Secondary screen-plate layout. 
Screen plate depicting the orientation of the different classes of siRNAs used during screen.  White colour 
coded circles represent the siRNAs obtained from the primary screen while pink (p65), yellow (non-
targeting), red (XPO1) and brown (INCENP) circles present the Internal controls which were added to 
account for variations in phenotype resulting during screening. The blue circles represent uninfected and 
no siRNA treated wells while the green circles are siRNA treated but no bacterial infection. 
Images were analyzed by quantitative confocal microscopy and resulting data 
from the screen were computed using a computational based approach. A total of 6 
replicated screens were performed and the number of bacteria in each well was 
expressed as the average bacteria per cell. For data interpretation, data normalization 
was performed by averaging the total number of bacteria in each well from the 6 
replicate screens. The targeted siRNAs were grouped into different clusters depending 
on the variation in the average number of bacteria expressed in each well relative to the 
number of bacteria in the non-targeting siRNA treated wells. Data are shown as mean 
with standard deviation (Figure 6.23). The dotted and the solid black lines represent 1, 2, 
3 and 4 STDEV from the control. 
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Figure 6.23: Statistical quantification of secondary screen data. 
Targeted siRNAs were grouped into different clusters depending on the variation in the average number of 
bacteria expressed in each well relative to the number of bacteria in the non-targeting siRNA treated wells. 
Data are shown as mean with standard deviation. Dotted and the solid black lines represent 1, 2, 3 and 4 
STDV from the non-targeting control. Selected hits were all from the cluster with  > 4 STDV from the 
control, n = 24. 
Figure 6.24 shows an extrapolated image view resulting from the screen after 
HeLa cells was treated with NEK6 siRNA. This result depicted that silencing the NEK6 
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Figure 6.24: NEK6 siRNA induced silencing. 
The siRNA transfected HeLa cells were exposed to GFP-L.monocytogenes for 3 hours. Cells were fixed, 
permeabilized and cell nuclei and actin cytoskeleton counter-stained with 0.1 %M Phalloidin 647 and 12 
µg/ml Hoechst 33324 stains respectively. Imaging was performed at 10X using a confocal imaging system 
with four fields acquired per well. The upper panel represents cells treated with non-targeting siRNA 
control while the lower panel represents cells treated with an on-target (NEK6) siRNA. The intracellular 
GFP-bacteria, cell nuclei and cells actin cytoskeleton are represented as green granules, blue and red 
colours respectively. Scale bar 25 µm. n = 6. 
For absolute certainty, we selected as the strongest hits those siRNAs whose 
resulting effect gave a STDEV greater than 4 (Table 6.2). To examine whether there is a 
significant difference between the average number of bacteria from the selected hits to 
those of the control, a student T-test was performed (Figure 6.25). The results obtained 
depicted that the average number of bacteria present in the wells following treatment of 
the cells with the respective siRNAs, were significantly different (p< 0.0001) from those 
of the control. 
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Figure 6.25: Student T-test analysis of secondary hits. 
The student T-test was performed to determine the statistical difference in average bacteria per cell of the 
15 strongest genes selected relative to the non-targeting control. As shown by the statistical test, the 
average bacteria per cell of the hits were significantly different from those of the non-targeting. p<0.0001. 
n = 24. 
Table 6.2: Strongest hits resulting from the secondary screen 
Gene Names Mean bacteria/cell STDEV N 
UQCRC1 9.28606575 2.55296335130693 48 
GUCY2F 9.325791 2.62954064918008 24 
BAHD1 9.3984545 1.69299501335469 24 
INPP5B 9.6329645 3.01775355487085 24 
LATS2 9.91962 2.83910848443451 24 
CYP4A22 9.927026 3.25691156615411 24 
CNOT7 10.139127 2.42269430614165 24 
TLK1 10.209128 2.70786092824864 24 
ACOT6 10.408104 2.09612650741346 24 
NPR2 10.495962 2.57717763722927 24 
ADAMTS1 10.811063 2.6994244435332 24 
EPHB2 11.052552 2.32057009391403 24 
ECEL1 11.06599 2.93840021939801 24 
ADAM30 11.1301055 2.2458633760299 24 
NEK6 11.8288085 3.45229379157522 24 
Hits were selected from a single cluster (> 4 STDEV from the negative control [non-targeting siRNA]) 





6.4.3 Functional characterization of secondary hits 
6.4.3.1 BAHD1 role in L. monocytogenes infection 
Intracellular bacteria use their effector proteins (virulence factors) to hijack host 
cellular functions to proliferate within the host cell. On the other hand, host cells 
respond to the latter process by activating the appropriate defense transcriptional 
programs (Lebreton, Lakisic et al. 2011). Recently, it has been shown that the bacterial 
virulence factor, LntA targets the host chromatin repressor, the bromo adjacent 
homology domain containing 1 protein (BAHD1) in the nucleus to activate interferon 
stimulated genes. This interaction in turn mediates immune responses to control 
bacterial colonization of the host cell (Cossart 2011; Lebreton, Lakisic et al. 2011; 
Lebreton, Cossart et al. 2012). 
The BAHD1 gene is a host-silencing factor that orchestrates heterochromatin 
assembly at specific genes (Lebreton, Lakisic et al. 2011), which the bacterial pathogen 
uses to its advantage to control host gene expression to propagate its intracellular 




Figure 6.26: BAHD1-LntA mediated responses. 
[A] Interplay between the bacterial virulence factor (LntA) and the host BAHD1 silencing complex 
represses a set of immunity genes induced by type III interferon in cells. [B] BAHD1 acts as a silencer by 
tethering chromatin regulators (HP1, MBD1, KAP1) and chromatin modifying enzymes (HMT and 
HDAC) to sequence-specific transcription factors, enabling local chromatin compaction at specific target 







6.4.3.2 INPP5B potential role in L. monocytogenes host cell colonization 
INPP5B is an inositol 5-phosphatase that preferentially dephosphorylates the 5) 
position of PI(4,5)P2 and PI(3,4,5)P3. This gene is known to be identical to the 
oculocerebrorenal syndrome of lowe gene (OCRL). The two proteins have primarily 
been studied in different contexts but appear to have at least partially overlapping 
functions and similar enzymatic properties (Zhang, Jefferson et al. 1995; Bohdanowicz, 
Balkin et al. 2012). Studies conducted by Kuhbacher et al. demonstrated diminishing the 
activity of OCRL leads to an increase in the internalization levels of L. monocytogenes 
in HeLa cells (Kuhbacher, Dambournet et al. 2012). They showed that OCRL regulates 
bacterial colonization of HeLa cells by modulating signaling cascades downstream of 
the Met receptor, which is a major entry point used by the bacteria. In the same study, 
they demonstrated that through its phosphatase enzymatic activity, OCRL restricts 
L. monocytogenes entry into host cell by modulating actin dynamics at bacterial 
internalization sites. 
INPP5B may also play an important role in the regulation of L. monocytogenes at 
the phagosomal level. Upon internalization the bacteria pathogen are transiently 
entrapped in a tight phagosomal compartment before accessing their replicative niche. 
Work done by Bohdanowicz et al. demonstrated that INPP5B are important contributors 
to the signaling that is pivotal for phagocytosis (Bohdanowicz, Balkin et al. 2012). In the 
study, INPP5B was recruited to the phagosome by the adaptor protein, phosphotyrosine 
interaction, PH domain and leucine zipper containing-2 (APPL1), which is encoded by 
the small GTPase Rab5 protein. Rab5 protein involvement in L. moncytogenes entry into 
host cells has also been demonstrated (Jiwanni, Wang et al. 2012). 
6.4.3.3 LATS2 potential role in L. monocytogenes infection 
Internalization of the bacterium L. monocytogenes into its replicative niche is 
mediated by two specific host proteins; the tyrosine kinase receptor MetA and the E-
cadherin  (E-cad) (Bonazzi, Lecuit et al. 2009). The latter protein is a transmembrane 
molecule that plays an important role in cell adhesion, forming adherens junctions to 
bind cells together within tissues. The bacteria exploit this host cellular process to gain 
access into the cell. It is therefore reasonable to believe that suppression in the 
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expression of E-cad may play a vital role in bacterial colonization of the host cell. 
Recent studies have demonstrated the potential involvement of the tumor repressor gene 
LATS2 in the regulation of E-cad activation (Mazda, Nishi et al. 2011). The increase in 
bacteria host cell colonization observed in this study can be attributed to the E-cad 
inactivation following suppression of LATS2 transcriptional repressor by the LATS2 
siRNA. Figure 6.27 shows the suggested E-cad response following suppression of the 
LATS2 transcriptional repressor gene. 
Figure 6.27: Possible mechanism of E-cadherin by LATS2 siRNA. 
The transcription of E-cadherin is suppressed by LATS2 transcriptional repressor (left). When LATS2 is 
suppressed, the transcriptional repression of E-cadherin is alleviated. Adapted from Mazda et al., 2011 













CONCLUDING REMARKS AND PERSPECTIVES  
Although the bacterial pathogen L. monocytogenes has been used as a model 
organism to understand host-pathogen interactions for the past 15 years, researchers 
have not yet entirely elucidated the actual human host factors hijacked by the pathogen 
during infection. With the introduction of high-content array based screens, scientists are 
beginning to unveil some of the host adaptor proteins involved during infection. Here we 
described a high-density siRNA array platform and its subsequent implementation in 
search of human host factors involved during L. monocytogenes infection.  
High throughput RNAi array-based phenotypic screening is increasingly 
becoming an important platform to screen for genes involved in biological pathways or 
affected during bacterial and viral infection. Researchers are currently using this high-
density array platform to concurrently interrogate large number of genes involved in 
many cellular processes. Despite the impressive nature of the array technology, scientists 
are still faced with some major problems when performing high content screening 
(Echeverri, Beachy et al. 2006). 
A major challenge faced when conducting a high-content RNAi-based screening 
is the off-target effect (Echeverri, Beachy et al. 2006; Sharma and Rao 2009; Mohr, 
Bakal et al. 2010), which if not properly controlled, may significantly contribute to false 
discovery of candidate proteins. The off-target effects experienced in array screening 
can be attributed to; [1] if the siRNA sequence used is complementary or nearly 
identical to a sequence in an unrelated mRNA, [2] if the ‘seed region’ of an siRNA binds 
with a weakly complementary sequence in the 3’ untranslated region of the unrelated 
mRNA in which case, the siRNA can act like a microRNA and cause reduction of non-
target proteins through mRNA degradation and lastly, [3] the use of saturated doses of 
siRNAs during screening may activate the antiviral type 1 interferon response in a 
sequence-independent manner (Echeverri, Beachy et al. 2006). 
A second drawback seen in RNAi screens is the lack of overlap among screen 
hits when independent but related screens are performed. This effect has been 
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demonstrated in studies carried out on mammalian cells infected with the human 
immuno-deficiency virus (König, Zhou et al. 2008; Zhou, Xu et al. 2008; Yeung, Houzet 
et al. 2009). Also, a similar study performed on two different Drosophila cell types, 
assaying for components of the JAK/STAT signaling pathway resulted in only 25% 
overlap in hits identified (Beller, Sztalryd et al. 2008; Guo, Walther et al. 2008). 
Another challenge faced by researchers in the field of high-content screening is 
choosing the appropriate statistical methods to define the initial ‘hit’ list (Niederlein, 
Meyenhofer et al. 2009; Huang 2010). High-content screenings generally generate huge 
datasets that makes data handling very cumbersome and difficult to analyze. Also high 
throughput screeners are faced with the problem of choosing the appropriate arbitrary 
threshold for hit selection. As to the latter, different groups used different arbitrary 
threshold levels depending on the axis of apparent activity (Genovesio, Kwon et al. 
2011).  
To address these drawbacks, we adjusted our screening approach by optimizing 
the assay responses to the internal controls. The control values enabled us to define the 
baseline and signal values for the screen, which we reliably use to predict where the 
relevant targets should belong. The former was achieved by titrating the doses, 
incubation times and other variables used during validation screen assays. Also to 
minimize phenotypic variation in our screening approach we made use of a pool siRNA 
library that has been reported to greatly reduce the of-target effect (Tilesi, Fradiani et al. 
2009). To increase the stringency in our hit selection, we used 13 measuring parameters, 
across fifteen screens yielding 614,250 experiments (including the internal controls). 
Data resulting from the screens were analyzed using a multi-dimensional analytical tool, 
the principal component analysis (PCA). The latter was used to create a correlation 
matrix of all variables by reducing the dimensionality of the dataset consisting of 
interrelated variables, while retaining as much of the variation present in the data as 
possible. This approach enabled us to generate different clusters of candidate genes 
depending on the different phenotypes expressed. 
It was important to validate the screening platform to establish the high-density 
array was suitable for use in screening. To this end, a matrix of measurements was 
 118 
 
applied to determine print quality that were chosen based on the known outputs expected 
from RNAi array experiments, for example that spots should be printed and gene 
silencing be measurable. Criteria including the number of printed spots, dried spot 
intensity, shape and efficiency of RELA/p65 silencing were selected. Here, we 
demonstrated that printed nucleic acid spots size were regular with an average surface 
diameter of 351%m±0.5%m (Figure 4.1), gene silencing was measurable with a > 70 % 
silencing efficiency (Figure 4.3-4.5), and spot-to-spot cross contamination was minimal 
(Figure 4.2). 
We further demonstrated the effectiveness of the array platform by screening for 
cellular components involved in the TNF-# to NF-"B signaling pathway. The NF-"B 
signaling pathway was chosen because it has been extensively characterized and 
documented. Here we used the high-density siRNA array comprising of all the kinases, 
phosphatases, ubiquitinylases and proteases to screen for genes involved in the 
regulation of TNF-# induced NF-"B/RELA nuclear translocation. To achieve this, a 
TNF-# induced NF-"B/RELA nuclear translocation assay was performed and the 
Z-factor (Z’) for the assay calculated. A Z’ >7 (Figure 5.5 D) indicated a suitable 
difference in signal and background values together with low variability making the 
assay suitable for use in screening for potential human host factors implicated in the 
NF-"B/RELA signaling pathway (Zhang, Chung et al. 1999). As documented in other 
studies (Ngo, Davis et al. 2006; Luo, Cheung et al. 2008; Sharma and Rao 2009), 
increasing the number of replicates in a screen helps to minimized false discovery in the 
screen. To achieve the latter standard, we performed a total of 32 replicate screens using 
the assay format described above. For data analysis, 12 criteria were incorporated each 
directed to measure the RELA nucleus to cytoplamic ratio intensity. For hit selection we 
focused only on genes whose silencing resulted in a decrease in nucleus to cytoplasmic 
ratio intensity. Here we identified 51 genes to be implicated in the TNF-# to 
NF-"B/RELA signaling pathway (Figure 5.9). Genes were interrogated for protein-
protein interactions using the pathway studio and 26 of the genes had direct interaction 
with the NF-"B signaling pathway amongst which we identified two genes; CHUK 
(Conserved Helix-Loop-Helix Ubiquitous Kinase) and IKBKB (Inhibitor Of Kappa 
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Light Polypeptide Gene Enhancer In B-Cells, Kinase Beta), which are key regulators to 
the pathway (Figure 5.10). 
Transposing the array format used in the TNF-# to NF-"B (RELA), we screened 
for human host factors involved in L. monocytogenes infection. To achieve this, we first 
conducted experiments to demonstrate that the bacteria were internalized in the cell 
rather than lying on the cell surface. The bacterial pathogen once internalized 
polymerizes the host actin cytoskeleton to generate an actin rocket tail. By staining the 
cell actin cytoskeleton we demonstrated that the bacteria were internalized as we could 
see the bacterial actin rocket tails by visual inspection of the fluorescently labeled 
images of the infected cells. This was further confirmed through a Z-scan series 
performed on the infected cells (Figure 6.3). For internalized bacterial quantification we 
used an off-the-shelf image analysis software from the Ultra image Xpress from 
Molecular Devices (Figure 6.4-6.6). The analysis platform was used to quantify for the 
optimal MOI for infection as well as the optimal infection time required for screening 
(Figure 6.9). Here we performed 15 replicate screens and data from the screens were 
normalized against the existing values of the non-targeting control. For hit identification, 
we employed 13 bacteria quantification parameters. Data were projected into the PCA 
and using a >2 STDV from the mean value of the control, we identified candidate genes 
whose silencing enhanced or hindered bacteria entry as well as those that affected the 
cell actin cytoskeleton. 
To eradicate any errors that may have resulted from the array screening and to 
further confirm the stringency of the hits, we reproduced the screen in 96-well plates 
using a new set of pooled siRNAs corresponding to the primary hits. The screen was 
reproduced six times and extracted data were normalized against the existing values of 
the negative control (non-targeting siRNA). Using a >4 STDV cut-off mark from the 
control, we identified 15 candidate genes whose silencing greatly enhanced bacterial 
entry. Among the candidate genes obtained, we recognized a transcription factor, bromo 
adjacent homology domain containing 1 (BAHD1), whose interaction with the bacterial 
virulence factor LntA has been shown to mediate bacterial colonization of the host cell. 
The inositol polyphosphate-5-phosphatase (INPPB5) gene may achieve the latter by 
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regulating bacterial internalization by modulating actin dynamics at bacterial 
internalization sites as shown with the oculocerebrorenal syndrome of lowe (OCRL) 
gene with which the INPP5B shares an identical sequence and overlapping enzyme 
activities (Bohdanowicz, Balkin et al. 2012; Kuhbacher, Dambournet et al. 2012). We 
also identified the large tumor suppressor kinase 2 (LATS2) that may play a potential 
role in bacterial colonization by modulating the expression of the host E-cad receptor 
(Mazda, Nishi et al. 2011). 
Undoubtedly further validation steps are usually required to confirm primary 
candidate genes originating from the TNF-# to NF-"B (RELA) as well as for 
L. monocytogenes screens. The most commonly used approach to confirm primary 
candidate genes in siRNA pooled screens is to reproduce the results using the individual 
siRNA duplexes from the pooled siRNA. The idea behind this strategy is that if two or 
more different siRNA duplexes yield the same phenotypic expression for a particular 
gene, the chance that this is an off-target effect is considerably reduced and, therefore, 
the hit is confirmed. However, studies have shown that there is an estimated probability 
of  > 95 % gene silencing when using siRNA pooled libraries (Echeverri and Perrimon 
2006; Sharma and Rao 2009; Mohr, Bakal et al. 2010; Yang, Lacson et al. 2012).  
Another approach that could be introduced in further validation of the prime 
candidates is using gene-specific quantitative methods such RT-PCR or microarray 
analysis (Yang, Lacson et al. 2012). These validation approaches will give a perspective 
on which RNAi reagents are over or under-represented in the experimental set(s) 
compared with the control set(s). 
The list of 65 genes established during the screen likely does not exhaustively 
recapitulate all aspects involved in bacteria-host interactions during the pathogen’s 
entire life cycle. It should however be noted that these candidate genes only provide us 
with an inventory list of hits that are or may be taking part in one or more stages of the 
pathogen intracellular life cycle. To obtain important information about a gene function 
as well as the molecular events that underlie a biological process or pathway, further 
studies will be required. This can be addressed through the use of classical genetic 
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screens, which when properly performed will provide hint about the molecular events 
that underpin a particular biological process.  
In conclusion, the list does however generate potential new candidates of cellular 
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Appendix table 1: p65 (NF-!B) nuclear import candidate genes 
Gene Symbol Gene Name GO Molecular Function 
ACVR2 Activin A receptor type 2A Protein kinase activity 
CDC14B Cell division cycle 14B Protein serine/threonine phosphatase activity 
CDC25C Cell division cycle 25C Protein tyrosine phosphatase activity 
CDKN2D Cyclin-dependent kinase inhibitor 2D Cyclin-dependent protein serine/threonine kinase inhibitor activity 
CHUK Conserved helix-loop-lelix ubiquitous kinase Protein kinase activity 
CIT Citron (Rho-interacting, Serine/Threonine Kinase 21) Protein serine/threonine kinase activity 
CKM Creatine Kinase, Muscle Creatine kinase activity 
CTDSP2 Carboxy-terminal domain RNA polymerase II polypeptide a small phosphatase Protein binding 
DUSP11 Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting) RNA binding 
EPHB4 Ephrin type-B receptor 4 Ephrin receptor activity, Transmembrane receptor protein tyrosine kinase activity 
EYA1 Eyes absent homolog 1 (Drosophila) Protein tyrosine phosphatase activity 
FGR Feline gardner-rasheed sarcoma viral oncogene homolog Non-membrane spanning protein tyrosine kinase activity 
GAK Cyclin G associated kinase Protein serine/threonine kinase activity, ATP binding 
GALK1 Galactokinase 1 Galactokinase activity 
GNE Glucosamine (UDP-N-Acetyl)-2-epimerase/N-acetylmannosamine kinase ATP binding 
GUCY2C Guanylate cyclase 2C (heat stable enterotoxin receptor) Protein binding, Guanylate cyclase activity 
HK3 Hexokinase 3 (white cell) Glucokinase activity 
IKBKB Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase Beta Protein kinase activity 
ITPKB Inositol-trisphosphate 3-kinase B Protein binding 
LATS2 Large tumor suppressor kinase 2 Protein binding activity, ATP binding 
MAP2K1 Mitogen-activated protein kinase kinase 1 Protein kinase activity 
MAPK11 Mitogen-activated protein kinase 11 Protein kinase activity, MAP kinase activity 
MPP3 Membrane protein, palmitoylated 3 (mAGUK p55 subfamily member 3) Guanylate kinase activity 
MTMR14 Myotubularin related protein 14 Phosphatidylinositol-3-phosphatase activity 
MYLK Myosin light chain kinase Myosin light chain kinase activity, Actin binding 
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NME6 NME/NM23 nucleoside diphosphate kinase 6 Nucleoside diphosphate kinase activity 
NT5C 5', 3'-Nucleotidase, cytosolic Nucleotidase activity 
NT5C1A 5'-Nucleotidase, cytosolic IA Nucleotide binding, 5'-nucleotidase activity 
PFKFB1 6-Phosphofructo-2-kinase/Fructose-2,6-biphosphatase 1 6-phosphofructo-2-kinase activity 
PGAM2 Phosphoglycerate mutase 2 (muscle) Phosphoglycerate mutase activity 
PIK3R4 Phosphoinositide-3-kinase, regulatory subunit 4 Protein kinase activity 
PPM1K Protein phosphatase, Mg2+/Mn2+ dependent, 1K Catalytic activity 
PPM1L Protein phosphatase, Mg2+/Mn2+ dependent, 1L Catalytic activity 
PPM1M Protein phosphatase, Mg2+/Mn2+ dependent, 1M Catalytic activity 
PPM2C Pyruvate dehyrogenase phosphatase catalytic subunit 1 Catalytic activity 
PPP1R8 Protein phosphatase 1, regulatory subunit 8 Protein serine/threonine phosphatase inhibitor activity 
PPP2R1A Protein phosphatase 2, regulatory subunit A, alpha Antigen binding, Protein phosphatase type 2A regulator activity 
PPP2R2A Protein phosphatase 2, regulatory subunit B, alpha Protein serine/threonine phosphatase activity 
PPP2R4 Protein phosphatase 2A activator, regulatory subunit 4 Receptor binding, Protein tyrosine phosphatase activator activity 
PPP2R5A Protein phosphatase 2, regulatory subunit B', alpha Protein binding 
PPP4C Protein phosphatase 4, catalytic subunit NF-kappaB-inducing kinase activity 
PRKAR1B Protein kinase, CAMP-dependent, regulatory, type I, Beta cAMP-dependent protein kinase regulator activity 
PRKCH Protein kinase C, Eta Protein kinase activity 
PTEN Phosphatase and tensin homolog Phosphatidylinositol-3-phosphatase activity 
PTPDC1 Protein tyrosine phosphatase domain containing 1 Protein tyrosine phosphatase activity 
PTPRJ Protein tyrosine phosphatase, receptor type, J Protein tyrosine phosphatase activity 
RAGE MAPK/MAK/MRK overlapping kinase Protein serine/threonine kinase activity 
RELA V-Rel avian reticuloendotheliosis viral oncogene homolog A DNA binding, Chromatin binding 
RIOK3 RIO kinase 3 Catalytic activity 
STK23 SRSF Protein Kinase 3 Protein kinase activity 
ZAP70 Zeta-Chain (TCR) associated protein kinase 70kDa Phosphotyrosine binding, Protein binding 
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Appendix table 2: Statistical quantification of candidate genes (< 2STDV): Cellular functions, biological processes and molecular functions  
Gene Name Cellular function/component(s) Biological process /GO ID Molecular function/GO ID 
PPP6C Catalytic subunit of protein phosphatase 6 (PP6). PP6 is a component of a signaling 
pathway regulating cell cycle progression in response to IL2 receptor stimulation. 
cytosol (GO:0005829) 




Phosphoprotein phosphatase activity (GO:0004721) 
Protein serine/threonine phosphatase activity (GO:0004722) 
Protein binding (GO:0005515) 
Metal ion binding (GO:0046872) 
EPHA4 Receptor tyrosine kinase, which binds membrane-bound ephrin family ligands residing on 
adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. 
Cytoplasm (GO:0005737) 
Mitochondrial outer membrane (GO:0005741) 
Endoplasmic reticulum (GO:0005783) 
Golgi apparatus (GO:0005794) 
Integral to plasma membrane (GO:0005887) 
Cell adhesion (GO:0007155) 
Axon guidance (GO:0007411) 
Adult walking behaviour 
(GO:0007628) 
Motor neuron axon guidance 
(GO:0008045) 
glial cell migration (GO:0008347) 
Protein kinase activity (GO:0004672) 
GPI-linked ephrin receptor activity (GO:0005004) 
transmembrane-ephrin receptor activity (GO:0005005) 
Protein binding (GO:0005515) 
ATP binding (GO:0005524) 
 
PAK7 Serine/threonine protein kinase that plays a role in a variety of different signaling 
pathways including 
Cytoskeleton regulation, cell migration, proliferation or cell survival. 
Nucleus              (GO:0005634) 
Mitochondrion   (GO:0005739) 
Apoptotic process (GO:0006915) 
Cytoskeleton organization 
(GO:0007010) 
Signal transduction (GO:0007165) 
Cell proliferation (GO:0008283) 
Cell growth (GO:0016049) 
Protein serine/threonine kinase activity (GO:0004674) 






This gene product is a member of a large family of CDC2-related serine/threonine protein 






Signal transduction (GO:0007165) 
Sex differentiation (GO:0007548) 
Protein kinase activity (GO:0004672) 
cyclin-dependent protein kinase activity (GO:0004693) 
ATP binding (GO:0005524) 
MARCH6 This gene encodes a member of a family of membrane-associated E3 ubiquitin ligases 
containing RING-CH-type zinc finger motifs. E3 ubiquitin-protein ligase that promotes 
ubiquitination of DIO2, leading to its degradation. 
Integral to endoplasmic reticulum membrane (GO:0030176) 
Protein ubiquitination (GO:0016567) 
Protein K48-linked ubiquitination 
(GO:0070936) 
Ubiquitin-protein ligase activity (GO:0004842 
Zinc ion binding (GO:0008270) 
Enzyme binding (GO:0019899) 
ubiquitin conjugating enzyme binding (GO:0031624) 
PTPN9 
 
Protein-tyrosine phosphatase that could participate in the transfer of hydrophobic ligands 
or in functions of the Golgi apparatus. 
Protein dephosphorylation 
(GO:0006470) 
Protein tyrosine phosphatase activity (GO:0004725) 
Non-membrane spanning protein tyrosine phosphatase activity 
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cytoplasmic part (GO:0044444) peptidyl-tyrosine dephosphorylation 
(GO:0035335) 
(GO:0004726) 
Protein binding (GO:0005515) 
CDK17 May play a role in terminally differentiated neurons. Has a Ser/Thr-phosphorylating 
activity for histone H1 (By similarity). 
Protein phosphorylation 
(GO:0006468) 
Protein kinase activity (GO:0004672) 
Protein serine/threonine kinase activity (GO:0004674) 
Cyclin-dependent protein kinase activity (GO:0004693) 
ATP binding (GO:0005524 
NLN Hydrolyzes oligopeptides such as neurotensin, bradykinin and dynorphin A (By 
similarity). 
Mitochondrion (GO:0005739) 
Mitochondrial intermembrane space (GO:0005758) 
Proteolysis (GO:0006508) metalloendopeptidase activity (GO:0004222) 
Metal ion binding (GO:0046872) 
MAPKAP
K5 
Tumor suppressor serine/threonine-protein kinase involved in mTORC1 signalling and 
post-transcriptional regulation. 
Nucleus (GO:0005634) 
NOT nucleolus (GO:0005730) 
Cytoplasm (GO:0005737) 
MAPK cascade (GO:0000165) 
Activation of MAPK activity 
(GO:0000187) 




Response to stress (GO:0006950) 
p53 binding (GO:0002039) 
Protein kinase activity (GO:0004672) 
Protein serine/threonine kinase activity (GO:0004674) 
MAP kinase kinase activity (GO:0004708) 
Protein binding (GO:0005515) 
PON1 Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. 
Extracellular region (GO:0005576) 
Extracellular space (GO:0005615) 
Microsome (GO:0005792) 
High-density lipoprotein particle (GO:0034364) 
Spherical high-density lipoprotein particle (GO:0034366) 
Lipid metabolic process 
(GO:0006629) 
Cholesterol metabolic process 
(GO:0008203) 
Response to external stimulus 
(GO:0009605) 
Response to toxin (GO:0009636) 
Positive regulation of cholesterol 
efflux (GO:0010875) 
Aryldialkylphosphatase activity (GO:0004063) 
Arylesterase activity (GO:0004064) 
Calcium ion binding (GO:0005509) 
Phospholipid binding (GO:0005543) 
Protein homodimerization activity (GO:0042803) 
MAPK6 Atypical MAPK protein. Phosphorylates microtubule-associated protein 2 (MAP2) and 
MAPKAPK5. 
Nucleus (GO:0005634) 
MAPK cascade (GO:0000165) 
Protein phosphorylation 
(GO:0006468) 
Protein serine/threonine kinase activity  (GO:0004674) 
MAP kinase activity (GO:0004707) 
Protein binding (GO:0005515) 
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Cytoplasm (GO:0005737) Cell cycle (GO:0007049) 
Signal transduction (GO:0007165) 
 
ATP binding (GO:0005524) 
Protein kinase binding (GO:0019901) 
PPP1R12A Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part 
of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting 
HIF1AN-dependent suppression of HIF1A activity. 
Kinetochore (GO:0000776) 
Centrosome (GO:0005813) 
Contractile fiber (GO:0043292) 




Signal transduction (GO:0007165) 
Regulation of cell adhesion 
(GO:0030155) 
Regulation of myosin-light-chain-
Phosphatase activity (GO:0035507) 
Phosphoprotein phosphatase activity (GO:0004721) 
Enzyme inhibitor activity (GO:0004857) 
Signal transducer activity (GO:0004871) 
Protein binding (GO:0005515) 
Phosphatase regulator activity (GO:0019208 
PPP2R2D B regulatory subunit of protein phosphatase 2A (PP2A) that plays a key role in cell cycle 
by controlling mitosis entry and exit. 





Signal transduction (GO:0007165) 
Exit from mitosis (GO:0010458) 
Cell division (GO:0051301) 
Phosphatidate phosphatase activity (GO:0008195) 
Phosphatidate phosphatase activity (GO:0008195) 
ERBB4 Tyrosine-protein kinase that plays an essential role as cell surface receptor for 
neuregulins and EGF family members and regulates development of the heart, the central 
nervous system and the mammary gland, gene transcription, cell proliferation, 
differentiation, migration and apoptosis. 
Extracellular region (GO:0005576) 
Nucleus (GO:0005634) 
Nucleoplasm (GO:0005654) 
NOT nucleolus (GO:0005730) 
Cytoplasm (GO:0005737) 
Neural crest cell migration 
(GO:0001755) 




Apoptotic process (GO:0006915) 
Signal transduction (GO:0007165) 
Protein tyrosine kinase activity (GO:0004713) 
Transmembrane receptor protein tyrosine kinase activity 
(GO:0004714) 
Receptor signaling protein tyrosine kinase activity (GO:0004716) 
Epidermal growth factor receptor binding (GO:0005154) 






Appendix Ttable 3: Statistical quantification of candidate genes (> 2STDV); Cellular functions, biological processes and molecular functions  
 Cellular function Biological process /GO ID Molecular function/GO ID 
NEK4 Seems to act exclusively upon threonine residues (By similarity). 
Nucleus (GO:0005634) 
NOT nucleolus (GO:0005730) 
Protein phosphorylation 
(GO:0006468)  
Mitosis (GO:0007067)    
Cell division  (GO:0051301)    
Protein serine/threonine kinase activity (GO:0004674) 
ATP binding (GO:0005524)  
Metal ion binding (GO:0046872) 
CAMKK2 Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered 
signaling cascade involved in a number of cellular processes. 
Intracellular (GO:0005622)   
Cytoplasm (GO:0005737)     
 





Regulation of protein kinase activity 
(GO:0045859)   
Positive regulation of transcription, 
DNA-dependent (GO:0045893)  
Protein autophosphorylation 
(GO:0046777)  
Protein serine/threonine kinase activity (GO:0004674)  
Calmodulin dependent protein kinase activity (GO:0004683)  
Protein tyrosine kinase activity (GO:0004713)  
Calcium ion binding (GO:0005509)  
Calmodulin binding GO:0005516)   
 
CELF4 RNA-binding protein implicated in the regulation of pre-mRNA alternative splicing. 
Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific 
and developmentally regulated alternative splicing. 
Nucleus (GO:0005634)   
NOT nucleolus  (GO:0005730)   
Cytoplasm (GO:0005737)   
 
Alternative mRNA splicing, via 
spliceosome (GO:0000380)     
Regulation of alternative mRNA 
splicing, via spliceosome 
(GO:0000381)      
mRNA splice site selection 
(GO:0006376)      
Germ cell development (GO:0007281)      
Embryo development (GO:0009790)       
Positive regulation of mRNA splicing, 
via spliceosome (GO:0048026)       
Negative regulation of excitatory 
postsynaptic membrane potential 
Nucleotide binding (GO:0000166)     
Translation repressor activity, nucleic acid binding (GO:0000900)     
mRNA binding (GO:0003729)     
BRE binding (GO:0042835 
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(GO:0090394)       
EPHB1 Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family 
ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into 
neighboring cells. 
Cytoplasm (GO:0005737)     
Integral to plasma membrane (GO:0005887)      
Membrane (GO:0016020)      
Integral to membrane (GO:0016021)      
Axon (GO:0030424)      
 
 
Cell-substrate adhesion (GO:0031589)        
Regulation of JNK cascade 
(GO:0046328)        
Protein autophosphorylation 
(GO:0046777)         
Ephrin receptor signaling pathway 
(GO:0048013)        
Cell chemotaxis (GO:0060326)        
Regulation of ERK1 and ERK2 
cascade (GO:0070372)       
Angiogenesis (GO:0001525)      
Protein tyrosine kinase activity (GO:0004713)        
Ephrin receptor activity (GO:0005003)        
Transmembrane-ephrin receptor activity (GO:0005005)        
Protein binding (GO:0005515)        
ATP binding (GO:0005524)        
 
RFFL Has E3 ubiquitin protein ligase activity. Regulates the levels of CASP8 and CASP10 by 
targeting them for proteasomal degradation. 
Cytoplasm (GO:0005737)    
Membrane (GO:0016020)     
Cytoplasmic membrane-bounded vesicle (GO:0016023)    
 
Intracellular protein transport 
(GO:0006886)        
Apoptotic process (GO:0006886)        
Protein ubiquitination (GO:0016567)       
 
Zinc ion binding (GO:0008270)    
Ligase activity (GO:0016874)      
 
CDK12 Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA 
splicing. 
Cyclin K-CDK12 complex (GO:0002944)    
Nucleus (GO:0005634)            
Nucleolus (GO:0005730)       
Nuclear speck (GO:0016607)     
Nuclear cyclin-dependent protein kinase holoenzyme complex (GO:0019908)    
 
mRNA processing (GO:0006397)   
RNA splicing  (GO:0008380)     
Regulation of MAP kinase activity 
(GO:0043405)       
Protein autophosphorylation  
(GO:0046777)      
Phosphorylation of RNA polymerase 
II C-terminal domain (GO:0070816)     
Protein kinase activity  (GO:0004672)    
Cyclin-dependent protein kinase activity (GO:0004693)     
Protein binding  (GO:0005515)     
ATP binding (GO:0005524))    
RNA polymerase II carboxy-terminal domain kinase activity 
(GO:0008353)        
 
PTP4A1 Protein tyrosine phosphatase which stimulates progression from G1 into S phase during 
mitosis. 
Nucleus (GO:0005634)    
Cell cycle (GO:0007049)    
Multicellular organismal development 
(GO:0007275)     
Protein tyrosine phosphatase activity (GO:0004725)    
Phosphatase activity (GO:0016791) 
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Cytoplasm  (GO:0005737)    
Early endosome (GO:0005769)    
Endoplasmic reticulum (GO:0005783)    
Spindle (GO:0005819)    
 
Positive regulation of cell migration 
(GO:0030335)      
Peptidyl-tyrosine dephosphorylation 
(GO:0035335)       
PRKCZ Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in 
phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) 
kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell 
proliferation, cell polarity, inflammatory response and maintenance of long-term 
potentiation (LTP). 
Intracellular (GO:0005622)    
Membrane fraction (GO:0005624)    
Soluble fraction (GO:0005625)    
Nucleus (GO:0005634)    
Nuclear envelope (GO:0005635)   
 
Microtubule cytoskeleton organization 
(GO:0000226)    
Positive regulation of cell-matrix 
adhesion (GO:0001954)     
Protein phosphorylation 
(GO:0006468)  
Inflammatory response (GO:0006954)    
Signal transduction (GO:0007165)  
Protein kinase activity (GO:0004672)    
Protein serine/threonine Kinase activity (GO:0004674)   
Protein kinase C activity (GO:0004697)    
Protein binding (GO:0005515)   
ATP binding (GO:0005524)    
Insulin receptor substrate binding (GO:0043560)   
KCNK13 Potassium channel displaying weak inward rectification in symmetrical K(+) solution (By 
similarity). 
Plasma membrane (GO:0005886)   
Integral to membrane (GO:0016021)   
 
Synaptic transmission (GO:0007268)    
Potassium ion transmembrane 
transport (GO:0071805)   
Voltage-gated ion channel activity (GO:0005244)   
Potassium channel activity (GO:0005267)   





Signal transduction GO:0007165) 
Protein kinase activity (GO:0004672)  
Protein serine/threonine kinase activity (GO:0004674)  
Cyclin-dependent protein Kinase activity (GO:0004693)    
ATP binding (GO:0005524) 
ZNRF2 May play a role in the establishment and maintenance of neuronal transmission and 
plasticity via its ubiquitin ligase activity. 
Lysosomal membrane (GO:0005765)   
Plasma membrane (GO:0005886)   
Protein ubiquitination (GO:0016567) Zinc ion binding (GO:0008270)  
Ligase activity (GO:0016874) 
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Endosome membrane (GO:0010008)   
Cell junction (GO:0030054)   
Presynaptic membrane (GO:0042734)  
TSSK6 Required for sperm production and function. Plays a role in DNA condensation during 




Multicellular organismal development 
(GO:0007275) 
Sperm chromatin condensation 
GO:0035092)   
Magnesium ion binding (GO:0000287)  
Protein serine/threonine kinase activity (GO:0004674)  
Protein binding (GO:0005515)   
ATP binding (GO:0005524) 
RNF24 May play a role in TRPCs intracellular trafficking. 
Golgi membrane (GO:0000139) 
Integral to membrane (GO:0016021) 
 Zinc ion binding (GO:0008270) 
STK4 Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the 






Cell morphogenesis GO:0000902 
Patterning of blood vessels 
GO:0001569 
Neural tube formation GO:0001841 
Endocardium development 
GO:0003157 
Protein phosphorylation GO:0006468 
Magnesium ion binding GO:0000287 
Protein serine/threonine kinase activit GO:0004674 
Protein binding GO:0005515 
ATP binding GO:0005524 
Transcription factor binding GO:0008134 
SH3RF2 Inhibits PPP1CA phosphatase activity. May be a E3 ubiquitin-protein ligase (Potential). 
May play a role in cardiac function. 
 
negative regulation of phosphatase 
activity (GO:0010923)   
protein ubiquitination (GO:0016567)   
Protein phosphatase inhibitor activity (GO:0004864)   
Protein binding (GO:0005515)   
Protein phosphatase 1 binding GO:0008157)  
Zinc ion binding (GO:0008270)    
Ligase activity (GO:0016874)   
Phosphatase binding (GO:0019902)  
C2 Component C2 which is part of the classical pathway of the complement system is cleaved 
by activated factor C1 into two fragments: C2b and C2a. C2a, a serine protease, then 
combines with complement factor 4b to generate the C3 or C5 convertase. 
Extracellular region GO:0005576 
Extracellular space GO:0005615 
Proteolysis GO:0006508 
Complement activation GO:0006956 
Complement activation, classical 
pathway GO:0006958 
Regulation of complement activation 




Innate immune response GO:0045087 





Intracellular membrane-bounded organelle GO:0043231 
 
Pyrimidine nucleobase metabolic 
process GO:0006206 
Feeding behavior GO:0007631 
Nucleotide biosynthetic process 
GO:0009165 
Pyrimidine nucleoside salvage 
GO:0043097 
UMP salvage GO:0044206 
Uridine kinase activity GO:0004849 
Protein binding GO:0005515 
ATP binding GO:0005524 
Kinase activity GO:0016301 
Phosphotransferase activity, alcohol group as acceptor 
GO:0016773 
Nucleoside kinase activity GO:0019206 
 
VRK1 Serine/threonine kinase involved in Golgi disassembly during the cell cycle: following 
phosphorylation by PLK3 during mitosis, required to induce Golgi fragmentation. 
Nucleus GO:0005634 
NOT nucleolus GO:0005730 
Cytoplasm GO:0005737 
Golgi stack GO:0005795 
Spindle GO:0005819 




Cell division GO:0051301 
Golgi disassembly GO:0090166 
Protein serine/threonine kinase activity GO:0004674 
Protein binding GO:0005515 
ATP binding GO:0005524 
Identical protein binding GO:0042802 
 
Appendix table 4: Statistical quantification of candidate genes (> 3STDV): Cellular functions, biological processes and molecular functions  
Gene 
Name 
Cellular function Biological process /GO ID Molecular function/GO ID 
ST6GALN
AC4 
Involved in the biosynthesis of ganglioside GD1A from GM1B. Transfers CMP-NeuAc 
with an alpha-2,6-linkage to GalNAc residue on NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc 
of glycoproteins and glycolipids. 
Golgi membrane GO:0000139 
Soluble fraction GO:0005625 
Nucleus GO:0005634 
Golgi apparatus GO:0005794 
Integral to Golgi membrane GO:0030173 
protein glycosylation GO:0006486 
glycolipid metabolic process 
GO:0006664 
O-glycan processing GO:0016266 
Post-translational protein modification 
GO:0043687 
Cellular protein metabolic process 
GO:0044267 
sialyltransferase activity GO:0008373 
(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-
galactosaminide 6-alpha-sialyltransferase activity GO:0047290 
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 ARIH2 E3 ubiquitin-protein ligase mediating 'Lys-48'-and 'Lys-63'-linked polyubiquitination and 
subsequent 






ubiquitin-dependent protein catabolic 
process GO:0006511 
Multicellular organismal development 
GO:0007275 
Protein ubiquitination involved in 
ubiquitin-dependent protein catabolic 
process GO:0042787 
Developmental cell growth 
GO:0048588 
Nucleic acid binding GO:0003676 
Ubiquitin-protein ligase activity GO:0004842 
Protein binding GO:0005515 
Zinc ion binding GO:0008270 
ZACN Zinc-activated ligand-gated ion channel. 
Membrane fraction GO:0005624 
Plasma membrane GO:0005886 
Integral to membrane GO:0016021 
Postsynaptic membrane GO:0045211 
Response to zinc ion GO:0010043 Receptor activity GO:0004872 
Extracellular ligand-gated ion channel activity GO:0005230 
Zinc ion binding GO:0008270 
AIFM3 Induces apoptosis through a caspase dependent pathway. Reduces mitochondrial 
membrane potential. 
NOT nucleus GO:0005634 
Cytoplasm GO:0005737 
Mitochondrion GO:0005739 
Mitochondrial inner membrane GO:0005743 
Endoplasmic reticulum GO:0005783 
 
Induction of apoptosis GO:0006917 
Activation of cysteine-type 
endopeptidase activity involved in 
apoptotic process by cytochrome c 
GO:0008635 
Electron transport chain GO:0022900 
Cell redox homeostasis GO:0045454 
Mitochondrial depolarization 
GO:0051882 
Cysteine-type endopeptidase activator activity involved in 
apoptotic process GO:0008656 
Oxidoreductase activity GO:0016491 
Metal ion binding GO:0046872 
Flavin adenine dinucleotide binding GO:0050660 
2 iron, 2 sulfur cluster binding GO:0051537 
PKIB Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this 
protein interacts with the catalytic subunit of the enzyme after the cAMP-induced 
dissociation of its regulatory chains (By similarity) 
 cAMP-dependent protein kinase inhibitor activity GO:0004862 
SRPK3 Serine/arginine-rich protein-specific kinase which specifically phosphorylates its 
substrates at serine residues located in regions rich in arginine/serine dipeptides, known as 
protein phosphorylation GO:0006468 
skeletal muscle tissue development 
protein serine/threonine kinase activity GO:0004674 







cell differentiation GO:0030154 
muscle tissue development  
GO:0060537 
KLK7 May catalyze the degradation of intercellular cohesive structures in the cornified layer of 
the skin in the continuous shedding of cells from the skin surface. Specific for amino acid 
residues with aromatic side chains in the P1 position. 
Extracellular region GO:0005576 
Epidermal lamellar body GO:0097209 
Proteolysis GO:0006508 
epidermis development GO:0008544 
serine-type endopeptidase activity GO:0004252 
serine-type peptidase activity GO:0008236 
ZAP70 Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. 
Regulates motility, adhesion and cytokine expression of mature T-cells, as well as 
thymocyte development. 




plasma membrane GO:0005886 
adaptive immune response 
GO:0002250 
protein phosphorylation GO:0006468 
immune response GO:0006955 




phosphotyrosine binding GO:0001784 
protein kinase activity GO:0004672 
protein tyrosine kinase activity GO:0004713 
non-membrane spanning protein tyrosine kinase activity 
GO:0004715 
protein binding GO:0005515 
RNF122 May induce necrosis and apoptosis. May play a role in cell viability. 
endoplasmic reticulum GO:0005783 
Golgi apparatus GO:0005794 
integral to membrane GO:0016021 
 zinc ion binding GO:0008270 





malate metabolic processGO:0006108 
NADP biosynthetic 
processGO:0006741 
response to hormone 
stimulusGO:0009725 
response to carbohydrate 
stimulusGO:0009743 
malic enzyme activity GO:0004470 
malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) 
activity GO:0004473 
electron carrier activity GO:0009055 
malate dehydrogenase (oxaloacetate-decarboxylating) activity 
GO:0016619 
manganese ion binding GO:0030145 
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MAPK9 Serine/threonine-protein kinase involved in various processes such as cell proliferation, 




cytosolic part GO:0044445 
release of cytochrome c from 
mitochondria GO:0001836 
positive regulation of protein 
phosphorylation GO:0001934 
toll-like receptor signaling pathway 
GO:0002224 
MyD88-dependent toll-like receptor 
signaling pathway GO:0002755 
MyD88-independent toll-like receptor 
signaling pathway GO:0002756 
stress-activated MAPK cascade 
GO:0051403 
protein kinase activity GO:0004672 
JUN kinase activity GO:0004705 
MAP kinase activity GO:0004707 
protein binding GO:0005515 
ATP binding GO:0005524 
KPNA6 Functions in nuclear protein import as an adapter protein for nuclear receptor KPNB1. 




protein import into nucleus 
GO:0006606 
NLS-bearing substrate import into 
nucleus GO:0006607 
protein binding GO:0005515 
protein transporter activity GO:0008565 
HIPK1 Serine/threonine-protein kinase involved in transcription regulation and TNF-mediated 
cellular apoptosis. Plays a role as a corepressor for homeodomain transcription factors. 
Nucleus GO:0005634 
Cytoplasm GO:0005737 
PML body GO:0016605 
Nuclear speck GO:0016607 
 
Eye development GO:0001654 
Transcription, DNA-dependent 
GO:0006351 
Regulation of transcription, DNA-
dependent GO:0006355 
Apoptotic process GO:0006915 
Smoothened signaling 
pathwayGO:0007224 
DNA binding GO:0003677 
Protein serine/threonine kinase activity GO:0004674 
Protein binding GO:0005515 
ATP binding GO:0005524 
AZU1 This is a neutrophil granule-derived antibacterial and monocyte- and fibroblast-specific 
chemotactic glycoprotein. Binds heparin. 
 Extracellular region GO:0005576 
Azurophil granule GO:0042582 
 
Microglial cell activation 
GO:0001774 
Proteolysis GO:0006508 
Inflammatory response GO:0006954 
Protein kinase C-activating G-protein 
 Serine-type endopeptidase activity GO:0004252 
Heparin binding GO:0008201 





coupled receptor signaling pathway 
GO:0007205 
Glial cell migration GO:0008347 
RFPL3   Zinc ion binding GO:0008270 
DUSP1 Dual specificity phosphatase that dephosphorylates MAP kinase MAPK1/ERK2 on both 
'Thr-183' and 'Tyr-185', regulating its activity during the meiotic cell cycle (By similarity). 





Inactivation of MAPK activity 
GO:0000188 
Endoderm formation GO:0001706 
Protein dephosphorylation 
GO:0006470 
Response to oxidative stress 
GO:0006979 
Cell cycle GO:0007049 
Non-membrane spanning protein tyrosine phosphatase activity  
GO:0004726 
 Protein binding GO:0005515   
Protein tyrosine/threonine phosphatase activity GO:0008330 
MAP kinase tyrosine/serine/threonine phosphatase activity 
GO:0017017 
 
WDSUB1 Ubiquitin ligase complex GO:0000151  Ubiquitin-protein ligase activity GO:0004842 
ADCY3 Mediates odorant detection (possibly) via modulation of intracellular cAMP concentration 
Intracellular GO:0005622 
Membrane fraction GO:0005624 
Nucleus GO:0005634 
Cytoplasm GO:0005737 
Plasma membrane GO:0005886 
 
Energy reserve metabolic process 
GO:0006112 
cAMP biosynthetic process 
GO:0006171 
Water transport GO:0006833 
Female meiosis GO:0007143 
Signal transduction GO:0007165 
Nucleotide binding GO:0000166 
Adenylate cyclase activity GO:0004016 
Protein binding GO:0005515 
Calmodulin binding GO:0005516 











Appendix table 4: Statistical quantification of candidate genes (> 4STDV): Cellular functions, biological processes and molecular functions  
Gene 
Name 
Cellular function Biological process /GO ID Molecular function/GO ID 
UQCRC1 This is a component of the ubiquinol-cytochrome c reductase complex (complex III or 
cytochrome b-c1 complex), which is part of th mitochondrial respiratory chain. This 
protein may mediate formation of the complex between cytochromes c and c1. 
Mitochondrion GO:0005739 
Mitochondrial inner membrane GO:0005743 
Mitochondrial respiratory chain GO:0005746 




Mitochondrial electron transport, 
ubiquinol to cytochrome c 
GO:0006122 
Proteolysis GO:0006508 
Aerobic respiration GO:0009060 
Response to activity GO:0014823 
Respiratory electron transport chain 
GO:0022904 
Response to alkaloid GO:0043279 




Metalloendopeptidase activity GO:0004222 
Protein binding GO:0005515 
Ubiquinol-cytochrome-c reductase activity GO:0008121 
Zinc ion binding GO:0008270 
Protein complex binding GO:0032403 
Metal ion binding GO:0046872 
 
GUCY2F Probably plays a specific functional role in the rods and/or cones of photoreceptors. It may 
be the enzyme involved in the resynthesis of cGMP required for recovery of the dark state 
after phototransduction. 
Membrane fraction GO:0005624 
Nuclear outer membrane GO:0005640 
Integral to plasma membrane GO:0005887 
 
cGMP biosynthetic process 
GO:0006182 
Receptor guanylyl cyclase signaling 
pathway GO:0007168 
Visual perception GO:0007601 
Intracellular signal transduction 
GO:0035556 
 
Guanylate cyclase activity GO:0004383   
Protein kinase activity GO:0004672 
Receptor activity GO:0004872 
Protein binding GO:0005515 
ATP binding GO:0005524 
GTP binding GO:0005525 
Protein homodimerization activity GO:0042803 
Protein heterodimerization activityGO:0046982 
BAHD1 Heterochromatin protein that acts as a transcription repressor and has the ability to 
promote the formation of large heterochromatic domains. 




DNA binding GO:0003677 
Chromatin binding GO:0003682 






Negative regulation of transcription, 
DNA-dependentGO:0045892 
 
INPP5B Hydrolyzes phosphatidylinositol 4,5-bisphosphate (PtIns(4,5)P2) and the signaling 
molecule phosphatidylinositol 1,4,5-trisphosphate (PtIns(1,4,5)P3), and thereby modulates 
cellular signaling events. 
 
Cytoplasm GO:0005737 
Endoplasmic reticulum-Golgi intermediate compartment GO:0005793 
Golgi apparatus GO:0005794 
Cytosol GO:0005829 
Microtubule cytoskeleton GO:0015630 
 
In utero embryonic development 
GO:0001701 
Small GTPase mediated signal 
transduction GO:0007264 
Spermatogenesis GO:0007283 




 Phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity 
GO:0004439 
Protein binding GO:0005515 
Metal ion binding GO:0046872 
Inositol-1, 4, 5-trisphosphate 5-phosphatase activity GO:0052658 
 
LATS2 Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in 
organ size control and tumor suppression by restricting proliferation and promoting 
apoptosis. The core of this pathway is composed of a 
kinase cascade wherein STK3/MST2 and STK4/MST1, 
Spindle pole GO:0000922 
Nucleus GO:0005634 
Microtubule organizing center GO:0005815 
Cytosol GO:0005829 
G1/S transition of mitotic cell cycle 
GO:0000082 
Protein phosphorylation GO:0006468 
Mitosis GO:0007067 
Intracellular protein kinase cascade 
GO:0007243 
Hormone-mediated signaling pathway 
GO:0009755 
Protein serine/threonine kinase activity GO:0004674 
Protein binding GO:0005515 
ATP binding GO:0005524 
Metal ion binding GO:0046872 
 
CYP4A22 Catalyzes the omega- and (omega-1)-hydroxylation of various fatty acids such as laurate 
and palmitate. Shows no activity towards arachidonic acid and prostaglandin A1. 
Endoplasmic reticulum membrane GO:0005789 
Microsome GO:0005792 
 
 Monooxygenase activity GO:0004497 
Iron ion binding GO:0005506 
Electron carrier activity GO:0009055 
Oxidoreductase activity, acting on paired donors, with 
incorporation or reduction of molecular oxygen GO:0016705 
Alkane 1-monooxygenase activity GO:0018685 
CNOT7 Ubiquitous transcription factor required for a diverse set of processes. It is a component of 
the CCR4 complex involved in the control of gene expression (By similarity). 
Cytoplasmic mRNA processing body GO:0000932 
Nuclear-transcribed mRNA catabolic 
process, deadenylation-dependent 
decay GO:0000288 
Nucleic acid binding GO:0003676 






CCR4-NOT complex GO:0030014 
 
 
Nuclear-transcribed mRNA poly(A) 








Poly (A)-specific ribonuclease activity GO:0004535 
Signal transducer activity GO:0004871 
Protein binding GO:0005515 
 
TLK1 Rapidly and transiently inhibited by phosphorylation following the generation of DNA 
double-stranded breaks during S-phase. This is cell cycle checkpoint and ATM-pathway 




Regulation of chromatin assembly or 
disassembly GO:0001672 
Protein phosphorylation GO:0006468 
Intracellular protein transport 
GO:0006886 
Response to DNA damage stimulus 
GO:0006974 
Cell cycle GO:0007049 
Protein serine/threonine kinase activity GO:0004674 
ATP binding GO:0005524 
kinase activity GO:0016301 
 
ACOT6 Cytosol GO:0005829  carboxylesterase activity GO:0004091 
NPR2 Receptor for the C-type natriuretic peptide NPPC/CNP hormone. Has guanylate cyclase 
activity upon binding of its ligand. May play a role in the regulation of skeletal growth. 
Intracellular GO:0005622 
Membrane fraction GO:0005624 
Plasma membrane GO:0005886 




cGMP biosynthetic process 
GO:0006182 
Signal transduction GO:0007165 
Cell surface receptor signaling 
pathway GO:0007166 
Receptor guanylyl cyclase signaling 
pathway GO:0007168 
Guanylate cyclase activity GO:0004383 
Protein kinase activity GO:0004672 
Receptor activity GO:0004872 
Transmembrane signaling receptor activity GO:0004888 
ATP binding GO:0005524 
 
ADAMTS1 Cleaves aggrecan, a cartilage proteoglycan, and may be involved in its turnover (By 
similarity). Has angiogenic inhibitor activity. Active metalloprotease, which may be 
associated with various inflammatory processes as well as development of cancer 
Ovulation from ovarian follicle 
GO:0001542 
Kidney development GO:0001822 
Metalloendopeptidase activity GO:0004222 
Protein binding GO:0005515 
Heparin binding GO:0008201 
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cachexia. May play a critical role in follicular rupture. 
Basement membrane GO:0005604 
Extracellular matrix GO:0031012 
Cytoplasmic vesicle GO:0031410 
 
Proteolysis GO:0006508 
Integrin-mediated signaling pathway 
GO:0007229 
Negative regulation of cell 
proliferation GO:0008285 
Metallopeptidase activity GO:0008237 
Zinc ion binding GO:0008270 
 
EPHB2 Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family 
ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into 
neighboring cells. 
 
Integral to plasma membrane GO:0005887 
Integral to membrane GO:0016021 
Axon GO:0030424 
Dendrite GO:0030425 
Neuronal cell body GO:0043025 
Cell morphogenesis GO:0000902 
Angiogenesis GO:0001525 
Urogenital system development 
GO:0001655 
Protein phosphorylation GO:0006468 
Transmembrane receptor protein 
tyrosine kinase signaling pathway 
GO:0007169 
 
Protein tyrosine kinase activity GO:0004713 
Receptor activity GO:0004872 
Ephrin receptor activity GO:0005003 
Transmembrane-ephrin receptor activity GO:0005005 
Receptor binding GO:0005102 
 
ECEL1 May contribute to the degradation of peptide hormones and be involved in the inactivation 
of neuronal Peptides. 
Intracellular GO:0005622 
Integral to plasma membrane GO:0005887 
 
Proteolysis GO:0006508 
Neuropeptide signaling pathway 
GO:0007218 
Intracellular signal transduction 
GO:0035556 
Metalloendopeptidase activity GO:0004222 
Metallopeptidase activity GO:0008237 
Metal ion binding GO:0046872 
 
ADAM30 May be involved in spermatogenesis and fertilization. 
 
Integral to membrane GO:0016021 
Proteolysis GO:0006508 Metalloendopeptidase activity GO:0004222 
Metallopeptidase activity GO:0008237 
Zinc ion binding GO:0008270 
NEK6 Protein kinase, which plays an important role in mitotic cell cycle progression. Required 
for chromosome segregation at metaphase-anaphase transition, robust mitotic spindle 
formation and cytokinesis. 
Spindle pole GO:0000922 
Nucleus GO:0005634 
Cytoplasm GO:0005737 
Microtubule organizing center GO:0005815 
Cytokinesis GO:0000910 
Protein phosphorylation GO:0006468 




Magnesium ion binding GO:0000287 
Protein kinase activity GO:0004672 
Protein serine/threonine kinase activity GO:0004674 
Signal transducer activity GO:0004871 




Microtubule GO:0005874  
 
